enr_pathway,one_lower_level,top_level,enr_description,one_lower_level_description,top_level_description
R-HSA-164843,R-HSA-5663205,R-HSA-1643685,2-LTR circle formation,Infectious disease,Disease
R-HSA-73843,R-HSA-71387,R-HSA-1430728,5-Phosphoribose 1-diphosphate biosynthesis,Metabolism of carbohydrates,Metabolism
R-HSA-1971475,R-HSA-71387,R-HSA-1430728,A tetrasaccharide linker sequence is required for GAG synthesis,Metabolism of carbohydrates,Metabolism
R-HSA-1971475,R-HSA-71387,R-HSA-1430728,A tetrasaccharide linker sequence is required for GAG synthesis,Metabolism of carbohydrates,Metabolism
R-HSA-5619084,R-HSA-5619115,R-HSA-1643685,ABC transporter disorders,Disorders of transmembrane transporters,Disease
R-HSA-1369062,R-HSA-382556,R-HSA-382551,ABC transporters in lipid homeostasis,ABC-family proteins mediated transport,Transport of small molecules
R-HSA-382556,R-HSA-382556,R-HSA-382551,ABC-family proteins mediated transport,ABC-family proteins mediated transport,Transport of small molecules
R-HSA-9033807,R-HSA-71387,R-HSA-1430728,ABO blood group biosynthesis,Metabolism of carbohydrates,Metabolism
R-HSA-9660821,R-HSA-5663205,R-HSA-1643685,ADORA2B mediated anti-inflammatory cytokines production,Infectious disease,Disease
R-HSA-418592,R-HSA-76002,R-HSA-109582,ADP signalling through P2Y purinoceptor 1,"Platelet activation, signaling and aggregation",Hemostasis
R-HSA-392170,R-HSA-76002,R-HSA-109582,ADP signalling through P2Y purinoceptor 12,"Platelet activation, signaling and aggregation",Hemostasis
R-HSA-198323,R-HSA-9006925,R-HSA-162582,AKT phosphorylates targets in the cytosol,Intracellular signaling by second messengers,Signal Transduction
R-HSA-198693,R-HSA-9006925,R-HSA-162582,AKT phosphorylates targets in the nucleus,Intracellular signaling by second messengers,Signal Transduction
R-HSA-211163,R-HSA-186712,R-HSA-1266738,AKT-mediated inactivation of FOXO1A,Regulation of beta-cell development,Developmental Biology
R-HSA-9700645,R-HSA-5663202,R-HSA-1643685,ALK mutants bind TKIs,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-112122,R-HSA-73942,R-HSA-73894,ALKBH2 mediated reversal of alkylation damage,DNA Damage Reversal,DNA Repair
R-HSA-112126,R-HSA-73942,R-HSA-73894,ALKBH3 mediated reversal of alkylation damage,DNA Damage Reversal,DNA Repair
R-HSA-163680,R-HSA-163685,R-HSA-1430728,AMPK inhibits chREBP transcriptional activation activity,Integration of energy metabolism,Metabolism
R-HSA-5467333,R-HSA-5663202,R-HSA-1643685,APC truncation mutants are not K63 polyubiquitinated,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-5467337,R-HSA-5663202,R-HSA-1643685,APC truncation mutants have impaired AXIN binding,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-179409,R-HSA-69278,R-HSA-1640170,APC-Cdc20 mediated degradation of Nek2A,"Cell Cycle, Mitotic",Cell Cycle
R-HSA-174143,R-HSA-69278,R-HSA-1640170,APC/C-mediated degradation of cell cycle proteins,"Cell Cycle, Mitotic",Cell Cycle
R-HSA-174048,R-HSA-69278,R-HSA-1640170,APC/C:Cdc20 mediated degradation of Cyclin B,"Cell Cycle, Mitotic",Cell Cycle
R-HSA-174154,R-HSA-69278,R-HSA-1640170,APC/C:Cdc20 mediated degradation of Securin,"Cell Cycle, Mitotic",Cell Cycle
R-HSA-176409,R-HSA-69278,R-HSA-1640170,APC/C:Cdc20 mediated degradation of mitotic proteins,"Cell Cycle, Mitotic",Cell Cycle
R-HSA-174178,R-HSA-69278,R-HSA-1640170,APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1,"Cell Cycle, Mitotic",Cell Cycle
R-HSA-179419,R-HSA-69278,R-HSA-1640170,APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint,"Cell Cycle, Mitotic",Cell Cycle
R-HSA-5649702,R-HSA-73884,R-HSA-73894,APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway,Base Excision Repair,DNA Repair
R-HSA-180689,R-HSA-5663205,R-HSA-1643685,APOBEC3G mediated resistance to HIV-1 infection,Infectious disease,Disease
R-HSA-5624958,R-HSA-5617833,R-HSA-1852241,ARL13B-mediated ciliary trafficking of INPP5E,Cilium Assembly,Organelle biogenesis and maintenance
R-HSA-170984,R-HSA-9006934,R-HSA-162582,ARMS-mediated activation,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-9717264,R-HSA-5663202,R-HSA-1643685,ASP-3026- resistant ALK mutants,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-380994,R-HSA-2262752,R-HSA-8953897,ATF4 activates genes in response to endoplasmic reticulum  stress,Cellular responses to stress,Cellular responses to stimuli
R-HSA-381183,R-HSA-2262752,R-HSA-8953897,ATF6 (ATF6-alpha) activates chaperone genes,Cellular responses to stress,Cellular responses to stimuli
R-HSA-381033,R-HSA-2262752,R-HSA-8953897,ATF6 (ATF6-alpha) activates chaperones,Cellular responses to stress,Cellular responses to stimuli
R-HSA-1296025,R-HSA-1296071,R-HSA-112316,ATP sensitive Potassium channels,Potassium Channels,Neuronal System
R-HSA-450408,R-HSA-450531,R-HSA-8953854,AUF1 (hnRNP D0) binds and destabilizes mRNA,Regulation of mRNA stability by proteins that bind AU-rich elements,Metabolism of RNA
R-HSA-8854518,R-HSA-69278,R-HSA-1640170,AURKA Activation by TPX2,"Cell Cycle, Mitotic",Cell Cycle
R-HSA-5467340,R-HSA-5663202,R-HSA-1643685,AXIN missense mutants destabilize the destruction complex,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-2161541,R-HSA-2161522,R-HSA-1430728,Abacavir metabolism,Abacavir transport and metabolism,Metabolism
R-HSA-2161517,R-HSA-2161522,R-HSA-1430728,Abacavir transmembrane transport,Abacavir transport and metabolism,Metabolism
R-HSA-2161522,R-HSA-2161522,R-HSA-1430728,Abacavir transport and metabolism,Abacavir transport and metabolism,Metabolism
R-HSA-73930,R-HSA-73884,R-HSA-73894,Abasic sugar-phosphate removal via the single-nucleotide replacement pathway,Base Excision Repair,DNA Repair
R-HSA-9659787,R-HSA-9675126,R-HSA-1643685,Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects,Diseases of mitotic cell cycle,Disease
R-HSA-9687139,R-HSA-9675126,R-HSA-1643685,Aberrant regulation of mitotic cell cycle due to RB1 defects,Diseases of mitotic cell cycle,Disease
R-HSA-9687136,R-HSA-9675126,R-HSA-1643685,Aberrant regulation of mitotic exit in cancer due to RB1 defects,Diseases of mitotic cell cycle,Disease
R-HSA-2978092,R-HSA-5668914,R-HSA-1643685,Abnormal conversion of 2-oxoglutarate to 2-hydroxyglutarate,Diseases of metabolism,Disease
R-HSA-167242,R-HSA-5663205,R-HSA-1643685,Abortive elongation of HIV-1 transcript in the absence of Tat,Infectious disease,Disease
R-HSA-156582,R-HSA-211859,R-HSA-1430728,Acetylation,Biological oxidations,Metabolism
R-HSA-264642,R-HSA-112315,R-HSA-112316,Acetylcholine Neurotransmitter Release Cycle,Transmission across Chemical Synapses,Neuronal System
R-HSA-181431,R-HSA-112315,R-HSA-112316,Acetylcholine binding and downstream events,Transmission across Chemical Synapses,Neuronal System
R-HSA-9667769,R-HSA-9659379,R-HSA-9709957,Acetylcholine inhibits contraction of outer hair cells,Sensory processing of sound,Sensory Perception
R-HSA-399997,R-HSA-163685,R-HSA-1430728,Acetylcholine regulates insulin secretion,Integration of energy metabolism,Metabolism
R-HSA-1300645,R-HSA-1187000,R-HSA-1474165,Acrosome Reaction and Sperm:Oocyte Membrane Binding,Fertilization,Reproduction
R-HSA-2122948,R-HSA-157118,R-HSA-162582,Activated NOTCH1 Transmits Signal to the Nucleus,Signaling by NOTCH,Signal Transduction
R-HSA-9032845,R-HSA-9006934,R-HSA-162582,Activated NTRK2 signals through CDK5,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-9028731,R-HSA-9006934,R-HSA-162582,Activated NTRK2 signals through FRS2 and FRS3,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-9032500,R-HSA-9006934,R-HSA-162582,Activated NTRK2 signals through FYN,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-9028335,R-HSA-9006934,R-HSA-162582,Activated NTRK2 signals through PI3K,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-9026527,R-HSA-9006934,R-HSA-162582,Activated NTRK2 signals through PLCG1,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-9026519,R-HSA-9006934,R-HSA-162582,Activated NTRK2 signals through RAS,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-9603381,R-HSA-9006934,R-HSA-162582,Activated NTRK3 signals through PI3K,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-9034793,R-HSA-9006934,R-HSA-162582,Activated NTRK3 signals through PLCG1,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-9034864,R-HSA-9006934,R-HSA-162582,Activated NTRK3 signals through RAS,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-5625886,R-HSA-9716542,R-HSA-162582,Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3,"Signaling by Rho GTPases, Miro GTPases and RHOBTB3",Signal Transduction
R-HSA-2033519,R-HSA-5663202,R-HSA-1643685,Activated point mutants of FGFR2,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-111452,R-HSA-109581,R-HSA-5357801,Activation and oligomerization of BAK protein,Apoptosis,Programmed Cell Death
R-HSA-165158,R-HSA-9006934,R-HSA-162582,Activation of AKT2,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-165158,R-HSA-9006934,R-HSA-162582,Activation of AKT2,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-399710,R-HSA-112315,R-HSA-112316,Activation of AMPA receptors,Transmission across Chemical Synapses,Neuronal System
R-HSA-9619483,R-HSA-112315,R-HSA-112316,Activation of AMPK downstream of NMDARs,Transmission across Chemical Synapses,Neuronal System
R-HSA-176814,R-HSA-69278,R-HSA-1640170,Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins,"Cell Cycle, Mitotic",Cell Cycle
R-HSA-176187,R-HSA-69620,R-HSA-1640170,Activation of ATR in response to replication stress,Cell Cycle Checkpoints,Cell Cycle
R-HSA-111447,R-HSA-109581,R-HSA-5357801,Activation of BAD and translocation to mitochondria,Apoptosis,Programmed Cell Death
R-HSA-114452,R-HSA-109581,R-HSA-5357801,Activation of BH3-only proteins,Apoptosis,Programmed Cell Death
R-HSA-111446,R-HSA-109581,R-HSA-5357801,Activation of BIM and translocation to mitochondria,Apoptosis,Programmed Cell Death
R-HSA-139910,R-HSA-109581,R-HSA-5357801,Activation of BMF and translocation to mitochondria,Apoptosis,Programmed Cell Death
R-HSA-174577,R-HSA-168249,R-HSA-168256,Activation of C3 and C5,Innate Immune System,Immune System
R-HSA-451308,R-HSA-112315,R-HSA-112316,Activation of Ca-permeable Kainate Receptor,Transmission across Chemical Synapses,Neuronal System
R-HSA-1296041,R-HSA-1296071,R-HSA-112316,Activation of G protein gated Potassium channels,Potassium Channels,Neuronal System
R-HSA-991365,R-HSA-112315,R-HSA-112316,Activation of GABAB receptors,Transmission across Chemical Synapses,Neuronal System
R-HSA-5619507,R-HSA-5619507,R-HSA-1266738,Activation of HOX genes during differentiation,Activation of HOX genes during differentiation,Developmental Biology
R-HSA-936964,R-HSA-168249,R-HSA-168256,Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon,Innate Immune System,Immune System
R-HSA-1592389,R-HSA-1474228,R-HSA-1474244,Activation of Matrix Metalloproteinases,Degradation of the extracellular matrix,Extracellular matrix organization
R-HSA-1169091,R-HSA-1280218,R-HSA-168256,Activation of NF-kappaB in B cells,Adaptive Immune System,Immune System
R-HSA-2980767,R-HSA-69278,R-HSA-1640170,"Activation of NIMA Kinases NEK9, NEK6, NEK7","Cell Cycle, Mitotic",Cell Cycle
R-HSA-442755,R-HSA-112315,R-HSA-112316,Activation of NMDA receptors and postsynaptic events,Transmission across Chemical Synapses,Neuronal System
R-HSA-111448,R-HSA-109581,R-HSA-5357801,Activation of NOXA and translocation to mitochondria,Apoptosis,Programmed Cell Death
R-HSA-451307,R-HSA-112315,R-HSA-112316,Activation of Na-permeable kainate receptors,Transmission across Chemical Synapses,Neuronal System
R-HSA-2151209,R-HSA-1592230,R-HSA-1852241,Activation of PPARGC1A (PGC-1alpha) by phosphorylation,Mitochondrial biogenesis,Organelle biogenesis and maintenance
R-HSA-139915,R-HSA-109581,R-HSA-5357801,Activation of PUMA and translocation to mitochondria,Apoptosis,Programmed Cell Death
R-HSA-428540,R-HSA-9675108,R-HSA-1266738,Activation of RAC1,Nervous system development,Developmental Biology
R-HSA-9619229,R-HSA-112315,R-HSA-112316,Activation of RAC1 downstream of NMDARs,Transmission across Chemical Synapses,Neuronal System
R-HSA-1169092,R-HSA-1280218,R-HSA-168256,Activation of RAS in B cells,Adaptive Immune System,Immune System
R-HSA-5635838,R-HSA-5358351,R-HSA-162582,Activation of SMO,Signaling by Hedgehog,Signal Transduction
R-HSA-187015,R-HSA-9006934,R-HSA-162582,Activation of TRKA receptors,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-5617472,R-HSA-5619507,R-HSA-1266738,Activation of anterior HOX genes in hindbrain development during early embryogenesis,Activation of HOX genes during differentiation,Developmental Biology
R-HSA-111459,R-HSA-109581,R-HSA-5357801,Activation of caspases through apoptosome-mediated cleavage,Apoptosis,Programmed Cell Death
R-HSA-2426168,R-HSA-556833,R-HSA-1430728,Activation of gene expression by SREBF (SREBP),Metabolism of lipids,Metabolism
R-HSA-451326,R-HSA-112315,R-HSA-112316,Activation of kainate receptors upon glutamate binding,Transmission across Chemical Synapses,Neuronal System
R-HSA-450341,R-HSA-168249,R-HSA-168256,Activation of the AP-1 family of transcription factors,Innate Immune System,Immune System
R-HSA-450341,R-HSA-168249,R-HSA-168256,Activation of the AP-1 family of transcription factors,Innate Immune System,Immune System
R-HSA-450341,R-HSA-168249,R-HSA-168256,Activation of the AP-1 family of transcription factors,Innate Immune System,Immune System
R-HSA-450341,R-HSA-168249,R-HSA-168256,Activation of the AP-1 family of transcription factors,Innate Immune System,Immune System
R-HSA-450341,R-HSA-1280215,R-HSA-168256,Activation of the AP-1 family of transcription factors,Cytokine Signaling in Immune system,Immune System
R-HSA-450341,R-HSA-168249,R-HSA-168256,Activation of the AP-1 family of transcription factors,Innate Immune System,Immune System
R-HSA-450341,R-HSA-168249,R-HSA-168256,Activation of the AP-1 family of transcription factors,Innate Immune System,Immune System
R-HSA-450341,R-HSA-168249,R-HSA-168256,Activation of the AP-1 family of transcription factors,Innate Immune System,Immune System
R-HSA-450341,R-HSA-168249,R-HSA-168256,Activation of the AP-1 family of transcription factors,Innate Immune System,Immune System
R-HSA-450341,R-HSA-168249,R-HSA-168256,Activation of the AP-1 family of transcription factors,Innate Immune System,Immune System
R-HSA-8866907,R-HSA-73857,R-HSA-74160,Activation of the TFAP2 (AP-2) family of transcription factors,RNA Polymerase II Transcription,Gene expression (Transcription)
R-HSA-72662,R-HSA-72766,R-HSA-392499,"Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S",Translation,Metabolism of proteins
R-HSA-2485179,R-HSA-2187338,R-HSA-9709957,Activation of the phototransduction cascade,Visual phototransduction,Sensory Perception
R-HSA-68962,R-HSA-69002,R-HSA-69306,Activation of the pre-replicative complex,DNA Replication Pre-Initiation,DNA Replication
R-HSA-68962,R-HSA-69278,R-HSA-1640170,Activation of the pre-replicative complex,"Cell Cycle, Mitotic",Cell Cycle
R-HSA-75108,R-HSA-109581,R-HSA-5357801,"Activation, myristolyation of BID and translocation to mitochondria",Apoptosis,Programmed Cell Death
R-HSA-114294,R-HSA-109581,R-HSA-5357801,"Activation, translocation and oligomerization of BAX",Apoptosis,Programmed Cell Death
R-HSA-1482798,R-HSA-556833,R-HSA-1430728,Acyl chain remodeling of CL,Metabolism of lipids,Metabolism
R-HSA-1482883,R-HSA-556833,R-HSA-1430728,Acyl chain remodeling of DAG and TAG,Metabolism of lipids,Metabolism
R-HSA-1482788,R-HSA-556833,R-HSA-1430728,Acyl chain remodelling of PC,Metabolism of lipids,Metabolism
R-HSA-1482839,R-HSA-556833,R-HSA-1430728,Acyl chain remodelling of PE,Metabolism of lipids,Metabolism
R-HSA-1482925,R-HSA-556833,R-HSA-1430728,Acyl chain remodelling of PG,Metabolism of lipids,Metabolism
R-HSA-1482922,R-HSA-556833,R-HSA-1430728,Acyl chain remodelling of PI,Metabolism of lipids,Metabolism
R-HSA-1482801,R-HSA-556833,R-HSA-1430728,Acyl chain remodelling of PS,Metabolism of lipids,Metabolism
R-HSA-1280218,R-HSA-1280218,R-HSA-168256,Adaptive Immune System,Adaptive Immune System,Immune System
R-HSA-417973,R-HSA-372790,R-HSA-162582,Adenosine P1 receptors,Signaling by GPCR,Signal Transduction
R-HSA-170660,R-HSA-372790,R-HSA-162582,Adenylate cyclase activating pathway,Signaling by GPCR,Signal Transduction
R-HSA-170670,R-HSA-372790,R-HSA-162582,Adenylate cyclase inhibitory pathway,Signaling by GPCR,Signal Transduction
R-HSA-170670,R-HSA-112315,R-HSA-112316,Adenylate cyclase inhibitory pathway,Transmission across Chemical Synapses,Neuronal System
R-HSA-418990,R-HSA-446728,R-HSA-1500931,Adherens junctions interactions,Cell junction organization,Cell-Cell communication
R-HSA-392023,R-HSA-76002,R-HSA-109582,Adrenaline signalling through Alpha-2 adrenergic receptor,"Platelet activation, signaling and aggregation",Hemostasis
R-HSA-400042,R-HSA-163685,R-HSA-1430728,"Adrenaline,noradrenaline inhibits insulin secretion",Integration of energy metabolism,Metabolism
R-HSA-390696,R-HSA-372790,R-HSA-162582,Adrenoceptors,Signaling by GPCR,Signal Transduction
R-HSA-879415,R-HSA-168249,R-HSA-168256,Advanced glycosylation endproduct receptor signaling,Innate Immune System,Immune System
R-HSA-5423646,R-HSA-211859,R-HSA-1430728,Aflatoxin activation and detoxification,Biological oxidations,Metabolism
R-HSA-9646399,R-HSA-1632852,R-HSA-9612973,Aggrephagy,Macroautophagy,Autophagy
R-HSA-351143,R-HSA-71291,R-HSA-1430728,Agmatine biosynthesis,Metabolism of amino acids and derivatives,Metabolism
R-HSA-8964540,R-HSA-71291,R-HSA-1430728,Alanine metabolism,Metabolism of amino acids and derivatives,Metabolism
R-HSA-1462054,R-HSA-168249,R-HSA-168256,Alpha-defensins,Innate Immune System,Immune System
R-HSA-389599,R-HSA-556833,R-HSA-1430728,Alpha-oxidation of phytanate,Metabolism of lipids,Metabolism
R-HSA-9645460,R-HSA-168249,R-HSA-168256,Alpha-protein kinase 1 signaling pathway,Innate Immune System,Immune System
R-HSA-9006821,R-HSA-9675126,R-HSA-1643685,Alternative Lengthening of Telomeres (ALT),Diseases of mitotic cell cycle,Disease
R-HSA-173736,R-HSA-168249,R-HSA-168256,Alternative complement activation,Innate Immune System,Immune System
R-HSA-140179,R-HSA-211859,R-HSA-1430728,Amine Oxidase reactions,Biological oxidations,Metabolism
R-HSA-375280,R-HSA-372790,R-HSA-162582,Amine ligand-binding receptors,Signaling by GPCR,Signal Transduction
R-HSA-156587,R-HSA-211859,R-HSA-1430728,Amino Acid conjugation,Biological oxidations,Metabolism
R-HSA-352230,R-HSA-425407,R-HSA-382551,Amino acid transport across the plasma membrane,SLC-mediated transmembrane transport,Transport of small molecules
R-HSA-9639288,R-HSA-2262752,R-HSA-8953897,Amino acids regulate mTORC1,Cellular responses to stress,Cellular responses to stimuli
R-HSA-141444,R-HSA-69620,R-HSA-1640170,Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal,Cell Cycle Checkpoints,Cell Cycle
R-HSA-141424,R-HSA-69620,R-HSA-1640170,Amplification of signal from the kinetochores,Cell Cycle Checkpoints,Cell Cycle
R-HSA-977225,R-HSA-977225,R-HSA-392499,Amyloid fiber formation,Amyloid fiber formation,Metabolism of proteins
R-HSA-2214320,R-HSA-1474290,R-HSA-1474244,Anchoring fibril formation,Collagen formation,Extracellular matrix organization
R-HSA-5620912,R-HSA-5617833,R-HSA-1852241,Anchoring of the basal body to the plasma membrane,Cilium Assembly,Organelle biogenesis and maintenance
R-HSA-193048,R-HSA-556833,R-HSA-1430728,Androgen biosynthesis,Metabolism of lipids,Metabolism
R-HSA-2473224,R-HSA-9006936,R-HSA-162582,Antagonism of Activin by Follistatin,Signaling by TGFB family members,Signal Transduction
R-HSA-9662851,R-HSA-5663205,R-HSA-1643685,Anti-inflammatory response favouring Leishmania parasite infection,Infectious disease,Disease
R-HSA-983170,R-HSA-1280218,R-HSA-168256,"Antigen Presentation: Folding, assembly and peptide loading of class I MHC",Adaptive Immune System,Immune System
R-HSA-983695,R-HSA-1280218,R-HSA-168256,Antigen activates B Cell Receptor (BCR) leading to generation of second messengers,Adaptive Immune System,Immune System
R-HSA-1236975,R-HSA-1280218,R-HSA-168256,Antigen processing-Cross presentation,Adaptive Immune System,Immune System
R-HSA-983168,R-HSA-1280218,R-HSA-168256,Antigen processing: Ubiquitination & Proteasome degradation,Adaptive Immune System,Immune System
R-HSA-9639775,R-HSA-5663205,R-HSA-1643685,Antimicrobial action and antimicrobial resistance in Mtb,Infectious disease,Disease
R-HSA-6803157,R-HSA-168249,R-HSA-168256,Antimicrobial peptides,Innate Immune System,Immune System
R-HSA-1169410,R-HSA-1280215,R-HSA-168256,Antiviral mechanism by IFN-stimulated genes,Cytokine Signaling in Immune system,Immune System
R-HSA-109581,R-HSA-109581,R-HSA-5357801,Apoptosis,Apoptosis,Programmed Cell Death
R-HSA-140342,R-HSA-109581,R-HSA-5357801,Apoptosis induced DNA fragmentation,Apoptosis,Programmed Cell Death
R-HSA-351906,R-HSA-109581,R-HSA-5357801,Apoptotic cleavage of cell adhesion  proteins,Apoptosis,Programmed Cell Death
R-HSA-111465,R-HSA-109581,R-HSA-5357801,Apoptotic cleavage of cellular proteins,Apoptosis,Programmed Cell Death
R-HSA-75153,R-HSA-109581,R-HSA-5357801,Apoptotic execution phase,Apoptosis,Programmed Cell Death
R-HSA-111471,R-HSA-109581,R-HSA-5357801,Apoptotic factor-mediated response,Apoptosis,Programmed Cell Death
R-HSA-445717,R-HSA-445717,R-HSA-382551,Aquaporin-mediated transport,Aquaporin-mediated transport,Transport of small molecules
R-HSA-426048,R-HSA-372790,R-HSA-162582,Arachidonate production from DAG,Signaling by GPCR,Signal Transduction
R-HSA-426048,R-HSA-76002,R-HSA-109582,Arachidonate production from DAG,"Platelet activation, signaling and aggregation",Hemostasis
R-HSA-2142753,R-HSA-556833,R-HSA-1430728,Arachidonic acid metabolism,Metabolism of lipids,Metabolism
R-HSA-211957,R-HSA-211859,R-HSA-1430728,Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2,Biological oxidations,Metabolism
R-HSA-8937144,R-HSA-211859,R-HSA-1430728,Aryl hydrocarbon receptor signalling,Biological oxidations,Metabolism
R-HSA-446203,R-HSA-597592,R-HSA-392499,Asparagine N-linked glycosylation,Post-translational protein modification,Metabolism of proteins
R-HSA-8963693,R-HSA-71291,R-HSA-1430728,Aspartate and asparagine metabolism,Metabolism of amino acids and derivatives,Metabolism
R-HSA-175474,R-HSA-5663205,R-HSA-1643685,Assembly Of The HIV Virion,Infectious disease,Disease
R-HSA-9609736,R-HSA-112315,R-HSA-112316,Assembly and cell surface presentation of NMDA receptors,Transmission across Chemical Synapses,Neuronal System
R-HSA-168316,R-HSA-5663205,R-HSA-1643685,Assembly of Viral Components at the Budding Site,Infectious disease,Disease
R-HSA-8963889,R-HSA-174824,R-HSA-382551,Assembly of active LPL and LIPC lipase complexes,"Plasma lipoprotein assembly, remodeling, and clearance",Transport of small molecules
R-HSA-2022090,R-HSA-1474290,R-HSA-1474244,Assembly of collagen fibrils and other multimeric structures,Collagen formation,Extracellular matrix organization
R-HSA-68616,R-HSA-69002,R-HSA-69306,Assembly of the ORC complex at the origin of replication,DNA Replication Pre-Initiation,DNA Replication
R-HSA-9683439,R-HSA-5663205,R-HSA-1643685,Assembly of the SARS-CoV-1 Replication-Transcription Complex (RTC),Infectious disease,Disease
R-HSA-9694271,R-HSA-5663205,R-HSA-1643685,Assembly of the SARS-CoV-2 Replication-Transcription Complex (RTC),Infectious disease,Disease
R-HSA-68867,R-HSA-69002,R-HSA-69306,Assembly of the pre-replicative complex,DNA Replication Pre-Initiation,DNA Replication
R-HSA-390471,R-HSA-391251,R-HSA-392499,Association of TriC/CCT with target proteins during biosynthesis,Protein folding,Metabolism of proteins
R-HSA-210455,R-HSA-112315,R-HSA-112316,Astrocytic Glutamate-Glutamine Uptake And Metabolism,Transmission across Chemical Synapses,Neuronal System
R-HSA-4608870,R-HSA-195721,R-HSA-162582,Asymmetric localization of PCP proteins,Signaling by WNT,Signal Transduction
R-HSA-9678110,R-HSA-5663205,R-HSA-1643685,Attachment and Entry,Infectious disease,Disease
R-HSA-9694614,R-HSA-5663205,R-HSA-1643685,Attachment and Entry,Infectious disease,Disease
R-HSA-162791,R-HSA-597592,R-HSA-392499,Attachment of GPI anchor to uPAR,Post-translational protein modification,Metabolism of proteins
R-HSA-3371568,R-HSA-2262752,R-HSA-8953897,Attenuation phase,Cellular responses to stress,Cellular responses to stimuli
R-HSA-174084,R-HSA-69278,R-HSA-1640170,Autodegradation of Cdh1 by Cdh1:APC/C,"Cell Cycle, Mitotic",Cell Cycle
R-HSA-349425,R-HSA-69620,R-HSA-1640170,Autodegradation of the E3 ubiquitin ligase COP1,Cell Cycle Checkpoints,Cell Cycle
R-HSA-177539,R-HSA-5663205,R-HSA-1643685,Autointegration results in viral DNA circles,Infectious disease,Disease
R-HSA-9612973,R-HSA-9612973,R-HSA-9612973,Autophagy,Autophagy,Autophagy
R-HSA-422475,R-HSA-9675108,R-HSA-1266738,Axon guidance,Nervous system development,Developmental Biology
R-HSA-193634,R-HSA-73887,R-HSA-162582,Axonal growth inhibition (RHOA activation),Death Receptor Signalling,Signal Transduction
R-HSA-209563,R-HSA-73887,R-HSA-162582,Axonal growth stimulation,Death Receptor Signalling,Signal Transduction
R-HSA-5250924,R-HSA-212165,R-HSA-74160,B-WICH complex positively regulates rRNA expression,Epigenetic regulation of gene expression,Gene expression (Transcription)
R-HSA-5620922,R-HSA-5617833,R-HSA-1852241,BBSome-mediated cargo-targeting to cilium,Cilium Assembly,Organelle biogenesis and maintenance
R-HSA-9024909,R-HSA-9006934,R-HSA-162582,BDNF activates NTRK2 (TRKB) signaling,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-111453,R-HSA-109581,R-HSA-5357801,BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members,Apoptosis,Programmed Cell Death
R-HSA-1368108,R-HSA-1368108,R-HSA-400253,"BMAL1:CLOCK,NPAS2 activates circadian gene expression","BMAL1:CLOCK,NPAS2 activates circadian gene expression",Circadian Clock
R-HSA-73884,R-HSA-73884,R-HSA-73894,Base Excision Repair,Base Excision Repair,DNA Repair
R-HSA-73929,R-HSA-73884,R-HSA-73894,"Base-Excision Repair, AP Site Formation",Base Excision Repair,DNA Repair
R-HSA-210991,R-HSA-202733,R-HSA-109582,Basigin interactions,Cell surface interactions at the vascular wall,Hemostasis
R-HSA-1461957,R-HSA-168249,R-HSA-168256,Beta defensins,Innate Immune System,Immune System
R-HSA-77352,R-HSA-556833,R-HSA-1430728,Beta oxidation of butanoyl-CoA to acetyl-CoA,Metabolism of lipids,Metabolism
R-HSA-77346,R-HSA-556833,R-HSA-1430728,Beta oxidation of decanoyl-CoA to octanoyl-CoA-CoA,Metabolism of lipids,Metabolism
R-HSA-77350,R-HSA-556833,R-HSA-1430728,Beta oxidation of hexanoyl-CoA to butanoyl-CoA,Metabolism of lipids,Metabolism
R-HSA-77310,R-HSA-556833,R-HSA-1430728,Beta oxidation of lauroyl-CoA to decanoyl-CoA-CoA,Metabolism of lipids,Metabolism
R-HSA-77285,R-HSA-556833,R-HSA-1430728,Beta oxidation of myristoyl-CoA to lauroyl-CoA,Metabolism of lipids,Metabolism
R-HSA-77348,R-HSA-556833,R-HSA-1430728,Beta oxidation of octanoyl-CoA to hexanoyl-CoA,Metabolism of lipids,Metabolism
R-HSA-77305,R-HSA-556833,R-HSA-1430728,Beta oxidation of palmitoyl-CoA to myristoyl-CoA,Metabolism of lipids,Metabolism
R-HSA-3858494,R-HSA-195721,R-HSA-162582,Beta-catenin independent WNT signaling,Signaling by WNT,Signal Transduction
R-HSA-196299,R-HSA-195721,R-HSA-162582,Beta-catenin phosphorylation cascade,Signaling by WNT,Signal Transduction
R-HSA-389887,R-HSA-556833,R-HSA-1430728,Beta-oxidation of pristanoyl-CoA,Metabolism of lipids,Metabolism
R-HSA-390247,R-HSA-556833,R-HSA-1430728,Beta-oxidation of very long chain fatty acids,Metabolism of lipids,Metabolism
R-HSA-425381,R-HSA-425407,R-HSA-382551,Bicarbonate transporters,SLC-mediated transmembrane transport,Transport of small molecules
R-HSA-194068,R-HSA-556833,R-HSA-1430728,Bile acid and bile salt metabolism,Metabolism of lipids,Metabolism
R-HSA-2173782,R-HSA-2173782,R-HSA-5653656,Binding and Uptake of Ligands by Scavenger Receptors,Binding and Uptake of Ligands by Scavenger Receptors,Vesicle-mediated transport
R-HSA-173107,R-HSA-5663205,R-HSA-1643685,Binding and entry of HIV virion,Infectious disease,Disease
R-HSA-4411364,R-HSA-195721,R-HSA-162582,Binding of TCF/LEF:CTNNB1 to target gene promoters,Signaling by WNT,Signal Transduction
R-HSA-141333,R-HSA-211859,R-HSA-1430728,Biogenic amines are oxidatively deaminated to aldehydes by MAOA and MAOB,Biological oxidations,Metabolism
R-HSA-211859,R-HSA-211859,R-HSA-1430728,Biological oxidations,Biological oxidations,Metabolism
R-HSA-2466712,R-HSA-9675143,R-HSA-1643685,"Biosynthesis of A2E, implicated in retinal degradation",Diseases of the neuronal system,Disease
R-HSA-2466712,R-HSA-2187338,R-HSA-9709957,"Biosynthesis of A2E, implicated in retinal degradation",Visual phototransduction,Sensory Perception
R-HSA-9018676,R-HSA-556833,R-HSA-1430728,Biosynthesis of D-series resolvins,Metabolism of lipids,Metabolism
R-HSA-9018677,R-HSA-556833,R-HSA-1430728,Biosynthesis of DHA-derived SPMs,Metabolism of lipids,Metabolism
R-HSA-9026395,R-HSA-556833,R-HSA-1430728,Biosynthesis of DHA-derived sulfido conjugates,Metabolism of lipids,Metabolism
R-HSA-9018683,R-HSA-556833,R-HSA-1430728,Biosynthesis of DPA-derived SPMs,Metabolism of lipids,Metabolism
R-HSA-9025094,R-HSA-556833,R-HSA-1430728,Biosynthesis of DPAn-3 SPMs,Metabolism of lipids,Metabolism
R-HSA-9026403,R-HSA-556833,R-HSA-1430728,Biosynthesis of DPAn-3-derived 13-series resolvins,Metabolism of lipids,Metabolism
R-HSA-9026290,R-HSA-556833,R-HSA-1430728,Biosynthesis of DPAn-3-derived maresins,Metabolism of lipids,Metabolism
R-HSA-9026286,R-HSA-556833,R-HSA-1430728,Biosynthesis of DPAn-3-derived protectins and resolvins,Metabolism of lipids,Metabolism
R-HSA-9025106,R-HSA-556833,R-HSA-1430728,Biosynthesis of DPAn-6 SPMs,Metabolism of lipids,Metabolism
R-HSA-9023661,R-HSA-556833,R-HSA-1430728,Biosynthesis of E-series 18(R)-resolvins,Metabolism of lipids,Metabolism
R-HSA-9018896,R-HSA-556833,R-HSA-1430728,Biosynthesis of E-series 18(S)-resolvins,Metabolism of lipids,Metabolism
R-HSA-9018679,R-HSA-556833,R-HSA-1430728,Biosynthesis of EPA-derived SPMs,Metabolism of lipids,Metabolism
R-HSA-9020265,R-HSA-556833,R-HSA-1430728,Biosynthesis of aspirin-triggered D-series resolvins,Metabolism of lipids,Metabolism
R-HSA-9027604,R-HSA-556833,R-HSA-1430728,Biosynthesis of electrophilic ω-3 PUFA oxo-derivatives,Metabolism of lipids,Metabolism
R-HSA-9026762,R-HSA-556833,R-HSA-1430728,Biosynthesis of maresin conjugates in tissue regeneration (MCTR),Metabolism of lipids,Metabolism
R-HSA-9027307,R-HSA-556833,R-HSA-1430728,Biosynthesis of maresin-like SPMs,Metabolism of lipids,Metabolism
R-HSA-9018682,R-HSA-556833,R-HSA-1430728,Biosynthesis of maresins,Metabolism of lipids,Metabolism
R-HSA-9026766,R-HSA-556833,R-HSA-1430728,Biosynthesis of protectin and resolvin conjugates in tissue regeneration (PCTR and RCTR),Metabolism of lipids,Metabolism
R-HSA-9018681,R-HSA-556833,R-HSA-1430728,Biosynthesis of protectins,Metabolism of lipids,Metabolism
R-HSA-9018678,R-HSA-556833,R-HSA-1430728,Biosynthesis of specialized proresolving mediators (SPMs),Metabolism of lipids,Metabolism
R-HSA-446193,R-HSA-597592,R-HSA-392499,"Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein",Post-translational protein modification,Metabolism of proteins
R-HSA-196780,R-HSA-196854,R-HSA-1430728,Biotin transport and metabolism,Metabolism of vitamins and cofactors,Metabolism
R-HSA-9636467,R-HSA-5663205,R-HSA-1643685,Blockage of phagosome acidification,Infectious disease,Disease
R-HSA-9033658,R-HSA-71387,R-HSA-1430728,Blood group systems biosynthesis,Metabolism of carbohydrates,Metabolism
R-HSA-70895,R-HSA-71291,R-HSA-1430728,Branched-chain amino acid catabolism,Metabolism of amino acids and derivatives,Metabolism
R-HSA-352238,R-HSA-109581,R-HSA-5357801,Breakdown of the nuclear lamina,Apoptosis,Programmed Cell Death
R-HSA-168302,R-HSA-5663205,R-HSA-1643685,Budding,Infectious disease,Disease
R-HSA-162588,R-HSA-5663205,R-HSA-1643685,Budding and maturation of HIV virion,Infectious disease,Disease
R-HSA-450385,R-HSA-450531,R-HSA-8953854,Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA,Regulation of mRNA stability by proteins that bind AU-rich elements,Metabolism of RNA
R-HSA-8851680,R-HSA-1280218,R-HSA-168256,Butyrophilin (BTN) family interactions,Adaptive Immune System,Immune System
R-HSA-5621481,R-HSA-168249,R-HSA-168256,C-type lectin receptors (CLRs),Innate Immune System,Immune System
R-HSA-75102,R-HSA-75072,R-HSA-8953854,C6 deamination of adenosine,mRNA Editing,Metabolism of RNA
R-HSA-5218900,R-HSA-5218859,R-HSA-5357801,CASP8 activity is inhibited,Regulated Necrosis,Programmed Cell Death
R-HSA-9662834,R-HSA-5663205,R-HSA-1643685,CD163 mediating an anti-inflammatory response,Infectious disease,Disease
R-HSA-5621575,R-HSA-168249,R-HSA-168256,CD209 (DC-SIGN) signaling,Innate Immune System,Immune System
R-HSA-5690714,R-HSA-1280218,R-HSA-168256,CD22 mediated BCR regulation,Adaptive Immune System,Immune System
R-HSA-389356,R-HSA-1280218,R-HSA-168256,CD28 co-stimulation,Adaptive Immune System,Immune System
R-HSA-389357,R-HSA-1280218,R-HSA-168256,CD28 dependent PI3K/Akt signaling,Adaptive Immune System,Immune System
R-HSA-389359,R-HSA-1280218,R-HSA-168256,CD28 dependent Vav1 pathway,Adaptive Immune System,Immune System
R-HSA-9013148,R-HSA-9716542,R-HSA-162582,CDC42 GTPase cycle,"Signaling by Rho GTPases, Miro GTPases and RHOBTB3",Signal Transduction
R-HSA-68689,R-HSA-69002,R-HSA-69306,CDC6 association with the ORC:origin complex,DNA Replication Pre-Initiation,DNA Replication
R-HSA-69017,R-HSA-69278,R-HSA-1640170,CDK-mediated phosphorylation and removal of Cdc6,"Cell Cycle, Mitotic",Cell Cycle
R-HSA-69017,R-HSA-69239,R-HSA-69306,CDK-mediated phosphorylation and removal of Cdc6,Synthesis of DNA,DNA Replication
R-HSA-68827,R-HSA-69002,R-HSA-69306,CDT1 association with the CDC6:ORC:origin complex,DNA Replication Pre-Initiation,DNA Replication
R-HSA-447041,R-HSA-9675108,R-HSA-1266738,CHL1 interactions,Nervous system development,Developmental Biology
R-HSA-5607763,R-HSA-168249,R-HSA-168256,CLEC7A (Dectin-1) induces NFAT activation,Innate Immune System,Immune System
R-HSA-5607764,R-HSA-168249,R-HSA-168256,CLEC7A (Dectin-1) signaling,Innate Immune System,Immune System
R-HSA-5660668,R-HSA-168249,R-HSA-168256,CLEC7A/inflammasome pathway,Innate Immune System,Immune System
R-HSA-6811434,R-HSA-199991,R-HSA-5653656,COPI-dependent Golgi-to-ER retrograde traffic,Membrane Trafficking,Vesicle-mediated transport
R-HSA-6811436,R-HSA-199991,R-HSA-5653656,COPI-independent Golgi-to-ER retrograde traffic,Membrane Trafficking,Vesicle-mediated transport
R-HSA-6807878,R-HSA-199991,R-HSA-5653656,COPI-mediated anterograde transport,Membrane Trafficking,Vesicle-mediated transport
R-HSA-6807878,R-HSA-597592,R-HSA-392499,COPI-mediated anterograde transport,Post-translational protein modification,Metabolism of proteins
R-HSA-204005,R-HSA-199991,R-HSA-5653656,COPII-mediated vesicle transport,Membrane Trafficking,Vesicle-mediated transport
R-HSA-204005,R-HSA-597592,R-HSA-392499,COPII-mediated vesicle transport,Post-translational protein modification,Metabolism of proteins
R-HSA-140180,R-HSA-211859,R-HSA-1430728,COX reactions,Biological oxidations,Metabolism
R-HSA-199920,R-HSA-9006934,R-HSA-162582,CREB phosphorylation,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-199920,R-HSA-168249,R-HSA-168256,CREB phosphorylation,Innate Immune System,Immune System
R-HSA-199920,R-HSA-168249,R-HSA-168256,CREB phosphorylation,Innate Immune System,Immune System
R-HSA-199920,R-HSA-168249,R-HSA-168256,CREB phosphorylation,Innate Immune System,Immune System
R-HSA-199920,R-HSA-168249,R-HSA-168256,CREB phosphorylation,Innate Immune System,Immune System
R-HSA-199920,R-HSA-1280215,R-HSA-168256,CREB phosphorylation,Cytokine Signaling in Immune system,Immune System
R-HSA-199920,R-HSA-168249,R-HSA-168256,CREB phosphorylation,Innate Immune System,Immune System
R-HSA-199920,R-HSA-168249,R-HSA-168256,CREB phosphorylation,Innate Immune System,Immune System
R-HSA-199920,R-HSA-168249,R-HSA-168256,CREB phosphorylation,Innate Immune System,Immune System
R-HSA-199920,R-HSA-168249,R-HSA-168256,CREB phosphorylation,Innate Immune System,Immune System
R-HSA-199920,R-HSA-168249,R-HSA-168256,CREB phosphorylation,Innate Immune System,Immune System
R-HSA-442742,R-HSA-112315,R-HSA-112316,CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling,Transmission across Chemical Synapses,Neuronal System
R-HSA-442720,R-HSA-112315,R-HSA-112316,CREB1 phosphorylation through the activation of Adenylate Cyclase,Transmission across Chemical Synapses,Neuronal System
R-HSA-442729,R-HSA-112315,R-HSA-112316,CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde,Transmission across Chemical Synapses,Neuronal System
R-HSA-8874211,R-HSA-2262752,R-HSA-8953897,CREB3 factors activate genes,Cellular responses to stress,Cellular responses to stimuli
R-HSA-399956,R-HSA-9675108,R-HSA-1266738,CRMPs in Sema3A signaling,Nervous system development,Developmental Biology
R-HSA-2024101,R-HSA-71387,R-HSA-1430728,CS/DS degradation,Metabolism of carbohydrates,Metabolism
R-HSA-389513,R-HSA-1280218,R-HSA-168256,CTLA4 inhibitory signaling,Adaptive Immune System,Immune System
R-HSA-211999,R-HSA-211859,R-HSA-1430728,CYP2E1 reactions,Biological oxidations,Metabolism
R-HSA-111996,R-HSA-372790,R-HSA-162582,Ca-dependent events,Signaling by GPCR,Signal Transduction
R-HSA-1296052,R-HSA-1296071,R-HSA-112316,Ca2+ activated K+ channels,Potassium Channels,Neuronal System
R-HSA-4086398,R-HSA-195721,R-HSA-162582,Ca2+ pathway,Signaling by WNT,Signal Transduction
R-HSA-111997,R-HSA-372790,R-HSA-162582,CaM pathway,Signaling by GPCR,Signal Transduction
R-HSA-111997,R-HSA-9006925,R-HSA-162582,CaM pathway,Intracellular signaling by second messengers,Signal Transduction
R-HSA-111932,R-HSA-372790,R-HSA-162582,CaMK IV-mediated phosphorylation of CREB,Signaling by GPCR,Signal Transduction
R-HSA-111932,R-HSA-9006925,R-HSA-162582,CaMK IV-mediated phosphorylation of CREB,Intracellular signaling by second messengers,Signal Transduction
R-HSA-2025928,R-HSA-1280218,R-HSA-168256,Calcineurin activates NFAT,Adaptive Immune System,Immune System
R-HSA-419812,R-HSA-372790,R-HSA-162582,Calcitonin-like ligand receptors,Signaling by GPCR,Signal Transduction
R-HSA-111933,R-HSA-372790,R-HSA-162582,Calmodulin induced events,Signaling by GPCR,Signal Transduction
R-HSA-111933,R-HSA-9006925,R-HSA-162582,Calmodulin induced events,Intracellular signaling by second messengers,Signal Transduction
R-HSA-901042,R-HSA-597592,R-HSA-392499,Calnexin/calreticulin cycle,Post-translational protein modification,Metabolism of proteins
R-HSA-111957,R-HSA-372790,R-HSA-162582,Cam-PDE 1 activation,Signaling by GPCR,Signal Transduction
R-HSA-111957,R-HSA-9006925,R-HSA-162582,Cam-PDE 1 activation,Intracellular signaling by second messengers,Signal Transduction
R-HSA-72737,R-HSA-72766,R-HSA-392499,Cap-dependent Translation Initiation,Translation,Metabolism of proteins
R-HSA-8955332,R-HSA-597592,R-HSA-392499,Carboxyterminal post-translational modifications of tubulin,Post-translational protein modification,Metabolism of proteins
R-HSA-5576891,R-HSA-5576891,R-HSA-397014,Cardiac conduction,Cardiac conduction,Muscle contraction
R-HSA-5694530,R-HSA-199991,R-HSA-5653656,Cargo concentration in the ER,Membrane Trafficking,Vesicle-mediated transport
R-HSA-5694530,R-HSA-597592,R-HSA-392499,Cargo concentration in the ER,Post-translational protein modification,Metabolism of proteins
R-HSA-8856825,R-HSA-199991,R-HSA-5653656,Cargo recognition for clathrin-mediated endocytosis,Membrane Trafficking,Vesicle-mediated transport
R-HSA-5620920,R-HSA-5617833,R-HSA-1852241,Cargo trafficking to the periciliary membrane,Cilium Assembly,Organelle biogenesis and maintenance
R-HSA-200425,R-HSA-556833,R-HSA-1430728,Carnitine metabolism,Metabolism of lipids,Metabolism
R-HSA-71262,R-HSA-71291,R-HSA-1430728,Carnitine synthesis,Metabolism of amino acids and derivatives,Metabolism
R-HSA-140534,R-HSA-109581,R-HSA-5357801,Caspase activation via Death Receptors in the presence of ligand,Apoptosis,Programmed Cell Death
R-HSA-418889,R-HSA-109581,R-HSA-5357801,Caspase activation via Dependence Receptors in the absence of ligand,Apoptosis,Programmed Cell Death
R-HSA-5357769,R-HSA-109581,R-HSA-5357801,Caspase activation via extrinsic apoptotic signalling pathway,Apoptosis,Programmed Cell Death
R-HSA-264870,R-HSA-109581,R-HSA-5357801,Caspase-mediated cleavage of cytoskeletal proteins,Apoptosis,Programmed Cell Death
R-HSA-209905,R-HSA-71291,R-HSA-1430728,Catecholamine biosynthesis,Metabolism of amino acids and derivatives,Metabolism
R-HSA-426117,R-HSA-425407,R-HSA-382551,Cation-coupled Chloride cotransporters,SLC-mediated transmembrane transport,Transport of small molecules
R-HSA-174184,R-HSA-69278,R-HSA-1640170,Cdc20:Phospho-APC/C mediated degradation of Cyclin A,"Cell Cycle, Mitotic",Cell Cycle
R-HSA-1640170,R-HSA-1640170,R-HSA-1640170,Cell Cycle,Cell Cycle,Cell Cycle
R-HSA-69620,R-HSA-69620,R-HSA-1640170,Cell Cycle Checkpoints,Cell Cycle Checkpoints,Cell Cycle
R-HSA-69278,R-HSA-69278,R-HSA-1640170,"Cell Cycle, Mitotic","Cell Cycle, Mitotic",Cell Cycle
R-HSA-204998,R-HSA-73887,R-HSA-162582,"Cell death signalling via NRAGE, NRIF and NADE",Death Receptor Signalling,Signal Transduction
R-HSA-446728,R-HSA-446728,R-HSA-1500931,Cell junction organization,Cell junction organization,Cell-Cell communication
R-HSA-9664424,R-HSA-5663205,R-HSA-1643685,Cell recruitment (pro-inflammatory response),Infectious disease,Disease
R-HSA-1222541,R-HSA-5663205,R-HSA-1643685,Cell redox homeostasis,Infectious disease,Disease
R-HSA-202733,R-HSA-202733,R-HSA-109582,Cell surface interactions at the vascular wall,Cell surface interactions at the vascular wall,Hemostasis
R-HSA-1500931,R-HSA-1500931,R-HSA-1500931,Cell-Cell communication,Cell-Cell communication,Cell-Cell communication
R-HSA-421270,R-HSA-446728,R-HSA-1500931,Cell-cell junction organization,Cell junction organization,Cell-Cell communication
R-HSA-446353,R-HSA-446728,R-HSA-1500931,Cell-extracellular matrix interactions,Cell junction organization,Cell-Cell communication
R-HSA-2559583,R-HSA-2262752,R-HSA-8953897,Cellular Senescence,Cellular responses to stress,Cellular responses to stimuli
R-HSA-189200,R-HSA-425407,R-HSA-382551,Cellular hexose transport,SLC-mediated transmembrane transport,Transport of small molecules
R-HSA-9711123,R-HSA-2262752,R-HSA-8953897,Cellular response to chemical stress,Cellular responses to stress,Cellular responses to stimuli
R-HSA-3371556,R-HSA-2262752,R-HSA-8953897,Cellular response to heat stress,Cellular responses to stress,Cellular responses to stimuli
R-HSA-1234174,R-HSA-2262752,R-HSA-8953897,Cellular response to hypoxia,Cellular responses to stress,Cellular responses to stimuli
R-HSA-9711097,R-HSA-2262752,R-HSA-8953897,Cellular response to starvation,Cellular responses to stress,Cellular responses to stimuli
R-HSA-8953897,R-HSA-8953897,R-HSA-8953897,Cellular responses to stimuli,Cellular responses to stimuli,Cellular responses to stimuli
R-HSA-2262752,R-HSA-2262752,R-HSA-8953897,Cellular responses to stress,Cellular responses to stress,Cellular responses to stimuli
R-HSA-380287,R-HSA-69278,R-HSA-1640170,Centrosome maturation,"Cell Cycle, Mitotic",Cell Cycle
R-HSA-193681,R-HSA-73887,R-HSA-162582,Ceramide signalling,Death Receptor Signalling,Signal Transduction
R-HSA-163765,R-HSA-163685,R-HSA-1430728,ChREBP activates metabolic gene expression,Integration of energy metabolism,Metabolism
R-HSA-9613829,R-HSA-9613829,R-HSA-9612973,Chaperone Mediated Autophagy,Chaperone Mediated Autophagy,Autophagy
R-HSA-390466,R-HSA-391251,R-HSA-392499,Chaperonin-mediated protein folding,Protein folding,Metabolism of proteins
R-HSA-380108,R-HSA-372790,R-HSA-162582,Chemokine receptors bind chemokines,Signaling by GPCR,Signal Transduction
R-HSA-75035,R-HSA-69620,R-HSA-1640170,Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex,Cell Cycle Checkpoints,Cell Cycle
R-HSA-191273,R-HSA-556833,R-HSA-1430728,Cholesterol biosynthesis,Metabolism of lipids,Metabolism
R-HSA-6807047,R-HSA-556833,R-HSA-1430728,Cholesterol biosynthesis via desmosterol,Metabolism of lipids,Metabolism
R-HSA-6807062,R-HSA-556833,R-HSA-1430728,Cholesterol biosynthesis via lathosterol,Metabolism of lipids,Metabolism
R-HSA-6798163,R-HSA-71291,R-HSA-1430728,Choline catabolism,Metabolism of amino acids and derivatives,Metabolism
R-HSA-2022870,R-HSA-71387,R-HSA-1430728,Chondroitin sulfate biosynthesis,Metabolism of carbohydrates,Metabolism
R-HSA-1793185,R-HSA-71387,R-HSA-1430728,Chondroitin sulfate/dermatan sulfate metabolism,Metabolism of carbohydrates,Metabolism
R-HSA-3247509,R-HSA-3247509,R-HSA-4839726,Chromatin modifying enzymes,Chromatin modifying enzymes,Chromatin organization
R-HSA-4839726,R-HSA-4839726,R-HSA-4839726,Chromatin organization,Chromatin organization,Chromatin organization
R-HSA-73886,R-HSA-73886,R-HSA-1640170,Chromosome Maintenance,Chromosome Maintenance,Cell Cycle
R-HSA-8963888,R-HSA-174824,R-HSA-382551,Chylomicron assembly,"Plasma lipoprotein assembly, remodeling, and clearance",Transport of small molecules
R-HSA-8964026,R-HSA-174824,R-HSA-382551,Chylomicron clearance,"Plasma lipoprotein assembly, remodeling, and clearance",Transport of small molecules
R-HSA-8963901,R-HSA-174824,R-HSA-382551,Chylomicron remodeling,"Plasma lipoprotein assembly, remodeling, and clearance",Transport of small molecules
R-HSA-5617833,R-HSA-5617833,R-HSA-1852241,Cilium Assembly,Cilium Assembly,Organelle biogenesis and maintenance
R-HSA-400253,R-HSA-400253,R-HSA-400253,Circadian Clock,Circadian Clock,Circadian Clock
R-HSA-71403,R-HSA-1428517,R-HSA-1430728,Citric acid cycle (TCA cycle),The citric acid (TCA) cycle and respiratory electron transport,Metabolism
R-HSA-373076,R-HSA-372790,R-HSA-162582,Class A/1 (Rhodopsin-like receptors),Signaling by GPCR,Signal Transduction
R-HSA-373080,R-HSA-372790,R-HSA-162582,Class B/2 (Secretin family receptors),Signaling by GPCR,Signal Transduction
R-HSA-420499,R-HSA-372790,R-HSA-162582,Class C/3 (Metabotropic glutamate/pheromone receptors),Signaling by GPCR,Signal Transduction
R-HSA-983169,R-HSA-1280218,R-HSA-168256,Class I MHC mediated antigen processing & presentation,Adaptive Immune System,Immune System
R-HSA-9603798,R-HSA-9603798,R-HSA-9609507,Class I peroxisomal membrane protein import,Class I peroxisomal membrane protein import,Protein localization
R-HSA-1296053,R-HSA-1296071,R-HSA-112316,Classical Kir channels,Potassium Channels,Neuronal System
R-HSA-173623,R-HSA-168249,R-HSA-168256,Classical antibody-mediated complement activation,Innate Immune System,Immune System
R-HSA-8856828,R-HSA-199991,R-HSA-5653656,Clathrin-mediated endocytosis,Membrane Trafficking,Vesicle-mediated transport
R-HSA-110331,R-HSA-73884,R-HSA-73894,Cleavage of the damaged purine,Base Excision Repair,DNA Repair
R-HSA-110329,R-HSA-73884,R-HSA-73894,Cleavage of the damaged pyrimidine,Base Excision Repair,DNA Repair
R-HSA-196741,R-HSA-196854,R-HSA-1430728,"Cobalamin (Cbl, vitamin B12) transport and metabolism",Metabolism of vitamins and cofactors,Metabolism
R-HSA-196783,R-HSA-196854,R-HSA-1430728,Coenzyme A biosynthesis,Metabolism of vitamins and cofactors,Metabolism
R-HSA-2470946,R-HSA-69278,R-HSA-1640170,Cohesin Loading onto Chromatin,"Cell Cycle, Mitotic",Cell Cycle
R-HSA-1650814,R-HSA-1474290,R-HSA-1474244,Collagen biosynthesis and modifying enzymes,Collagen formation,Extracellular matrix organization
R-HSA-8948216,R-HSA-1474290,R-HSA-1474244,Collagen chain trimerization,Collagen formation,Extracellular matrix organization
R-HSA-1442490,R-HSA-1474228,R-HSA-1474244,Collagen degradation,Degradation of the extracellular matrix,Extracellular matrix organization
R-HSA-1474290,R-HSA-1474290,R-HSA-1474244,Collagen formation,Collagen formation,Extracellular matrix organization
R-HSA-140875,R-HSA-140877,R-HSA-109582,Common Pathway of Fibrin Clot Formation,Formation of Fibrin Clot (Clotting Cascade),Hemostasis
R-HSA-8948700,R-HSA-9006925,R-HSA-162582,Competing endogenous RNAs (ceRNAs) regulate PTEN translation,Intracellular signaling by second messengers,Signal Transduction
R-HSA-166658,R-HSA-168249,R-HSA-168256,Complement cascade,Innate Immune System,Immune System
R-HSA-6799198,R-HSA-1428517,R-HSA-1430728,Complex I biogenesis,The citric acid (TCA) cycle and respiratory electron transport,Metabolism
R-HSA-2514853,R-HSA-69278,R-HSA-1640170,Condensation of Prometaphase Chromosomes,"Cell Cycle, Mitotic",Cell Cycle
R-HSA-2299718,R-HSA-69278,R-HSA-1640170,Condensation of Prophase Chromosomes,"Cell Cycle, Mitotic",Cell Cycle
R-HSA-177135,R-HSA-211859,R-HSA-1430728,Conjugation of benzoate with glycine,Biological oxidations,Metabolism
R-HSA-159424,R-HSA-211859,R-HSA-1430728,Conjugation of carboxylic acids,Biological oxidations,Metabolism
R-HSA-177162,R-HSA-211859,R-HSA-1430728,Conjugation of phenylacetate with glutamine,Biological oxidations,Metabolism
R-HSA-177128,R-HSA-211859,R-HSA-1430728,Conjugation of salicylate with glycine,Biological oxidations,Metabolism
R-HSA-5674400,R-HSA-5663202,R-HSA-1643685,Constitutive Signaling by AKT1 E17K in Cancer,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-2219530,R-HSA-5663202,R-HSA-1643685,Constitutive Signaling by Aberrant PI3K in Cancer,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-5637810,R-HSA-5663202,R-HSA-1643685,Constitutive Signaling by EGFRvIII,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-1236382,R-HSA-5663202,R-HSA-1643685,Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-2691232,R-HSA-5663202,R-HSA-1643685,Constitutive Signaling by NOTCH1 HD Domain Mutants,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-2894862,R-HSA-5663202,R-HSA-1643685,Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-2644606,R-HSA-5663202,R-HSA-1643685,Constitutive Signaling by NOTCH1 PEST Domain Mutants,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-2660826,R-HSA-5663202,R-HSA-1643685,Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-9634285,R-HSA-5663202,R-HSA-1643685,Constitutive Signaling by Overexpressed ERBB2,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-176407,R-HSA-69278,R-HSA-1640170,Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase,"Cell Cycle, Mitotic",Cell Cycle
R-HSA-6814122,R-HSA-391251,R-HSA-392499,Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding,Protein folding,Metabolism of proteins
R-HSA-389958,R-HSA-391251,R-HSA-392499,Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding,Protein folding,Metabolism of proteins
R-HSA-388841,R-HSA-1280218,R-HSA-168256,Costimulation by the CD28 family,Adaptive Immune System,Immune System
R-HSA-71288,R-HSA-71291,R-HSA-1430728,Creatine metabolism,Metabolism of amino acids and derivatives,Metabolism
R-HSA-166786,R-HSA-168249,R-HSA-168256,Creation of C4 and C2 activators,Innate Immune System,Immune System
R-HSA-8949613,R-HSA-1592230,R-HSA-1852241,Cristae formation,Mitochondrial biogenesis,Organelle biogenesis and maintenance
R-HSA-1236973,R-HSA-1280218,R-HSA-168256,Cross-presentation of particulate exogenous antigens (phagosomes),Adaptive Immune System,Immune System
R-HSA-1236978,R-HSA-1280218,R-HSA-168256,Cross-presentation of soluble exogenous antigens (endosomes),Adaptive Immune System,Immune System
R-HSA-2243919,R-HSA-1474290,R-HSA-1474244,Crosslinking of collagen fibrils,Collagen formation,Extracellular matrix organization
R-HSA-69273,R-HSA-69278,R-HSA-1640170,Cyclin A/B1/B2 associated events during G2/M transition,"Cell Cycle, Mitotic",Cell Cycle
R-HSA-69656,R-HSA-69278,R-HSA-1640170,Cyclin A:Cdk2-associated events at S phase entry,"Cell Cycle, Mitotic",Cell Cycle
R-HSA-69231,R-HSA-69278,R-HSA-1640170,Cyclin D associated events in G1,"Cell Cycle, Mitotic",Cell Cycle
R-HSA-69202,R-HSA-69278,R-HSA-1640170,Cyclin E associated events during G1/S transition,"Cell Cycle, Mitotic",Cell Cycle
R-HSA-1614603,R-HSA-71291,R-HSA-1430728,Cysteine formation from homocysteine,Metabolism of amino acids and derivatives,Metabolism
R-HSA-211897,R-HSA-211859,R-HSA-1430728,Cytochrome P450 - arranged by substrate type,Biological oxidations,Metabolism
R-HSA-111461,R-HSA-109581,R-HSA-5357801,Cytochrome c-mediated apoptotic response,Apoptosis,Programmed Cell Death
R-HSA-1280215,R-HSA-1280215,R-HSA-168256,Cytokine Signaling in Immune system,Cytokine Signaling in Immune system,Immune System
R-HSA-9707564,R-HSA-2262752,R-HSA-8953897,Cytoprotection by HMOX1,Cellular responses to stress,Cellular responses to stimuli
R-HSA-2564830,R-HSA-2564830,R-HSA-1430728,Cytosolic iron-sulfur cluster assembly,Cytosolic iron-sulfur cluster assembly,Metabolism
R-HSA-1834949,R-HSA-168249,R-HSA-168256,Cytosolic sensors of pathogen-associated DNA,Innate Immune System,Immune System
R-HSA-156584,R-HSA-211859,R-HSA-1430728,Cytosolic sulfonation of small molecules,Biological oxidations,Metabolism
R-HSA-379716,R-HSA-72766,R-HSA-392499,Cytosolic tRNA aminoacylation,Translation,Metabolism of proteins
R-HSA-1489509,R-HSA-9006925,R-HSA-162582,DAG and IP3 signaling,Intracellular signaling by second messengers,Signal Transduction
R-HSA-2172127,R-HSA-168249,R-HSA-168256,DAP12 interactions,Innate Immune System,Immune System
R-HSA-2424491,R-HSA-168249,R-HSA-168256,DAP12 signaling,Innate Immune System,Immune System
R-HSA-180024,R-HSA-372790,R-HSA-162582,DARPP-32 events,Signaling by GPCR,Signal Transduction
R-HSA-418885,R-HSA-9675108,R-HSA-1266738,DCC mediated attractive signaling,Nervous system development,Developmental Biology
R-HSA-168928,R-HSA-168249,R-HSA-168256,DDX58/IFIH1-mediated induction of interferon-alpha/beta,Innate Immune System,Immune System
R-HSA-3134963,R-HSA-168249,R-HSA-168256,DEx/H-box helicases activate type I IFN and inflammatory cytokines production,Innate Immune System,Immune System
R-HSA-73893,R-HSA-73893,R-HSA-73894,DNA Damage Bypass,DNA Damage Bypass,DNA Repair
R-HSA-5696394,R-HSA-5696398,R-HSA-73894,DNA Damage Recognition in GG-NER,Nucleotide Excision Repair,DNA Repair
R-HSA-73942,R-HSA-73942,R-HSA-73894,DNA Damage Reversal,DNA Damage Reversal,DNA Repair
R-HSA-2559586,R-HSA-2262752,R-HSA-8953897,DNA Damage/Telomere Stress Induced Senescence,Cellular responses to stress,Cellular responses to stimuli
R-HSA-5693606,R-HSA-5693532,R-HSA-73894,DNA Double Strand Break Response,DNA Double-Strand Break Repair,DNA Repair
R-HSA-5693532,R-HSA-5693532,R-HSA-73894,DNA Double-Strand Break Repair,DNA Double-Strand Break Repair,DNA Repair
R-HSA-73894,R-HSA-73894,R-HSA-73894,DNA Repair,DNA Repair,DNA Repair
R-HSA-69306,R-HSA-69306,R-HSA-69306,DNA Replication,DNA Replication,DNA Replication
R-HSA-69002,R-HSA-69002,R-HSA-69306,DNA Replication Pre-Initiation,DNA Replication Pre-Initiation,DNA Replication
R-HSA-5334118,R-HSA-212165,R-HSA-74160,DNA methylation,Epigenetic regulation of gene expression,Gene expression (Transcription)
R-HSA-68952,R-HSA-69278,R-HSA-1640170,DNA replication initiation,"Cell Cycle, Mitotic",Cell Cycle
R-HSA-68952,R-HSA-69239,R-HSA-69306,DNA replication initiation,Synthesis of DNA,DNA Replication
R-HSA-69190,R-HSA-69278,R-HSA-1640170,DNA strand elongation,"Cell Cycle, Mitotic",Cell Cycle
R-HSA-69190,R-HSA-69239,R-HSA-69306,DNA strand elongation,Synthesis of DNA,DNA Replication
R-HSA-376172,R-HSA-9675108,R-HSA-1266738,DSCAM interactions,Nervous system development,Developmental Biology
R-HSA-9669914,R-HSA-5663202,R-HSA-1643685,Dasatinib-resistant KIT mutants,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-3769402,R-HSA-195721,R-HSA-162582,Deactivation of the beta-catenin transactivating complex,Signaling by WNT,Signal Transduction
R-HSA-429947,R-HSA-429914,R-HSA-8953854,Deadenylation of mRNA,Deadenylation-dependent mRNA decay,Metabolism of RNA
R-HSA-429914,R-HSA-429914,R-HSA-8953854,Deadenylation-dependent mRNA decay,Deadenylation-dependent mRNA decay,Metabolism of RNA
R-HSA-73887,R-HSA-73887,R-HSA-162582,Death Receptor Signalling,Death Receptor Signalling,Signal Transduction
R-HSA-5607761,R-HSA-168249,R-HSA-168256,Dectin-1 mediated noncanonical NF-kB signaling,Innate Immune System,Immune System
R-HSA-5621480,R-HSA-168249,R-HSA-168256,Dectin-2 family,Innate Immune System,Immune System
R-HSA-5682113,R-HSA-5619115,R-HSA-1643685,Defective ABCA1 causes TGD,Disorders of transmembrane transporters,Disease
R-HSA-5682294,R-HSA-5619115,R-HSA-1643685,Defective ABCA12 causes ARCI4B,Disorders of transmembrane transporters,Disease
R-HSA-5688399,R-HSA-5668914,R-HSA-1643685,Defective ABCA3 causes SMDP3,Diseases of metabolism,Disease
R-HSA-5683678,R-HSA-5619115,R-HSA-1643685,Defective ABCA3 causes SMDP3,Disorders of transmembrane transporters,Disease
R-HSA-5678520,R-HSA-5619115,R-HSA-1643685,Defective ABCB11 causes PFIC2 and BRIC2,Disorders of transmembrane transporters,Disease
R-HSA-5678771,R-HSA-5619115,R-HSA-1643685,"Defective ABCB4 causes PFIC3, ICP3 and GBD1",Disorders of transmembrane transporters,Disease
R-HSA-5683371,R-HSA-5619115,R-HSA-1643685,Defective ABCB6 causes MCOPCB7,Disorders of transmembrane transporters,Disease
R-HSA-5679001,R-HSA-5619115,R-HSA-1643685,Defective ABCC2 causes DJS,Disorders of transmembrane transporters,Disease
R-HSA-5690338,R-HSA-5619115,R-HSA-1643685,Defective ABCC6 causes PXE,Disorders of transmembrane transporters,Disease
R-HSA-5683177,R-HSA-5619115,R-HSA-1643685,Defective ABCC8 can cause hypo- and hyper-glycemias,Disorders of transmembrane transporters,Disease
R-HSA-5678420,R-HSA-5619115,R-HSA-1643685,"Defective ABCC9 causes CMD10, ATFB12 and Cantu syndrome",Disorders of transmembrane transporters,Disease
R-HSA-5684045,R-HSA-5619115,R-HSA-1643685,Defective ABCD1 causes ALD,Disorders of transmembrane transporters,Disease
R-HSA-5683329,R-HSA-5668914,R-HSA-1643685,Defective ABCD4 causes MAHCJ,Diseases of metabolism,Disease
R-HSA-5683329,R-HSA-5619115,R-HSA-1643685,Defective ABCD4 causes MAHCJ,Disorders of transmembrane transporters,Disease
R-HSA-5679096,R-HSA-5619115,R-HSA-1643685,Defective ABCG5 causes sitosterolemia,Disorders of transmembrane transporters,Disease
R-HSA-5679090,R-HSA-5619115,R-HSA-1643685,Defective ABCG8 causes GBD4 and sitosterolemia,Disorders of transmembrane transporters,Disease
R-HSA-5579031,R-HSA-5668914,R-HSA-1643685,Defective ACTH causes obesity and POMCD,Diseases of metabolism,Disease
R-HSA-5579007,R-HSA-5668914,R-HSA-1643685,Defective ACY1 causes encephalopathy,Diseases of metabolism,Disease
R-HSA-5578997,R-HSA-5668914,R-HSA-1643685,Defective AHCY causes HMAHCHD,Diseases of metabolism,Disease
R-HSA-4549380,R-HSA-5668914,R-HSA-1643685,Defective ALG1 causes ALG1-CDG (CDG-1k),Diseases of metabolism,Disease
R-HSA-4551295,R-HSA-5668914,R-HSA-1643685,Defective ALG11 causes ALG11-CDG (CDG-1p),Diseases of metabolism,Disease
R-HSA-4720489,R-HSA-5668914,R-HSA-1643685,Defective ALG12 causes ALG12-CDG (CDG-1g),Diseases of metabolism,Disease
R-HSA-5633231,R-HSA-5668914,R-HSA-1643685,Defective ALG14 causes congenital myasthenic syndrome (ALG14-CMS),Diseases of metabolism,Disease
R-HSA-4549349,R-HSA-5668914,R-HSA-1643685,Defective ALG2 causes ALG2-CDG (CDG-1i),Diseases of metabolism,Disease
R-HSA-4720475,R-HSA-5668914,R-HSA-1643685,Defective ALG3 causes ALG3-CDG (CDG-1d),Diseases of metabolism,Disease
R-HSA-4724289,R-HSA-5668914,R-HSA-1643685,Defective ALG6 causes ALG6-CDG (CDG-1c),Diseases of metabolism,Disease
R-HSA-4724325,R-HSA-5668914,R-HSA-1643685,Defective ALG8 causes ALG8-CDG (CDG-1h),Diseases of metabolism,Disease
R-HSA-4720454,R-HSA-5668914,R-HSA-1643685,Defective ALG9 causes ALG9-CDG (CDG-1l),Diseases of metabolism,Disease
R-HSA-3359462,R-HSA-5668914,R-HSA-1643685,Defective AMN causes hereditary megaloblastic anemia 1,Diseases of metabolism,Disease
R-HSA-5619099,R-HSA-5619115,R-HSA-1643685,"Defective AVP does not bind AVPR1A,B and causes neurohypophyseal diabetes insipidus (NDI)",Disorders of transmembrane transporters,Disease
R-HSA-9036092,R-HSA-5619115,R-HSA-1643685,Defective AVP does not bind AVPR2 and causes neurohypophyseal diabetes insipidus (NDI),Disorders of transmembrane transporters,Disease
R-HSA-4420332,R-HSA-5668914,R-HSA-1643685,Defective B3GALT6 causes EDSP2 and SEMDJL1,Diseases of metabolism,Disease
R-HSA-5083635,R-HSA-5668914,R-HSA-1643685,Defective B3GALTL causes Peters-plus syndrome (PpS),Diseases of metabolism,Disease
R-HSA-3560801,R-HSA-5668914,R-HSA-1643685,Defective B3GAT3 causes JDSSDHD,Diseases of metabolism,Disease
R-HSA-3656244,R-HSA-5668914,R-HSA-1643685,Defective B4GALT1 causes B4GALT1-CDG (CDG-2d),Diseases of metabolism,Disease
R-HSA-4793953,R-HSA-5668914,R-HSA-1643685,Defective B4GALT1 causes B4GALT1-CDG (CDG-2d),Diseases of metabolism,Disease
R-HSA-3560783,R-HSA-5668914,R-HSA-1643685,"Defective B4GALT7 causes EDS, progeroid type",Diseases of metabolism,Disease
R-HSA-3371598,R-HSA-5668914,R-HSA-1643685,Defective BTD causes biotidinase deficiency,Diseases of metabolism,Disease
R-HSA-9605310,R-HSA-9675135,R-HSA-1643685,Defective Base Excision Repair Associated with MUTYH,Diseases of DNA repair,Disease
R-HSA-9616334,R-HSA-9675135,R-HSA-1643685,Defective Base Excision Repair Associated with NEIL1,Diseases of DNA repair,Disease
R-HSA-9629232,R-HSA-9675135,R-HSA-1643685,Defective Base Excision Repair Associated with NEIL3,Diseases of DNA repair,Disease
R-HSA-9616333,R-HSA-9675135,R-HSA-1643685,Defective Base Excision Repair Associated with NTHL1,Diseases of DNA repair,Disease
R-HSA-9656249,R-HSA-9675135,R-HSA-1643685,Defective Base Excision Repair Associated with OGG1,Diseases of DNA repair,Disease
R-HSA-5083632,R-HSA-5668914,R-HSA-1643685,Defective C1GALT1C1 causes Tn polyagglutination syndrome (TNPS),Diseases of metabolism,Disease
R-HSA-3359485,R-HSA-5668914,R-HSA-1643685,Defective CD320 causes methylmalonic aciduria,Diseases of metabolism,Disease
R-HSA-5678895,R-HSA-5619115,R-HSA-1643685,Defective CFTR causes cystic fibrosis,Disorders of transmembrane transporters,Disease
R-HSA-3595174,R-HSA-5668914,R-HSA-1643685,"Defective CHST14 causes EDS, musculocontractural type",Diseases of metabolism,Disease
R-HSA-3595172,R-HSA-5668914,R-HSA-1643685,Defective CHST3 causes SEDCJD,Diseases of metabolism,Disease
R-HSA-3656225,R-HSA-5668914,R-HSA-1643685,Defective CHST6 causes MCDC1,Diseases of metabolism,Disease
R-HSA-3595177,R-HSA-5668914,R-HSA-1643685,Defective CHSY1 causes TPBS,Diseases of metabolism,Disease
R-HSA-5619060,R-HSA-5619115,R-HSA-1643685,Defective CP causes aceruloplasminemia (ACERULOP),Disorders of transmembrane transporters,Disease
R-HSA-5688890,R-HSA-5668914,R-HSA-1643685,Defective CSF2RA causes SMDP4,Diseases of metabolism,Disease
R-HSA-5688849,R-HSA-5668914,R-HSA-1643685,Defective CSF2RB causes SMDP5,Diseases of metabolism,Disease
R-HSA-3359463,R-HSA-5668914,R-HSA-1643685,Defective CUBN causes hereditary megaloblastic anemia 1,Diseases of metabolism,Disease
R-HSA-5579026,R-HSA-5668914,R-HSA-1643685,Defective CYP11A1 causes AICSR,Diseases of metabolism,Disease
R-HSA-5579017,R-HSA-5668914,R-HSA-1643685,Defective CYP11B1 causes AH4,Diseases of metabolism,Disease
R-HSA-5579009,R-HSA-5668914,R-HSA-1643685,Defective CYP11B2 causes CMO-1 deficiency,Diseases of metabolism,Disease
R-HSA-5579028,R-HSA-5668914,R-HSA-1643685,Defective CYP17A1 causes AH5,Diseases of metabolism,Disease
R-HSA-5579030,R-HSA-5668914,R-HSA-1643685,Defective CYP19A1 causes AEXS,Diseases of metabolism,Disease
R-HSA-5579000,R-HSA-5668914,R-HSA-1643685,Defective CYP1B1 causes Glaucoma,Diseases of metabolism,Disease
R-HSA-5579021,R-HSA-5668914,R-HSA-1643685,Defective CYP21A2 causes AH3,Diseases of metabolism,Disease
R-HSA-5579010,R-HSA-5668914,R-HSA-1643685,Defective CYP24A1 causes HCAI,Diseases of metabolism,Disease
R-HSA-5579015,R-HSA-5668914,R-HSA-1643685,Defective CYP26B1 causes RHFCA,Diseases of metabolism,Disease
R-HSA-5579004,R-HSA-5668914,R-HSA-1643685,Defective CYP26C1 causes FFDD4,Diseases of metabolism,Disease
R-HSA-5578996,R-HSA-5668914,R-HSA-1643685,Defective CYP27A1 causes CTX,Diseases of metabolism,Disease
R-HSA-5579014,R-HSA-5668914,R-HSA-1643685,Defective CYP27B1 causes VDDR1A,Diseases of metabolism,Disease
R-HSA-5579027,R-HSA-5668914,R-HSA-1643685,Defective CYP27B1 causes VDDR1B,Diseases of metabolism,Disease
R-HSA-5579011,R-HSA-5668914,R-HSA-1643685,Defective CYP2U1 causes SPG56,Diseases of metabolism,Disease
R-HSA-5579005,R-HSA-5668914,R-HSA-1643685,Defective CYP4F22 causes ARCI5,Diseases of metabolism,Disease
R-HSA-5579013,R-HSA-5668914,R-HSA-1643685,Defective CYP7B1 causes SPG5A and CBAS3,Diseases of metabolism,Disease
R-HSA-4755609,R-HSA-5668914,R-HSA-1643685,Defective DHDDS causes retinitis pigmentosa 59,Diseases of metabolism,Disease
R-HSA-9699150,R-HSA-9675135,R-HSA-1643685,Defective DNA double strand break response due to BARD1 loss of function,Diseases of DNA repair,Disease
R-HSA-9663199,R-HSA-9675135,R-HSA-1643685,Defective DNA double strand break response due to BRCA1 loss of function,Diseases of DNA repair,Disease
R-HSA-4755583,R-HSA-5668914,R-HSA-1643685,Defective DOLK causes DOLK-CDG (CDG-1m),Diseases of metabolism,Disease
R-HSA-4549356,R-HSA-5668914,R-HSA-1643685,Defective DPAGT1 causes DPAGT1-CDG (CDG-1j) and CMSTA2,Diseases of metabolism,Disease
R-HSA-4717374,R-HSA-5668914,R-HSA-1643685,Defective DPM1 causes DPM1-CDG (CDG-1e),Diseases of metabolism,Disease
R-HSA-4719377,R-HSA-5668914,R-HSA-1643685,Defective DPM2 causes DPM2-CDG (CDG-1u),Diseases of metabolism,Disease
R-HSA-4719360,R-HSA-5668914,R-HSA-1643685,Defective DPM3 causes DPM3-CDG (CDG-1o),Diseases of metabolism,Disease
R-HSA-3656253,R-HSA-5668914,R-HSA-1643685,"Defective EXT1 causes exostoses 1, TRPS2 and CHDS",Diseases of metabolism,Disease
R-HSA-3656237,R-HSA-5668914,R-HSA-1643685,Defective EXT2 causes exostoses 2,Diseases of metabolism,Disease
R-HSA-9672387,R-HSA-9671793,R-HSA-1643685,Defective F8 accelerates dissociation of the A2 domain,Diseases of hemostasis,Disease
R-HSA-9672395,R-HSA-9671793,R-HSA-1643685,Defective F8 binding to the cell membrane,Diseases of hemostasis,Disease
R-HSA-9672393,R-HSA-9671793,R-HSA-1643685,Defective F8 binding to von Willebrand factor,Diseases of hemostasis,Disease
R-HSA-9672391,R-HSA-9671793,R-HSA-1643685,Defective F8 cleavage by thrombin,Diseases of hemostasis,Disease
R-HSA-9672397,R-HSA-9671793,R-HSA-1643685,Defective F8 secretion,Diseases of hemostasis,Disease
R-HSA-9674519,R-HSA-9671793,R-HSA-1643685,Defective F8 sulfation at Y1699,Diseases of hemostasis,Disease
R-HSA-9673221,R-HSA-9671793,R-HSA-1643685,Defective F9 activation,Diseases of hemostasis,Disease
R-HSA-9673218,R-HSA-9671793,R-HSA-1643685,Defective F9 secretion,Diseases of hemostasis,Disease
R-HSA-9673202,R-HSA-9671793,R-HSA-1643685,Defective F9 variant does not activate FX,Diseases of hemostasis,Disease
R-HSA-5579019,R-HSA-5668914,R-HSA-1643685,Defective FMO3 causes TMAU,Diseases of metabolism,Disease
R-HSA-5609977,R-HSA-5668914,R-HSA-1643685,Defective GALE can cause Epimerase-deficiency galactosemia (EDG),Diseases of metabolism,Disease
R-HSA-5609976,R-HSA-5668914,R-HSA-1643685,Defective GALK1 can cause Galactosemia II (GALCT2),Diseases of metabolism,Disease
R-HSA-5083636,R-HSA-5668914,R-HSA-1643685,Defective GALNT12 causes colorectal cancer 1 (CRCS1),Diseases of metabolism,Disease
R-HSA-5083625,R-HSA-5668914,R-HSA-1643685,Defective GALNT3 causes familial hyperphosphatemic tumoral calcinosis (HFTC),Diseases of metabolism,Disease
R-HSA-5609978,R-HSA-5668914,R-HSA-1643685,Defective GALT can cause Galactosemia,Diseases of metabolism,Disease
R-HSA-5619073,R-HSA-5619115,R-HSA-1643685,Defective GCK causes maturity-onset diabetes of the young 2 (MODY2),Disorders of transmembrane transporters,Disease
R-HSA-5578999,R-HSA-5668914,R-HSA-1643685,Defective GCLC causes HAGGSD,Diseases of metabolism,Disease
R-HSA-4085023,R-HSA-5668914,R-HSA-1643685,Defective GFPT1 causes CMSTA1,Diseases of metabolism,Disease
R-HSA-5579022,R-HSA-5668914,R-HSA-1643685,Defective GGT1 causes GLUTH,Diseases of metabolism,Disease
R-HSA-9035968,R-HSA-5668914,R-HSA-1643685,Defective GGT1 in aflatoxin detoxification causes GLUTH,Diseases of metabolism,Disease
R-HSA-3359457,R-HSA-5668914,R-HSA-1643685,Defective GIF causes intrinsic factor deficiency,Diseases of metabolism,Disease
R-HSA-4085011,R-HSA-5668914,R-HSA-1643685,"Defective GNE causes sialuria, Nonaka myopathy and inclusion body myopathy 2",Diseases of metabolism,Disease
R-HSA-5579006,R-HSA-5668914,R-HSA-1643685,Defective GSS causes GSS deficiency,Diseases of metabolism,Disease
R-HSA-9701193,R-HSA-9675135,R-HSA-1643685,Defective HDR through Homologous Recombination (HRR) due to PALB2 loss of function,Diseases of DNA repair,Disease
R-HSA-9704331,R-HSA-9675135,R-HSA-1643685,Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function,Diseases of DNA repair,Disease
R-HSA-9704646,R-HSA-9675135,R-HSA-1643685,Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function,Diseases of DNA repair,Disease
R-HSA-3656234,R-HSA-5668914,R-HSA-1643685,Defective HEXA causes GM2G1,Diseases of metabolism,Disease
R-HSA-3656248,R-HSA-5668914,R-HSA-1643685,Defective HEXB causes GM2G2,Diseases of metabolism,Disease
R-HSA-5619056,R-HSA-5619115,R-HSA-1643685,Defective HK1 causes hexokinase deficiency (HK deficiency),Disorders of transmembrane transporters,Disease
R-HSA-3371599,R-HSA-5668914,R-HSA-1643685,Defective HLCS causes multiple carboxylase deficiency,Diseases of metabolism,Disease
R-HSA-9670621,R-HSA-9675126,R-HSA-1643685,Defective Inhibition of DNA Recombination at Telomere,Diseases of mitotic cell cycle,Disease
R-HSA-9670615,R-HSA-9675126,R-HSA-1643685,Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations,Diseases of mitotic cell cycle,Disease
R-HSA-9670613,R-HSA-9675126,R-HSA-1643685,Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations,Diseases of mitotic cell cycle,Disease
R-HSA-9645722,R-HSA-9645723,R-HSA-1643685,Defective Intrinsic Pathway for Apoptosis Due to p14ARF Loss of Function,Diseases of programmed cell death,Disease
R-HSA-5083627,R-HSA-5668914,R-HSA-1643685,Defective LARGE causes MDDGA6 and MDDGB6,Diseases of metabolism,Disease
R-HSA-5083630,R-HSA-5668914,R-HSA-1643685,Defective LFNG causes SCDO3,Diseases of metabolism,Disease
R-HSA-4793950,R-HSA-5668914,R-HSA-1643685,Defective MAN1B1 causes MRT15,Diseases of metabolism,Disease
R-HSA-5579012,R-HSA-5668914,R-HSA-1643685,Defective MAOA causes BRUNS,Diseases of metabolism,Disease
R-HSA-5579024,R-HSA-5668914,R-HSA-1643685,Defective MAT1A causes MATD,Diseases of metabolism,Disease
R-HSA-4793952,R-HSA-5668914,R-HSA-1643685,Defective MGAT2 causes MGAT2-CDG (CDG-2a),Diseases of metabolism,Disease
R-HSA-3359475,R-HSA-5668914,R-HSA-1643685,Defective MMAA causes methylmalonic aciduria type cblA,Diseases of metabolism,Disease
R-HSA-3359471,R-HSA-5668914,R-HSA-1643685,Defective MMAB causes methylmalonic aciduria type cblB,Diseases of metabolism,Disease
R-HSA-3359474,R-HSA-5668914,R-HSA-1643685,Defective MMACHC causes methylmalonic aciduria and homocystinuria type cblC,Diseases of metabolism,Disease
R-HSA-3359473,R-HSA-5668914,R-HSA-1643685,Defective MMADHC causes methylmalonic aciduria and homocystinuria type cblD,Diseases of metabolism,Disease
R-HSA-4793954,R-HSA-5668914,R-HSA-1643685,Defective MOGS causes MOGS-CDG (CDG-2b),Diseases of metabolism,Disease
R-HSA-4687000,R-HSA-5668914,R-HSA-1643685,Defective MPDU1 causes MPDU1-CDG (CDG-1f),Diseases of metabolism,Disease
R-HSA-4043916,R-HSA-5668914,R-HSA-1643685,Defective MPI causes MPI-CDG (CDG-1b),Diseases of metabolism,Disease
R-HSA-3359469,R-HSA-5668914,R-HSA-1643685,Defective MTR causes methylmalonic aciduria and homocystinuria type cblG,Diseases of metabolism,Disease
R-HSA-3359467,R-HSA-5668914,R-HSA-1643685,Defective MTRR causes methylmalonic aciduria and homocystinuria type cblE,Diseases of metabolism,Disease
R-HSA-3359478,R-HSA-5668914,R-HSA-1643685,Defective MUT causes methylmalonic aciduria mut type,Diseases of metabolism,Disease
R-HSA-9608287,R-HSA-9675135,R-HSA-1643685,Defective MUTYH substrate binding,Diseases of DNA repair,Disease
R-HSA-9608290,R-HSA-9675135,R-HSA-1643685,Defective MUTYH substrate processing,Diseases of DNA repair,Disease
R-HSA-5545483,R-HSA-9675135,R-HSA-1643685,Defective Mismatch Repair Associated With MLH1,Diseases of DNA repair,Disease
R-HSA-5632928,R-HSA-9675135,R-HSA-1643685,Defective Mismatch Repair Associated With MSH2,Diseases of DNA repair,Disease
R-HSA-5632927,R-HSA-9675135,R-HSA-1643685,Defective Mismatch Repair Associated With MSH3,Diseases of DNA repair,Disease
R-HSA-5632968,R-HSA-9675135,R-HSA-1643685,Defective Mismatch Repair Associated With MSH6,Diseases of DNA repair,Disease
R-HSA-5632987,R-HSA-9675135,R-HSA-1643685,Defective Mismatch Repair Associated With PMS2,Diseases of DNA repair,Disease
R-HSA-4341670,R-HSA-5668914,R-HSA-1643685,Defective NEU1 causes sialidosis,Diseases of metabolism,Disease
R-HSA-9630222,R-HSA-9675135,R-HSA-1643685,Defective NTHL1 substrate binding,Diseases of DNA repair,Disease
R-HSA-9630221,R-HSA-9675135,R-HSA-1643685,Defective NTHL1 substrate processing,Diseases of DNA repair,Disease
R-HSA-9657050,R-HSA-9675135,R-HSA-1643685,Defective OGG1 Localization,Diseases of DNA repair,Disease
R-HSA-9656255,R-HSA-9675135,R-HSA-1643685,Defective OGG1 Substrate Binding,Diseases of DNA repair,Disease
R-HSA-9656256,R-HSA-9675135,R-HSA-1643685,Defective OGG1 Substrate Processing,Diseases of DNA repair,Disease
R-HSA-5578998,R-HSA-5668914,R-HSA-1643685,Defective OPLAH causes OPLAHD,Diseases of metabolism,Disease
R-HSA-3560796,R-HSA-5668914,R-HSA-1643685,Defective PAPSS2 causes SEMD-PA,Diseases of metabolism,Disease
R-HSA-5609974,R-HSA-5668914,R-HSA-1643685,Defective PGM1 causes PGM1-CDG (CDG1t),Diseases of metabolism,Disease
R-HSA-4043911,R-HSA-5668914,R-HSA-1643685,Defective PMM2 causes PMM2-CDG (CDG-1a),Diseases of metabolism,Disease
R-HSA-5083628,R-HSA-5668914,R-HSA-1643685,"Defective POMGNT1 causes MDDGA3, MDDGB3 and MDDGC3",Diseases of metabolism,Disease
R-HSA-5083633,R-HSA-5668914,R-HSA-1643685,"Defective POMT1 causes MDDGA1, MDDGB1 and MDDGC1",Diseases of metabolism,Disease
R-HSA-5083629,R-HSA-5668914,R-HSA-1643685,"Defective POMT2 causes MDDGA2, MDDGB2 and MDDGC2",Diseases of metabolism,Disease
R-HSA-4570571,R-HSA-5668914,R-HSA-1643685,Defective RFT1 causes RFT1-CDG (CDG-1n),Diseases of metabolism,Disease
R-HSA-5619042,R-HSA-5619115,R-HSA-1643685,Defective RHAG causes regulator type Rh-null hemolytic anemia (RHN),Disorders of transmembrane transporters,Disease
R-HSA-9693928,R-HSA-9645723,R-HSA-1643685,Defective RIPK1-mediated regulated necrosis,Diseases of programmed cell death,Disease
R-HSA-9657689,R-HSA-9671793,R-HSA-1643685,Defective SERPING1 causes hereditary angioedema,Diseases of hemostasis,Disease
R-HSA-5687868,R-HSA-5668914,R-HSA-1643685,Defective SFTPA2 causes IPF,Diseases of metabolism,Disease
R-HSA-5619048,R-HSA-5619115,R-HSA-1643685,"Defective SLC11A2 causes hypochromic microcytic anemia, with iron overload 1 (AHMIO1)",Disorders of transmembrane transporters,Disease
R-HSA-5619104,R-HSA-5619115,R-HSA-1643685,Defective SLC12A1 causes Bartter syndrome 1 (BS1),Disorders of transmembrane transporters,Disease
R-HSA-5619087,R-HSA-5619115,R-HSA-1643685,Defective SLC12A3 causes Gitelman syndrome (GS),Disorders of transmembrane transporters,Disease
R-HSA-5619039,R-HSA-5619115,R-HSA-1643685,"Defective SLC12A6 causes agenesis of the corpus callosum, with peripheral neuropathy (ACCPN)",Disorders of transmembrane transporters,Disease
R-HSA-5619070,R-HSA-5619115,R-HSA-1643685,Defective SLC16A1 causes symptomatic deficiency in lactate transport (SDLT),Disorders of transmembrane transporters,Disease
R-HSA-5619035,R-HSA-5619115,R-HSA-1643685,Defective SLC17A5 causes Salla disease (SD) and ISSD,Disorders of transmembrane transporters,Disease
R-HSA-5619076,R-HSA-5619115,R-HSA-1643685,Defective SLC17A8 causes autosomal dominant deafness 25 (DFNA25),Disorders of transmembrane transporters,Disease
R-HSA-5619067,R-HSA-5619115,R-HSA-1643685,Defective SLC1A1 is implicated in schizophrenia 18 (SCZD18) and dicarboxylic aminoaciduria (DCBXA),Disorders of transmembrane transporters,Disease
R-HSA-5619062,R-HSA-5619115,R-HSA-1643685,Defective SLC1A3 causes episodic ataxia 6 (EA6),Disorders of transmembrane transporters,Disease
R-HSA-5619111,R-HSA-5619115,R-HSA-1643685,Defective SLC20A2 causes idiopathic basal ganglia calcification 1 (IBGC1),Disorders of transmembrane transporters,Disease
R-HSA-5619071,R-HSA-5619115,R-HSA-1643685,Defective SLC22A12 causes renal hypouricemia 1 (RHUC1),Disorders of transmembrane transporters,Disease
R-HSA-5619066,R-HSA-5619115,R-HSA-1643685,Defective SLC22A18 causes lung cancer (LNCR) and embryonal rhabdomyosarcoma 1 (RMSE1),Disorders of transmembrane transporters,Disease
R-HSA-5619053,R-HSA-5619115,R-HSA-1643685,Defective SLC22A5 causes systemic primary carnitine deficiency (CDSP),Disorders of transmembrane transporters,Disease
R-HSA-5619077,R-HSA-5619115,R-HSA-1643685,Defective SLC24A1 causes congenital stationary night blindness 1D (CSNB1D),Disorders of transmembrane transporters,Disease
R-HSA-5619055,R-HSA-5619115,R-HSA-1643685,Defective SLC24A4 causes hypomineralized amelogenesis imperfecta (AI),Disorders of transmembrane transporters,Disease
R-HSA-5619036,R-HSA-5619115,R-HSA-1643685,Defective SLC24A5 causes oculocutaneous albinism 6 (OCA6),Disorders of transmembrane transporters,Disease
R-HSA-3560792,R-HSA-5668914,R-HSA-1643685,Defective SLC26A2 causes chondrodysplasias,Diseases of metabolism,Disease
R-HSA-3560792,R-HSA-5619115,R-HSA-1643685,Defective SLC26A2 causes chondrodysplasias,Disorders of transmembrane transporters,Disease
R-HSA-5619085,R-HSA-5619115,R-HSA-1643685,Defective SLC26A3 causes congenital secretory chloride diarrhea 1 (DIAR1),Disorders of transmembrane transporters,Disease
R-HSA-5619046,R-HSA-5619115,R-HSA-1643685,Defective SLC26A4 causes Pendred syndrome (PDS),Disorders of transmembrane transporters,Disease
R-HSA-5619108,R-HSA-5619115,R-HSA-1643685,Defective SLC27A4 causes ichthyosis prematurity syndrome (IPS),Disorders of transmembrane transporters,Disease
R-HSA-5619063,R-HSA-5619115,R-HSA-1643685,Defective SLC29A3 causes histiocytosis-lymphadenopathy plus syndrome (HLAS),Disorders of transmembrane transporters,Disease
R-HSA-5619043,R-HSA-5619115,R-HSA-1643685,Defective SLC2A1 causes GLUT1 deficiency syndrome 1 (GLUT1DS1),Disorders of transmembrane transporters,Disease
R-HSA-5619068,R-HSA-5619115,R-HSA-1643685,Defective SLC2A10 causes arterial tortuosity syndrome (ATS),Disorders of transmembrane transporters,Disease
R-HSA-5619098,R-HSA-5619115,R-HSA-1643685,Defective SLC2A2 causes Fanconi-Bickel syndrome (FBS),Disorders of transmembrane transporters,Disease
R-HSA-5619047,R-HSA-5619115,R-HSA-1643685,Defective SLC2A9 causes hypouricemia renal 2 (RHUC2),Disorders of transmembrane transporters,Disease
R-HSA-5619061,R-HSA-5619115,R-HSA-1643685,Defective SLC33A1 causes spastic paraplegia 42 (SPG42),Disorders of transmembrane transporters,Disease
R-HSA-5619040,R-HSA-5619115,R-HSA-1643685,Defective SLC34A1 causes hypophosphatemic nephrolithiasis/osteoporosis 1 (NPHLOP1),Disorders of transmembrane transporters,Disease
R-HSA-5687583,R-HSA-5668914,R-HSA-1643685,Defective SLC34A2 causes PALM,Diseases of metabolism,Disease
R-HSA-5619045,R-HSA-5619115,R-HSA-1643685,Defective SLC34A2 causes pulmonary alveolar microlithiasis (PALM),Disorders of transmembrane transporters,Disease
R-HSA-5619097,R-HSA-5619115,R-HSA-1643685,Defective SLC34A3 causes Hereditary hypophosphatemic rickets with hypercalciuria (HHRH),Disorders of transmembrane transporters,Disease
R-HSA-5619037,R-HSA-5619115,R-HSA-1643685,Defective SLC35A1 causes congenital disorder of glycosylation 2F (CDG2F),Disorders of transmembrane transporters,Disease
R-HSA-5663020,R-HSA-5619115,R-HSA-1643685,Defective SLC35A1 causes congenital disorder of glycosylation 2F (CDG2F),Disorders of transmembrane transporters,Disease
R-HSA-5619072,R-HSA-5619115,R-HSA-1643685,Defective SLC35A2 causes congenital disorder of glycosylation 2M (CDG2M),Disorders of transmembrane transporters,Disease
R-HSA-5619083,R-HSA-5619115,R-HSA-1643685,"Defective SLC35A3 causes arthrogryposis, mental retardation, and seizures (AMRS)",Disorders of transmembrane transporters,Disease
R-HSA-5619078,R-HSA-5619115,R-HSA-1643685,Defective SLC35C1 causes congenital disorder of glycosylation 2C (CDG2C),Disorders of transmembrane transporters,Disease
R-HSA-5579020,R-HSA-5668914,R-HSA-1643685,Defective SLC35D1 causes SCHBCKD,Diseases of metabolism,Disease
R-HSA-5619041,R-HSA-5619115,R-HSA-1643685,Defective SLC36A2 causes iminoglycinuria (IG) and hyperglycinuria (HG),Disorders of transmembrane transporters,Disease
R-HSA-5619088,R-HSA-5619115,R-HSA-1643685,"Defective SLC39A4 causes acrodermatitis enteropathica, zinc-deficiency type (AEZ)",Disorders of transmembrane transporters,Disease
R-HSA-5619113,R-HSA-5619115,R-HSA-1643685,Defective SLC3A1 causes cystinuria (CSNU),Disorders of transmembrane transporters,Disease
R-HSA-5655799,R-HSA-5619115,R-HSA-1643685,Defective SLC40A1 causes hemochromatosis 4 (HFE4) (duodenum),Disorders of transmembrane transporters,Disease
R-HSA-5619049,R-HSA-5619115,R-HSA-1643685,Defective SLC40A1 causes hemochromatosis 4 (HFE4) (macrophages),Disorders of transmembrane transporters,Disease
R-HSA-5619050,R-HSA-5619115,R-HSA-1643685,"Defective SLC4A1 causes hereditary spherocytosis type 4 (HSP4),  distal renal tubular acidosis (dRTA) and dRTA with hemolytic anemia (dRTA-HA)",Disorders of transmembrane transporters,Disease
R-HSA-5619054,R-HSA-5619115,R-HSA-1643685,"Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA)",Disorders of transmembrane transporters,Disease
R-HSA-5656364,R-HSA-5619115,R-HSA-1643685,Defective SLC5A1 causes congenital glucose/galactose malabsorption (GGM),Disorders of transmembrane transporters,Disease
R-HSA-5658208,R-HSA-5619115,R-HSA-1643685,Defective SLC5A2 causes renal glucosuria (GLYS1),Disorders of transmembrane transporters,Disease
R-HSA-5619096,R-HSA-5619115,R-HSA-1643685,Defective SLC5A5 causes thyroid dyshormonogenesis 1 (TDH1),Disorders of transmembrane transporters,Disease
R-HSA-5658471,R-HSA-5619115,R-HSA-1643685,Defective SLC5A7 causes distal hereditary motor neuronopathy 7A (HMN7A),Disorders of transmembrane transporters,Disease
R-HSA-5619114,R-HSA-5619115,R-HSA-1643685,Defective SLC5A7 causes distal hereditary motor neuronopathy 7A (HMN7A),Disorders of transmembrane transporters,Disease
R-HSA-5659729,R-HSA-5619115,R-HSA-1643685,Defective SLC6A18 may confer susceptibility to iminoglycinuria and/or hyperglycinuria,Disorders of transmembrane transporters,Disease
R-HSA-5619079,R-HSA-5619115,R-HSA-1643685,Defective SLC6A18 may confer susceptibility to iminoglycinuria and/or hyperglycinuria,Disorders of transmembrane transporters,Disease
R-HSA-5659735,R-HSA-5619115,R-HSA-1643685,Defective SLC6A19 causes Hartnup disorder (HND),Disorders of transmembrane transporters,Disease
R-HSA-5619044,R-HSA-5619115,R-HSA-1643685,Defective SLC6A19 causes Hartnup disorder (HND),Disorders of transmembrane transporters,Disease
R-HSA-5619109,R-HSA-5619115,R-HSA-1643685,Defective SLC6A2 causes orthostatic intolerance (OI),Disorders of transmembrane transporters,Disease
R-HSA-5619081,R-HSA-5619115,R-HSA-1643685,Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS),Disorders of transmembrane transporters,Disease
R-HSA-5660724,R-HSA-5619115,R-HSA-1643685,Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS),Disorders of transmembrane transporters,Disease
R-HSA-5619089,R-HSA-5619115,R-HSA-1643685,Defective SLC6A5 causes hyperekplexia 3 (HKPX3),Disorders of transmembrane transporters,Disease
R-HSA-5660862,R-HSA-5619115,R-HSA-1643685,Defective SLC7A7 causes lysinuric protein intolerance (LPI),Disorders of transmembrane transporters,Disease
R-HSA-5660883,R-HSA-5619115,R-HSA-1643685,Defective SLC7A9 causes cystinuria (CSNU),Disorders of transmembrane transporters,Disease
R-HSA-5619092,R-HSA-5619115,R-HSA-1643685,"Defective SLC9A6 causes  X-linked, syndromic mental retardation,, Christianson type (MRXSCH)",Disorders of transmembrane transporters,Disease
R-HSA-5619052,R-HSA-5619115,R-HSA-1643685,Defective SLC9A9 causes autism 16 (AUTS16),Disorders of transmembrane transporters,Disease
R-HSA-5619110,R-HSA-5619115,R-HSA-1643685,"Defective SLCO1B1 causes hyperbilirubinemia, Rotor type (HBLRR)",Disorders of transmembrane transporters,Disease
R-HSA-5619058,R-HSA-5619115,R-HSA-1643685,"Defective SLCO1B3 causes hyperbilirubinemia, Rotor type (HBLRR)",Disorders of transmembrane transporters,Disease
R-HSA-5619095,R-HSA-5619115,R-HSA-1643685,"Defective SLCO2A1 causes primary, autosomal recessive hypertrophic osteoarthropathy 2 (PHOAR2)",Disorders of transmembrane transporters,Disease
R-HSA-4755579,R-HSA-5668914,R-HSA-1643685,Defective SRD5A3 causes SRD5A3-CDG (CDG-1q) and KHRZ,Diseases of metabolism,Disease
R-HSA-3656243,R-HSA-5668914,R-HSA-1643685,Defective ST3GAL3 causes MCT12 and EIEE15,Diseases of metabolism,Disease
R-HSA-5579032,R-HSA-5668914,R-HSA-1643685,Defective TBXAS1 causes GHDD,Diseases of metabolism,Disease
R-HSA-3359454,R-HSA-5668914,R-HSA-1643685,Defective TCN2 causes hereditary megaloblastic anemia,Diseases of metabolism,Disease
R-HSA-5578995,R-HSA-5668914,R-HSA-1643685,Defective TPMT causes TPMT deficiency,Diseases of metabolism,Disease
R-HSA-5619107,R-HSA-5619115,R-HSA-1643685,Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC),Disorders of transmembrane transporters,Disease
R-HSA-5579002,R-HSA-5668914,R-HSA-1643685,Defective UGT1A1 causes hyperbilirubinemia,Diseases of metabolism,Disease
R-HSA-5579016,R-HSA-5668914,R-HSA-1643685,Defective UGT1A4 causes hyperbilirubinemia,Diseases of metabolism,Disease
R-HSA-9661069,R-HSA-9675126,R-HSA-1643685,"Defective binding of RB1 mutants to E2F1,(E2F2, E2F3)",Diseases of mitotic cell cycle,Disease
R-HSA-9672396,R-HSA-9671793,R-HSA-1643685,Defective cofactor function of FVIIIa variant,Diseases of hemostasis,Disease
R-HSA-9668250,R-HSA-9671793,R-HSA-1643685,Defective factor IX causes hemophilia B,Diseases of hemostasis,Disease
R-HSA-9672383,R-HSA-9671793,R-HSA-1643685,Defective factor IX causes thrombophilia,Diseases of hemostasis,Disease
R-HSA-9662001,R-HSA-9671793,R-HSA-1643685,Defective factor VIII causes hemophilia A,Diseases of hemostasis,Disease
R-HSA-9657688,R-HSA-9671793,R-HSA-1643685,Defective factor XII causes hereditary angioedema,Diseases of hemostasis,Disease
R-HSA-9673240,R-HSA-9671793,R-HSA-1643685,Defective gamma-carboxylation of F9,Diseases of hemostasis,Disease
R-HSA-5688031,R-HSA-5668914,R-HSA-1643685,Defective pro-SFTPB causes SMDP1 and RDS,Diseases of metabolism,Disease
R-HSA-5688354,R-HSA-5668914,R-HSA-1643685,Defective pro-SFTPC causes SMDP2 and RDS,Diseases of metabolism,Disease
R-HSA-9710421,R-HSA-9645723,R-HSA-1643685,Defective pyroptosis,Diseases of programmed cell death,Disease
R-HSA-9661070,R-HSA-9675126,R-HSA-1643685,Defective translocation of RB1 mutants to the nucleus,Diseases of mitotic cell cycle,Disease
R-HSA-3323169,R-HSA-5668914,R-HSA-1643685,Defects in biotin (Btn) metabolism,Diseases of metabolism,Disease
R-HSA-3296469,R-HSA-5668914,R-HSA-1643685,Defects in cobalamin (B12) metabolism,Diseases of metabolism,Disease
R-HSA-3296482,R-HSA-5668914,R-HSA-1643685,Defects in vitamin and cofactor metabolism,Diseases of metabolism,Disease
R-HSA-9651496,R-HSA-9671793,R-HSA-1643685,Defects of contact activation system (CAS) and kallikrein/kinin system (KKS),Diseases of hemostasis,Disease
R-HSA-1461973,R-HSA-168249,R-HSA-168256,Defensins,Innate Immune System,Immune System
R-HSA-4641257,R-HSA-195721,R-HSA-162582,Degradation of AXIN,Signaling by WNT,Signal Transduction
R-HSA-4641258,R-HSA-195721,R-HSA-162582,Degradation of DVL,Signaling by WNT,Signal Transduction
R-HSA-916853,R-HSA-112315,R-HSA-112316,Degradation of GABA,Transmission across Chemical Synapses,Neuronal System
R-HSA-5610780,R-HSA-5358351,R-HSA-162582,Degradation of GLI1 by the proteasome,Signaling by Hedgehog,Signal Transduction
R-HSA-5610783,R-HSA-5358351,R-HSA-162582,Degradation of GLI2 by the proteasome,Signaling by Hedgehog,Signal Transduction
R-HSA-195253,R-HSA-195721,R-HSA-162582,Degradation of beta-catenin by the destruction complex,Signaling by WNT,Signal Transduction
R-HSA-1614558,R-HSA-71291,R-HSA-1430728,Degradation of cysteine and homocysteine,Metabolism of amino acids and derivatives,Metabolism
R-HSA-1474228,R-HSA-1474228,R-HSA-1474244,Degradation of the extracellular matrix,Degradation of the extracellular matrix,Extracellular matrix organization
R-HSA-5467343,R-HSA-5663202,R-HSA-1643685,Deletions in the AMER1 gene destabilize the destruction complex,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-5467345,R-HSA-5663202,R-HSA-1643685,Deletions in the AXIN genes in hepatocellular carcinoma result in elevated WNT signaling,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-4419969,R-HSA-69278,R-HSA-1640170,Depolymerisation of the Nuclear Lamina,"Cell Cycle, Mitotic",Cell Cycle
R-HSA-606279,R-HSA-73886,R-HSA-1640170,Deposition of new CENPA-containing nucleosomes at the centromere,Chromosome Maintenance,Cell Cycle
R-HSA-73927,R-HSA-73884,R-HSA-73894,Depurination,Base Excision Repair,DNA Repair
R-HSA-73928,R-HSA-73884,R-HSA-73894,Depyrimidination,Base Excision Repair,DNA Repair
R-HSA-8862803,R-HSA-9645723,R-HSA-1643685,Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models,Diseases of programmed cell death,Disease
R-HSA-2022923,R-HSA-71387,R-HSA-1430728,Dermatan sulfate biosynthesis,Metabolism of carbohydrates,Metabolism
R-HSA-3299685,R-HSA-2262752,R-HSA-8953897,Detoxification of Reactive Oxygen Species,Cellular responses to stress,Cellular responses to stimuli
R-HSA-5688426,R-HSA-597592,R-HSA-392499,Deubiquitination,Post-translational protein modification,Metabolism of proteins
R-HSA-1266738,R-HSA-1266738,R-HSA-1266738,Developmental Biology,Developmental Biology,Developmental Biology
R-HSA-8935690,R-HSA-8935690,R-HSA-8963743,Digestion,Digestion,Digestion and absorption
R-HSA-8963743,R-HSA-8963743,R-HSA-8963743,Digestion and absorption,Digestion and absorption,Digestion and absorption
R-HSA-189085,R-HSA-8935690,R-HSA-8963743,Digestion of dietary carbohydrate,Digestion,Digestion and absorption
R-HSA-192456,R-HSA-8935690,R-HSA-8963743,Digestion of dietary lipid,Digestion,Digestion and absorption
R-HSA-69416,R-HSA-109581,R-HSA-5357801,Dimerization of procaspase-8,Apoptosis,Programmed Cell Death
R-HSA-4641262,R-HSA-195721,R-HSA-162582,Disassembly of the destruction complex and recruitment of AXIN to the membrane,Signaling by WNT,Signal Transduction
R-HSA-1643685,R-HSA-1643685,R-HSA-1643685,Disease,Disease,Disease
R-HSA-3781860,R-HSA-5668914,R-HSA-1643685,Diseases associated with N-glycosylation of proteins,Diseases of metabolism,Disease
R-HSA-3906995,R-HSA-5668914,R-HSA-1643685,Diseases associated with O-glycosylation of proteins,Diseases of metabolism,Disease
R-HSA-3560782,R-HSA-5668914,R-HSA-1643685,Diseases associated with glycosaminoglycan metabolism,Diseases of metabolism,Disease
R-HSA-5609975,R-HSA-5668914,R-HSA-1643685,Diseases associated with glycosylation precursor biosynthesis,Diseases of metabolism,Disease
R-HSA-5687613,R-HSA-5668914,R-HSA-1643685,Diseases associated with surfactant metabolism,Diseases of metabolism,Disease
R-HSA-5602358,R-HSA-5260271,R-HSA-1643685,Diseases associated with the TLR signaling cascade,Diseases of Immune System,Disease
R-HSA-2474795,R-HSA-9675143,R-HSA-1643685,Diseases associated with visual transduction,Diseases of the neuronal system,Disease
R-HSA-9605308,R-HSA-9675135,R-HSA-1643685,Diseases of Base Excision Repair,Diseases of DNA repair,Disease
R-HSA-9630747,R-HSA-9675132,R-HSA-1643685,Diseases of Cellular Senescence,Diseases of cellular response to stress,Disease
R-HSA-9675136,R-HSA-9675135,R-HSA-1643685,Diseases of DNA Double-Strand Break Repair,Diseases of DNA repair,Disease
R-HSA-9675135,R-HSA-9675135,R-HSA-1643685,Diseases of DNA repair,Diseases of DNA repair,Disease
R-HSA-5260271,R-HSA-5260271,R-HSA-1643685,Diseases of Immune System,Diseases of Immune System,Disease
R-HSA-5423599,R-HSA-9675135,R-HSA-1643685,Diseases of Mismatch Repair (MMR),Diseases of DNA repair,Disease
R-HSA-9673013,R-HSA-9675126,R-HSA-1643685,Diseases of Telomere Maintenance,Diseases of mitotic cell cycle,Disease
R-HSA-5663084,R-HSA-5668914,R-HSA-1643685,Diseases of carbohydrate metabolism,Diseases of metabolism,Disease
R-HSA-9675132,R-HSA-9675132,R-HSA-1643685,Diseases of cellular response to stress,Diseases of cellular response to stress,Disease
R-HSA-3781865,R-HSA-5668914,R-HSA-1643685,Diseases of glycosylation,Diseases of metabolism,Disease
R-HSA-9671793,R-HSA-9671793,R-HSA-1643685,Diseases of hemostasis,Diseases of hemostasis,Disease
R-HSA-5668914,R-HSA-5668914,R-HSA-1643685,Diseases of metabolism,Diseases of metabolism,Disease
R-HSA-9675126,R-HSA-9675126,R-HSA-1643685,Diseases of mitotic cell cycle,Diseases of mitotic cell cycle,Disease
R-HSA-9645723,R-HSA-9645723,R-HSA-1643685,Diseases of programmed cell death,Diseases of programmed cell death,Disease
R-HSA-5663202,R-HSA-5663202,R-HSA-1643685,Diseases of signal transduction by growth factor receptors and second messengers,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-9675143,R-HSA-9675143,R-HSA-1643685,Diseases of the neuronal system,Diseases of the neuronal system,Disease
R-HSA-114516,R-HSA-76002,R-HSA-109582,Disinhibition of SNARE formation,"Platelet activation, signaling and aggregation",Hemostasis
R-HSA-9675151,R-HSA-9675151,R-HSA-1643685,Disorders of Developmental Biology,Disorders of Developmental Biology,Disease
R-HSA-9697154,R-HSA-9675151,R-HSA-1643685,Disorders of Nervous System Development,Disorders of Developmental Biology,Disease
R-HSA-5619115,R-HSA-5619115,R-HSA-1643685,Disorders of transmembrane transporters,Disorders of transmembrane transporters,Disease
R-HSA-110357,R-HSA-73884,R-HSA-73894,Displacement of DNA glycosylase by APEX1,Base Excision Repair,DNA Repair
R-HSA-75205,R-HSA-75205,R-HSA-109582,Dissolution of Fibrin Clot,Dissolution of Fibrin Clot,Hemostasis
R-HSA-212676,R-HSA-112315,R-HSA-112316,Dopamine Neurotransmitter Release Cycle,Transmission across Chemical Synapses,Neuronal System
R-HSA-379401,R-HSA-112315,R-HSA-112316,Dopamine clearance from the synaptic cleft,Transmission across Chemical Synapses,Neuronal System
R-HSA-390651,R-HSA-372790,R-HSA-162582,Dopamine receptors,Signaling by GPCR,Signal Transduction
R-HSA-8863795,R-HSA-9006934,R-HSA-162582,Downregulation of ERBB2 signaling,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-1358803,R-HSA-9006934,R-HSA-162582,Downregulation of ERBB2:ERBB3 signaling,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-1253288,R-HSA-9006934,R-HSA-162582,Downregulation of ERBB4 signaling,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-2173795,R-HSA-9006936,R-HSA-162582,Downregulation of SMAD2/3:SMAD4 transcriptional activity,Signaling by TGFB family members,Signal Transduction
R-HSA-2173795,R-HSA-73857,R-HSA-74160,Downregulation of SMAD2/3:SMAD4 transcriptional activity,RNA Polymerase II Transcription,Gene expression (Transcription)
R-HSA-2173788,R-HSA-9006936,R-HSA-162582,Downregulation of TGF-beta receptor signaling,Signaling by TGFB family members,Signal Transduction
R-HSA-202424,R-HSA-1280218,R-HSA-168256,Downstream TCR signaling,Adaptive Immune System,Immune System
R-HSA-186763,R-HSA-9006934,R-HSA-162582,Downstream signal transduction,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-1168372,R-HSA-1280218,R-HSA-168256,Downstream signaling events of B Cell Receptor (BCR),Adaptive Immune System,Immune System
R-HSA-5654687,R-HSA-9006934,R-HSA-162582,Downstream signaling of activated FGFR1,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-5654696,R-HSA-9006934,R-HSA-162582,Downstream signaling of activated FGFR2,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-5654708,R-HSA-9006934,R-HSA-162582,Downstream signaling of activated FGFR3,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-5654716,R-HSA-9006934,R-HSA-162582,Downstream signaling of activated FGFR4,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-9665230,R-HSA-5663202,R-HSA-1643685,Drug resistance in ERBB2 KD mutants,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-9665737,R-HSA-5663202,R-HSA-1643685,Drug resistance in ERBB2 TMD/JMD mutants,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-9700649,R-HSA-5663202,R-HSA-1643685,Drug resistance of ALK mutants,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-9702506,R-HSA-5663202,R-HSA-1643685,Drug resistance of FLT3 mutants,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-9669937,R-HSA-5663202,R-HSA-1643685,Drug resistance of KIT mutants,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-9674415,R-HSA-5663202,R-HSA-1643685,Drug resistance of PDGFR mutants,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-9652282,R-HSA-9006934,R-HSA-162582,Drug-mediated inhibition of ERBB2 signaling,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-5696400,R-HSA-5696398,R-HSA-73894,Dual Incision in GG-NER,Nucleotide Excision Repair,DNA Repair
R-HSA-6782135,R-HSA-5696398,R-HSA-73894,Dual incision in TC-NER,Nucleotide Excision Repair,DNA Repair
R-HSA-113510,R-HSA-69278,R-HSA-1640170,E2F mediated regulation of DNA replication,"Cell Cycle, Mitotic",Cell Cycle
R-HSA-113507,R-HSA-69278,R-HSA-1640170,E2F-enabled inhibition of pre-replication complex formation,"Cell Cycle, Mitotic",Cell Cycle
R-HSA-8866654,R-HSA-597592,R-HSA-392499,E3 ubiquitin ligases ubiquitinate target proteins,Post-translational protein modification,Metabolism of proteins
R-HSA-3000178,R-HSA-3000178,R-HSA-1474244,ECM proteoglycans,ECM proteoglycans,Extracellular matrix organization
R-HSA-2179392,R-HSA-372790,R-HSA-162582,EGFR Transactivation by Gastrin,Signaling by GPCR,Signal Transduction
R-HSA-182971,R-HSA-9006934,R-HSA-162582,EGFR downregulation,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-212718,R-HSA-9006934,R-HSA-162582,EGFR interacts with phospholipase C-gamma,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-9619665,R-HSA-9675108,R-HSA-1266738,EGR2 and SOX10-mediated initiation of Schwann cell myelination,Nervous system development,Developmental Biology
R-HSA-9648025,R-HSA-69278,R-HSA-1640170,EML4 and NUDC in mitotic spindle formation,"Cell Cycle, Mitotic",Cell Cycle
R-HSA-2682334,R-HSA-9675108,R-HSA-1266738,EPH-Ephrin signaling,Nervous system development,Developmental Biology
R-HSA-3928665,R-HSA-9675108,R-HSA-1266738,EPH-ephrin mediated repulsion of cells,Nervous system development,Developmental Biology
R-HSA-3928663,R-HSA-9675108,R-HSA-1266738,EPHA-mediated growth cone collapse,Nervous system development,Developmental Biology
R-HSA-3928662,R-HSA-9675108,R-HSA-1266738,EPHB-mediated forward signaling,Nervous system development,Developmental Biology
R-HSA-901032,R-HSA-597592,R-HSA-392499,ER Quality Control Compartment (ERQC),Post-translational protein modification,Metabolism of proteins
R-HSA-199977,R-HSA-199991,R-HSA-5653656,ER to Golgi Anterograde Transport,Membrane Trafficking,Vesicle-mediated transport
R-HSA-199977,R-HSA-597592,R-HSA-392499,ER to Golgi Anterograde Transport,Post-translational protein modification,Metabolism of proteins
R-HSA-1236974,R-HSA-1280218,R-HSA-168256,ER-Phagosome pathway,Adaptive Immune System,Immune System
R-HSA-8847993,R-HSA-9006934,R-HSA-162582,ERBB2 Activates PTK6 Signaling,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-8847993,R-HSA-9006927,R-HSA-162582,ERBB2 Activates PTK6 Signaling,Signaling by Non-Receptor Tyrosine Kinases,Signal Transduction
R-HSA-6785631,R-HSA-9006934,R-HSA-162582,ERBB2 Regulates Cell Motility,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-427389,R-HSA-212165,R-HSA-74160,ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression,Epigenetic regulation of gene expression,Gene expression (Transcription)
R-HSA-198753,R-HSA-9006934,R-HSA-162582,ERK/MAPK targets,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-198753,R-HSA-168249,R-HSA-168256,ERK/MAPK targets,Innate Immune System,Immune System
R-HSA-198753,R-HSA-168249,R-HSA-168256,ERK/MAPK targets,Innate Immune System,Immune System
R-HSA-198753,R-HSA-168249,R-HSA-168256,ERK/MAPK targets,Innate Immune System,Immune System
R-HSA-198753,R-HSA-168249,R-HSA-168256,ERK/MAPK targets,Innate Immune System,Immune System
R-HSA-198753,R-HSA-1280215,R-HSA-168256,ERK/MAPK targets,Cytokine Signaling in Immune system,Immune System
R-HSA-198753,R-HSA-168249,R-HSA-168256,ERK/MAPK targets,Innate Immune System,Immune System
R-HSA-198753,R-HSA-168249,R-HSA-168256,ERK/MAPK targets,Innate Immune System,Immune System
R-HSA-198753,R-HSA-168249,R-HSA-168256,ERK/MAPK targets,Innate Immune System,Immune System
R-HSA-198753,R-HSA-168249,R-HSA-168256,ERK/MAPK targets,Innate Immune System,Immune System
R-HSA-198753,R-HSA-168249,R-HSA-168256,ERK/MAPK targets,Innate Immune System,Immune System
R-HSA-202670,R-HSA-9006934,R-HSA-162582,ERKs are inactivated,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-202670,R-HSA-168249,R-HSA-168256,ERKs are inactivated,Innate Immune System,Immune System
R-HSA-202670,R-HSA-168249,R-HSA-168256,ERKs are inactivated,Innate Immune System,Immune System
R-HSA-202670,R-HSA-168249,R-HSA-168256,ERKs are inactivated,Innate Immune System,Immune System
R-HSA-202670,R-HSA-168249,R-HSA-168256,ERKs are inactivated,Innate Immune System,Immune System
R-HSA-202670,R-HSA-1280215,R-HSA-168256,ERKs are inactivated,Cytokine Signaling in Immune system,Immune System
R-HSA-202670,R-HSA-168249,R-HSA-168256,ERKs are inactivated,Innate Immune System,Immune System
R-HSA-202670,R-HSA-168249,R-HSA-168256,ERKs are inactivated,Innate Immune System,Immune System
R-HSA-202670,R-HSA-168249,R-HSA-168256,ERKs are inactivated,Innate Immune System,Immune System
R-HSA-202670,R-HSA-168249,R-HSA-168256,ERKs are inactivated,Innate Immune System,Immune System
R-HSA-202670,R-HSA-168249,R-HSA-168256,ERKs are inactivated,Innate Immune System,Immune System
R-HSA-8939211,R-HSA-9006931,R-HSA-162582,ESR-mediated signaling,Signaling by Nuclear Receptors,Signal Transduction
R-HSA-162594,R-HSA-5663205,R-HSA-1643685,Early Phase of HIV Life Cycle,Infectious disease,Disease
R-HSA-114508,R-HSA-372790,R-HSA-162582,Effects of PIP2 hydrolysis,Signaling by GPCR,Signal Transduction
R-HSA-114508,R-HSA-76002,R-HSA-109582,Effects of PIP2 hydrolysis,"Platelet activation, signaling and aggregation",Hemostasis
R-HSA-391903,R-HSA-372790,R-HSA-162582,Eicosanoid ligand-binding receptors,Signaling by GPCR,Signal Transduction
R-HSA-211979,R-HSA-211859,R-HSA-1430728,Eicosanoids,Biological oxidations,Metabolism
R-HSA-1566948,R-HSA-1566948,R-HSA-1474244,Elastic fibre formation,Elastic fibre formation,Extracellular matrix organization
R-HSA-112303,R-HSA-112307,R-HSA-112316,Electric Transmission Across Gap Junctions,Transmission across Electrical Synapses,Neuronal System
R-HSA-2395516,R-HSA-1362409,R-HSA-1430728,Electron transport from NADPH to Ferredoxin,Mitochondrial iron-sulfur cluster biogenesis,Metabolism
R-HSA-139853,R-HSA-418346,R-HSA-109582,Elevation of cytosolic Ca2+ levels,Platelet homeostasis,Hemostasis
R-HSA-211976,R-HSA-211859,R-HSA-1430728,Endogenous sterols,Biological oxidations,Metabolism
R-HSA-917729,R-HSA-199991,R-HSA-5653656,Endosomal Sorting Complex Required For Transport (ESCRT),Membrane Trafficking,Vesicle-mediated transport
R-HSA-1236977,R-HSA-1280218,R-HSA-168256,Endosomal/Vacuolar pathway,Adaptive Immune System,Immune System
R-HSA-380972,R-HSA-165159,R-HSA-162582,Energy dependent regulation of mTOR by LKB1-AMPK,MTOR signalling,Signal Transduction
R-HSA-168275,R-HSA-5663205,R-HSA-1643685,Entry of Influenza Virion into Host Cell via Endocytosis,Infectious disease,Disease
R-HSA-379398,R-HSA-112315,R-HSA-112316,Enzymatic degradation of Dopamine by monoamine oxidase,Transmission across Chemical Synapses,Neuronal System
R-HSA-379397,R-HSA-112315,R-HSA-112316,Enzymatic degradation of dopamine by COMT,Transmission across Chemical Synapses,Neuronal System
R-HSA-3928664,R-HSA-9675108,R-HSA-1266738,Ephrin signaling,Nervous system development,Developmental Biology
R-HSA-212165,R-HSA-212165,R-HSA-74160,Epigenetic regulation of gene expression,Epigenetic regulation of gene expression,Gene expression (Transcription)
R-HSA-1237044,R-HSA-1480926,R-HSA-382551,Erythrocytes take up carbon dioxide and release oxygen,O2/CO2 exchange in erythrocytes,Transport of small molecules
R-HSA-1247673,R-HSA-1480926,R-HSA-382551,Erythrocytes take up oxygen and release carbon dioxide,O2/CO2 exchange in erythrocytes,Transport of small molecules
R-HSA-9027276,R-HSA-9006335,R-HSA-162582,Erythropoietin activates Phosphoinositide-3-kinase (PI3K),Signaling by Erythropoietin,Signal Transduction
R-HSA-9027277,R-HSA-9006335,R-HSA-162582,Erythropoietin activates Phospholipase C gamma (PLCG),Signaling by Erythropoietin,Signal Transduction
R-HSA-9027284,R-HSA-9006335,R-HSA-162582,Erythropoietin activates RAS,Signaling by Erythropoietin,Signal Transduction
R-HSA-9027283,R-HSA-9006335,R-HSA-162582,Erythropoietin activates STAT5,Signaling by Erythropoietin,Signal Transduction
R-HSA-9637679,R-HSA-5663205,R-HSA-1643685,Escape of Mtb from the phagocyte,Infectious disease,Disease
R-HSA-5657562,R-HSA-5668914,R-HSA-1643685,Essential fructosuria,Diseases of metabolism,Disease
R-HSA-5662853,R-HSA-5668914,R-HSA-1643685,Essential pentosuria,Diseases of metabolism,Disease
R-HSA-2468052,R-HSA-69278,R-HSA-1640170,Establishment of Sister Chromatid Cohesion,"Cell Cycle, Mitotic",Cell Cycle
R-HSA-193144,R-HSA-556833,R-HSA-1430728,Estrogen biosynthesis,Metabolism of lipids,Metabolism
R-HSA-9018519,R-HSA-9006931,R-HSA-162582,Estrogen-dependent gene expression,Signaling by Nuclear Receptors,Signal Transduction
R-HSA-9634638,R-HSA-9006931,R-HSA-162582,Estrogen-dependent nuclear events downstream of ESR-membrane signaling,Signaling by Nuclear Receptors,Signal Transduction
R-HSA-9634635,R-HSA-9006931,R-HSA-162582,Estrogen-stimulated signaling through PRKCZ,Signaling by Nuclear Receptors,Signal Transduction
R-HSA-71384,R-HSA-211859,R-HSA-1430728,Ethanol oxidation,Biological oxidations,Metabolism
R-HSA-156842,R-HSA-72766,R-HSA-392499,Eukaryotic Translation Elongation,Translation,Metabolism of proteins
R-HSA-72613,R-HSA-72766,R-HSA-392499,Eukaryotic Translation Initiation,Translation,Metabolism of proteins
R-HSA-72764,R-HSA-72766,R-HSA-392499,Eukaryotic Translation Termination,Translation,Metabolism of proteins
R-HSA-9630791,R-HSA-9675132,R-HSA-1643685,Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4,Diseases of cellular response to stress,Disease
R-HSA-9630794,R-HSA-9675132,R-HSA-1643685,Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6,Diseases of cellular response to stress,Disease
R-HSA-9646303,R-HSA-9675132,R-HSA-1643685,Evasion of Oncogene Induced Senescence Due to p14ARF Defects,Diseases of cellular response to stress,Disease
R-HSA-9630750,R-HSA-9675132,R-HSA-1643685,Evasion of Oncogene Induced Senescence Due to p16INK4A Defects,Diseases of cellular response to stress,Disease
R-HSA-9632697,R-HSA-9675132,R-HSA-1643685,Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4,Diseases of cellular response to stress,Disease
R-HSA-9632700,R-HSA-9675132,R-HSA-1643685,Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6,Diseases of cellular response to stress,Disease
R-HSA-9646304,R-HSA-9675132,R-HSA-1643685,Evasion of Oxidative Stress Induced Senescence Due to p14ARF Defects,Diseases of cellular response to stress,Disease
R-HSA-9632693,R-HSA-9675132,R-HSA-1643685,Evasion of Oxidative Stress Induced Senescence Due to p16INK4A Defects,Diseases of cellular response to stress,Disease
R-HSA-8941413,R-HSA-168249,R-HSA-168256,Events associated with phagocytolytic activity of PMN cells,Innate Immune System,Immune System
R-HSA-168274,R-HSA-5663205,R-HSA-1643685,Export of Viral Ribonucleoproteins from Nucleus,Infectious disease,Disease
R-HSA-9036866,R-HSA-9006934,R-HSA-162582,Expression and Processing of Neurotrophins,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-180786,R-HSA-73886,R-HSA-1640170,Extension of Telomeres,Chromosome Maintenance,Cell Cycle
R-HSA-9009391,R-HSA-9006931,R-HSA-162582,Extra-nuclear estrogen signaling,Signaling by Nuclear Receptors,Signal Transduction
R-HSA-1474244,R-HSA-1474244,R-HSA-1474244,Extracellular matrix organization,Extracellular matrix organization,Extracellular matrix organization
R-HSA-140834,R-HSA-140877,R-HSA-109582,Extrinsic Pathway of Fibrin Clot Formation,Formation of Fibrin Clot (Clotting Cascade),Hemostasis
R-HSA-8854050,R-HSA-69278,R-HSA-1640170,FBXL7 down-regulates AURKA during mitotic entry and in early mitosis,"Cell Cycle, Mitotic",Cell Cycle
R-HSA-2644605,R-HSA-5663202,R-HSA-1643685,FBXW7 Mutants and NOTCH1 in Cancer,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-2871809,R-HSA-168249,R-HSA-168256,FCERI mediated Ca+2 mobilization,Innate Immune System,Immune System
R-HSA-2871796,R-HSA-168249,R-HSA-168256,FCERI mediated MAPK activation,Innate Immune System,Immune System
R-HSA-2871837,R-HSA-168249,R-HSA-168256,FCERI mediated NF-kB activation,Innate Immune System,Immune System
R-HSA-2029481,R-HSA-168249,R-HSA-168256,FCGR activation,Innate Immune System,Immune System
R-HSA-9664323,R-HSA-5663205,R-HSA-1643685,FCGR3A-mediated IL10 synthesis,Infectious disease,Disease
R-HSA-9664422,R-HSA-5663205,R-HSA-1643685,FCGR3A-mediated phagocytosis,Infectious disease,Disease
R-HSA-190242,R-HSA-9006934,R-HSA-162582,FGFR1 ligand binding and activation,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-1839124,R-HSA-5663202,R-HSA-1643685,FGFR1 mutant receptor activation,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-190370,R-HSA-9006934,R-HSA-162582,FGFR1b ligand binding and activation,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-190374,R-HSA-9006934,R-HSA-162582,FGFR1c and Klotho ligand binding and activation,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-190373,R-HSA-9006934,R-HSA-162582,FGFR1c ligand binding and activation,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-6803529,R-HSA-9006934,R-HSA-162582,FGFR2 alternative splicing,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-190241,R-HSA-9006934,R-HSA-162582,FGFR2 ligand binding and activation,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-1839126,R-HSA-5663202,R-HSA-1643685,FGFR2 mutant receptor activation,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-190377,R-HSA-9006934,R-HSA-162582,FGFR2b ligand binding and activation,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-190375,R-HSA-9006934,R-HSA-162582,FGFR2c ligand binding and activation,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-190239,R-HSA-9006934,R-HSA-162582,FGFR3 ligand binding and activation,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-2033514,R-HSA-5663202,R-HSA-1643685,FGFR3 mutant receptor activation,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-190371,R-HSA-9006934,R-HSA-162582,FGFR3b ligand binding and activation,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-190372,R-HSA-9006934,R-HSA-162582,FGFR3c ligand binding and activation,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-190322,R-HSA-9006934,R-HSA-162582,FGFR4 ligand binding and activation,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-1839128,R-HSA-5663202,R-HSA-1643685,FGFR4 mutant receptor activation,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-5658623,R-HSA-9006934,R-HSA-162582,FGFRL1 modulation of FGFR1 signaling,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-9607240,R-HSA-1280215,R-HSA-168256,FLT3 Signaling,Cytokine Signaling in Immune system,Immune System
R-HSA-9702509,R-HSA-5663202,R-HSA-1643685,FLT3 mutants bind TKIs,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-9706377,R-HSA-5663202,R-HSA-1643685,FLT3 signaling by CBL mutants,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-9682385,R-HSA-5663202,R-HSA-1643685,FLT3 signaling in disease,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-9706374,R-HSA-1280215,R-HSA-168256,FLT3 signaling through SRC family kinases,Cytokine Signaling in Immune system,Immune System
R-HSA-217271,R-HSA-211859,R-HSA-1430728,FMO oxidises nucleophiles,Biological oxidations,Metabolism
R-HSA-9614085,R-HSA-73857,R-HSA-74160,FOXO-mediated transcription,RNA Polymerase II Transcription,Gene expression (Transcription)
R-HSA-9617828,R-HSA-73857,R-HSA-74160,FOXO-mediated transcription of cell cycle genes,RNA Polymerase II Transcription,Gene expression (Transcription)
R-HSA-9614657,R-HSA-73857,R-HSA-74160,FOXO-mediated transcription of cell death genes,RNA Polymerase II Transcription,Gene expression (Transcription)
R-HSA-9615017,R-HSA-73857,R-HSA-74160,"FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes",RNA Polymerase II Transcription,Gene expression (Transcription)
R-HSA-5654693,R-HSA-9006934,R-HSA-162582,FRS-mediated FGFR1 signaling,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-5654700,R-HSA-9006934,R-HSA-162582,FRS-mediated FGFR2 signaling,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-5654706,R-HSA-9006934,R-HSA-162582,FRS-mediated FGFR3 signaling,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-5654712,R-HSA-9006934,R-HSA-162582,FRS-mediated FGFR4 signaling,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-983231,R-HSA-983231,R-HSA-109582,Factors involved in megakaryocyte development and platelet production,Factors involved in megakaryocyte development and platelet production,Hemostasis
R-HSA-6783310,R-HSA-6783310,R-HSA-73894,Fanconi Anemia Pathway,Fanconi Anemia Pathway,DNA Repair
R-HSA-75157,R-HSA-73887,R-HSA-162582,FasL/ CD95L signaling,Death Receptor Signalling,Signal Transduction
R-HSA-434316,R-HSA-163685,R-HSA-1430728,Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion,Integration of energy metabolism,Metabolism
R-HSA-8978868,R-HSA-556833,R-HSA-1430728,Fatty acid metabolism,Metabolism of lipids,Metabolism
R-HSA-211935,R-HSA-211859,R-HSA-1430728,Fatty acids,Biological oxidations,Metabolism
R-HSA-75105,R-HSA-556833,R-HSA-1430728,Fatty acyl-CoA biosynthesis,Metabolism of lipids,Metabolism
R-HSA-2454202,R-HSA-168249,R-HSA-168256,Fc epsilon receptor (FCERI) signaling,Innate Immune System,Immune System
R-HSA-2029480,R-HSA-168249,R-HSA-168256,Fcgamma receptor (FCGR) dependent phagocytosis,Innate Immune System,Immune System
R-HSA-1187000,R-HSA-1187000,R-HSA-1474165,Fertilization,Fertilization,Reproduction
R-HSA-1566977,R-HSA-1566977,R-HSA-1474244,Fibronectin matrix formation,Fibronectin matrix formation,Extracellular matrix organization
R-HSA-2855086,R-HSA-168249,R-HSA-168256,Ficolins bind to repetitive carbohydrate structures on the target cell surface,Innate Immune System,Immune System
R-HSA-390450,R-HSA-391251,R-HSA-392499,Folding of actin by CCT/TriC,Protein folding,Metabolism of proteins
R-HSA-163210,R-HSA-1428517,R-HSA-1430728,Formation of ATP by chemiosmotic coupling,The citric acid (TCA) cycle and respiratory electron transport,Metabolism
R-HSA-140877,R-HSA-140877,R-HSA-109582,Formation of Fibrin Clot (Clotting Cascade),Formation of Fibrin Clot (Clotting Cascade),Hemostasis
R-HSA-167152,R-HSA-5663205,R-HSA-1643685,Formation of HIV elongation complex in the absence of HIV Tat,Infectious disease,Disease
R-HSA-167200,R-HSA-5663205,R-HSA-1643685,Formation of HIV-1 elongation complex containing HIV-1 Tat,Infectious disease,Disease
R-HSA-5696395,R-HSA-5696398,R-HSA-73894,Formation of Incision Complex in GG-NER,Nucleotide Excision Repair,DNA Repair
R-HSA-112382,R-HSA-73857,R-HSA-74160,Formation of RNA Pol II elongation complex,RNA Polymerase II Transcription,Gene expression (Transcription)
R-HSA-2559584,R-HSA-2262752,R-HSA-8953897,Formation of Senescence-Associated Heterochromatin Foci (SAHF),Cellular responses to stress,Cellular responses to stimuli
R-HSA-6781823,R-HSA-5696398,R-HSA-73894,Formation of TC-NER Pre-Incision Complex,Nucleotide Excision Repair,DNA Repair
R-HSA-72689,R-HSA-72766,R-HSA-392499,Formation of a pool of free 40S subunits,Translation,Metabolism of proteins
R-HSA-196025,R-HSA-199991,R-HSA-5653656,Formation of annular gap junctions,Membrane Trafficking,Vesicle-mediated transport
R-HSA-111458,R-HSA-109581,R-HSA-5357801,Formation of apoptosome,Apoptosis,Programmed Cell Death
R-HSA-77042,R-HSA-75072,R-HSA-8953854,Formation of editosomes by ADAR proteins,mRNA Editing,Metabolism of RNA
R-HSA-2408499,R-HSA-71291,R-HSA-1430728,Formation of selenosugars for excretion,Metabolism of amino acids and derivatives,Metabolism
R-HSA-113418,R-HSA-73857,R-HSA-74160,Formation of the Early Elongation Complex,RNA Polymerase II Transcription,Gene expression (Transcription)
R-HSA-75094,R-HSA-75072,R-HSA-8953854,Formation of the Editosome,mRNA Editing,Metabolism of RNA
R-HSA-167158,R-HSA-5663205,R-HSA-1643685,Formation of the HIV-1 Early Elongation Complex,Infectious disease,Disease
R-HSA-173599,R-HSA-211859,R-HSA-1430728,"Formation of the active cofactor, UDP-glucuronate",Biological oxidations,Metabolism
R-HSA-201722,R-HSA-195721,R-HSA-162582,Formation of the beta-catenin:TCF transactivating complex,Signaling by WNT,Signal Transduction
R-HSA-6809371,R-HSA-6805567,R-HSA-1266738,Formation of the cornified envelope,Keratinization,Developmental Biology
R-HSA-72695,R-HSA-72766,R-HSA-392499,"Formation of the ternary complex, and subsequently, the 43S complex",Translation,Metabolism of proteins
R-HSA-389960,R-HSA-391251,R-HSA-392499,Formation of tubulin folding intermediates by CCT/TriC,Protein folding,Metabolism of proteins
R-HSA-5661270,R-HSA-71387,R-HSA-1430728,Formation of xylulose-5-phosphate,Metabolism of carbohydrates,Metabolism
R-HSA-444473,R-HSA-372790,R-HSA-162582,Formyl peptide receptors bind formyl peptides and many other ligands,Signaling by GPCR,Signal Transduction
R-HSA-444209,R-HSA-372790,R-HSA-162582,Free fatty acid receptors,Signaling by GPCR,Signal Transduction
R-HSA-400451,R-HSA-163685,R-HSA-1430728,Free fatty acids regulate insulin secretion,Integration of energy metabolism,Metabolism
R-HSA-170968,R-HSA-9006934,R-HSA-162582,Frs2-mediated activation,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-5652227,R-HSA-71387,R-HSA-1430728,Fructose biosynthesis,Metabolism of carbohydrates,Metabolism
R-HSA-70350,R-HSA-71387,R-HSA-1430728,Fructose catabolism,Metabolism of carbohydrates,Metabolism
R-HSA-5652084,R-HSA-71387,R-HSA-1430728,Fructose metabolism,Metabolism of carbohydrates,Metabolism
R-HSA-168270,R-HSA-5663205,R-HSA-1643685,Fusion and Uncoating of the Influenza Virion,Infectious disease,Disease
R-HSA-168288,R-HSA-5663205,R-HSA-1643685,Fusion of the Influenza Virion to the Host Cell Endosome,Infectious disease,Disease
R-HSA-416482,R-HSA-372790,R-HSA-162582,G alpha (12/13) signalling events,Signaling by GPCR,Signal Transduction
R-HSA-418594,R-HSA-372790,R-HSA-162582,G alpha (i) signalling events,Signaling by GPCR,Signal Transduction
R-HSA-416476,R-HSA-372790,R-HSA-162582,G alpha (q) signalling events,Signaling by GPCR,Signal Transduction
R-HSA-418555,R-HSA-372790,R-HSA-162582,G alpha (s) signalling events,Signaling by GPCR,Signal Transduction
R-HSA-418597,R-HSA-372790,R-HSA-162582,G alpha (z) signalling events,Signaling by GPCR,Signal Transduction
R-HSA-8964315,R-HSA-372790,R-HSA-162582,G beta:gamma signalling through BTK,Signaling by GPCR,Signal Transduction
R-HSA-8964616,R-HSA-372790,R-HSA-162582,G beta:gamma signalling through CDC42,Signaling by GPCR,Signal Transduction
R-HSA-392451,R-HSA-372790,R-HSA-162582,G beta:gamma signalling through PI3Kgamma,Signaling by GPCR,Signal Transduction
R-HSA-418217,R-HSA-372790,R-HSA-162582,G beta:gamma signalling through PLC beta,Signaling by GPCR,Signal Transduction
R-HSA-1296059,R-HSA-1296071,R-HSA-112316,G protein gated Potassium channels,Potassium Channels,Neuronal System
R-HSA-202040,R-HSA-372790,R-HSA-162582,G-protein activation,Signaling by GPCR,Signal Transduction
R-HSA-397795,R-HSA-372790,R-HSA-162582,G-protein beta:gamma signalling,Signaling by GPCR,Signal Transduction
R-HSA-112040,R-HSA-372790,R-HSA-162582,G-protein mediated events,Signaling by GPCR,Signal Transduction
R-HSA-1538133,R-HSA-69278,R-HSA-1640170,G0 and Early G1,"Cell Cycle, Mitotic",Cell Cycle
R-HSA-69236,R-HSA-69278,R-HSA-1640170,G1 Phase,"Cell Cycle, Mitotic",Cell Cycle
R-HSA-69615,R-HSA-69620,R-HSA-1640170,G1/S DNA Damage Checkpoints,Cell Cycle Checkpoints,Cell Cycle
R-HSA-69206,R-HSA-69278,R-HSA-1640170,G1/S Transition,"Cell Cycle, Mitotic",Cell Cycle
R-HSA-69205,R-HSA-69278,R-HSA-1640170,G1/S-Specific Transcription,"Cell Cycle, Mitotic",Cell Cycle
R-HSA-68911,R-HSA-69278,R-HSA-1640170,G2 Phase,"Cell Cycle, Mitotic",Cell Cycle
R-HSA-69481,R-HSA-69620,R-HSA-1640170,G2/M Checkpoints,Cell Cycle Checkpoints,Cell Cycle
R-HSA-69473,R-HSA-69620,R-HSA-1640170,G2/M DNA damage checkpoint,Cell Cycle Checkpoints,Cell Cycle
R-HSA-69478,R-HSA-69620,R-HSA-1640170,G2/M DNA replication checkpoint,Cell Cycle Checkpoints,Cell Cycle
R-HSA-69275,R-HSA-69278,R-HSA-1640170,G2/M Transition,"Cell Cycle, Mitotic",Cell Cycle
R-HSA-180292,R-HSA-9006934,R-HSA-162582,GAB1 signalosome,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-977444,R-HSA-112315,R-HSA-112316,GABA B receptor activation,Transmission across Chemical Synapses,Neuronal System
R-HSA-977443,R-HSA-112315,R-HSA-112316,GABA receptor activation,Transmission across Chemical Synapses,Neuronal System
R-HSA-888568,R-HSA-112315,R-HSA-112316,GABA synthesis,Transmission across Chemical Synapses,Neuronal System
R-HSA-888590,R-HSA-112315,R-HSA-112316,"GABA synthesis, release, reuptake and degradation",Transmission across Chemical Synapses,Neuronal System
R-HSA-6787639,R-HSA-597592,R-HSA-392499,GDP-fucose biosynthesis,Post-translational protein modification,Metabolism of proteins
R-HSA-5635851,R-HSA-5358351,R-HSA-162582,GLI proteins bind promoters of Hh responsive genes to promote transcription,Signaling by Hedgehog,Signal Transduction
R-HSA-5610785,R-HSA-5358351,R-HSA-162582,GLI3 is processed to GLI3R by the proteasome,Signaling by Hedgehog,Signal Transduction
R-HSA-430116,R-HSA-76002,R-HSA-109582,GP1b-IX-V activation signalling,"Platelet activation, signaling and aggregation",Hemostasis
R-HSA-388396,R-HSA-372790,R-HSA-162582,GPCR downstream signalling,Signaling by GPCR,Signal Transduction
R-HSA-500792,R-HSA-372790,R-HSA-162582,GPCR ligand binding,Signaling by GPCR,Signal Transduction
R-HSA-114604,R-HSA-76002,R-HSA-109582,GPVI-mediated activation cascade,"Platelet activation, signaling and aggregation",Hemostasis
R-HSA-179812,R-HSA-9006934,R-HSA-162582,GRB2 events in EGFR signaling,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-1963640,R-HSA-9006934,R-HSA-162582,GRB2 events in ERBB2 signaling,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-354194,R-HSA-354192,R-HSA-162582,GRB2:SOS provides linkage to MAPK signaling for Integrins,Integrin signaling,Signal Transduction
R-HSA-354194,R-HSA-76002,R-HSA-109582,GRB2:SOS provides linkage to MAPK signaling for Integrins,"Platelet activation, signaling and aggregation",Hemostasis
R-HSA-1306955,R-HSA-9006934,R-HSA-162582,GRB7 events in ERBB2 signaling,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-72706,R-HSA-72766,R-HSA-392499,GTP hydrolysis and joining of the 60S ribosomal subunit,Translation,Metabolism of proteins
R-HSA-9726842,R-HSA-5663202,R-HSA-1643685,Gain-of-function MRAS complexes activate RAF signaling,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-70370,R-HSA-71387,R-HSA-1430728,Galactose catabolism,Metabolism of carbohydrates,Metabolism
R-HSA-163841,R-HSA-597592,R-HSA-392499,"Gamma carboxylation, hypusine formation and arylsulfatase activation",Post-translational protein modification,Metabolism of proteins
R-HSA-159740,R-HSA-597592,R-HSA-392499,Gamma-carboxylation of protein precursors,Post-translational protein modification,Metabolism of proteins
R-HSA-159854,R-HSA-597592,R-HSA-392499,"Gamma-carboxylation, transport, and amino-terminal cleavage of proteins",Post-translational protein modification,Metabolism of proteins
R-HSA-190861,R-HSA-199991,R-HSA-5653656,Gap junction assembly,Membrane Trafficking,Vesicle-mediated transport
R-HSA-190873,R-HSA-199991,R-HSA-5653656,Gap junction degradation,Membrane Trafficking,Vesicle-mediated transport
R-HSA-190828,R-HSA-199991,R-HSA-5653656,Gap junction trafficking,Membrane Trafficking,Vesicle-mediated transport
R-HSA-157858,R-HSA-199991,R-HSA-5653656,Gap junction trafficking and regulation,Membrane Trafficking,Vesicle-mediated transport
R-HSA-5696397,R-HSA-5696398,R-HSA-73894,Gap-filling DNA repair synthesis and ligation in GG-NER,Nucleotide Excision Repair,DNA Repair
R-HSA-6782210,R-HSA-5696398,R-HSA-73894,Gap-filling DNA repair synthesis and ligation in TC-NER,Nucleotide Excision Repair,DNA Repair
R-HSA-881907,R-HSA-372790,R-HSA-162582,Gastrin-CREB signalling pathway via PKC and MAPK,Signaling by GPCR,Signal Transduction
R-HSA-211000,R-HSA-211000,R-HSA-74160,Gene Silencing by RNA,Gene Silencing by RNA,Gene expression (Transcription)
R-HSA-8950505,R-HSA-1280215,R-HSA-168256,Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation,Cytokine Signaling in Immune system,Immune System
R-HSA-74160,R-HSA-74160,R-HSA-74160,Gene expression (Transcription),Gene expression (Transcription),Gene expression (Transcription)
R-HSA-202433,R-HSA-1280218,R-HSA-168256,Generation of second messenger molecules,Adaptive Immune System,Immune System
R-HSA-212436,R-HSA-73857,R-HSA-74160,Generic Transcription Pathway,RNA Polymerase II Transcription,Gene expression (Transcription)
R-HSA-5696399,R-HSA-5696398,R-HSA-73894,Global Genome Nucleotide Excision Repair (GG-NER),Nucleotide Excision Repair,DNA Repair
R-HSA-163359,R-HSA-163685,R-HSA-1430728,Glucagon signaling in metabolic regulation,Integration of energy metabolism,Metabolism
R-HSA-381676,R-HSA-163685,R-HSA-1430728,Glucagon-like Peptide-1 (GLP1) regulates insulin secretion,Integration of energy metabolism,Metabolism
R-HSA-420092,R-HSA-372790,R-HSA-162582,Glucagon-type ligand receptors,Signaling by GPCR,Signal Transduction
R-HSA-194002,R-HSA-556833,R-HSA-1430728,Glucocorticoid biosynthesis,Metabolism of lipids,Metabolism
R-HSA-70263,R-HSA-71387,R-HSA-1430728,Gluconeogenesis,Metabolism of carbohydrates,Metabolism
R-HSA-70326,R-HSA-71387,R-HSA-1430728,Glucose metabolism,Metabolism of carbohydrates,Metabolism
R-HSA-156588,R-HSA-211859,R-HSA-1430728,Glucuronidation,Biological oxidations,Metabolism
R-HSA-210500,R-HSA-112315,R-HSA-112316,Glutamate Neurotransmitter Release Cycle,Transmission across Chemical Synapses,Neuronal System
R-HSA-8964539,R-HSA-71291,R-HSA-1430728,Glutamate and glutamine metabolism,Metabolism of amino acids and derivatives,Metabolism
R-HSA-399721,R-HSA-112315,R-HSA-112316,"Glutamate binding, activation of AMPA receptors and synaptic plasticity",Transmission across Chemical Synapses,Neuronal System
R-HSA-156590,R-HSA-211859,R-HSA-1430728,Glutathione conjugation,Biological oxidations,Metabolism
R-HSA-174403,R-HSA-211859,R-HSA-1430728,Glutathione synthesis and recycling,Biological oxidations,Metabolism
R-HSA-1483206,R-HSA-556833,R-HSA-1430728,Glycerophospholipid biosynthesis,Metabolism of lipids,Metabolism
R-HSA-6814848,R-HSA-556833,R-HSA-1430728,Glycerophospholipid catabolism,Metabolism of lipids,Metabolism
R-HSA-6783984,R-HSA-71291,R-HSA-1430728,Glycine degradation,Metabolism of amino acids and derivatives,Metabolism
R-HSA-70221,R-HSA-71387,R-HSA-1430728,Glycogen breakdown (glycogenolysis),Metabolism of carbohydrates,Metabolism
R-HSA-8982491,R-HSA-71387,R-HSA-1430728,Glycogen metabolism,Metabolism of carbohydrates,Metabolism
R-HSA-3858516,R-HSA-5668914,R-HSA-1643685,Glycogen storage disease type 0 (liver GYS2),Diseases of metabolism,Disease
R-HSA-3828062,R-HSA-5668914,R-HSA-1643685,Glycogen storage disease type 0 (muscle GYS1),Diseases of metabolism,Disease
R-HSA-5357609,R-HSA-5668914,R-HSA-1643685,Glycogen storage disease type II (GAA),Diseases of metabolism,Disease
R-HSA-3878781,R-HSA-5668914,R-HSA-1643685,Glycogen storage disease type IV (GBE1),Diseases of metabolism,Disease
R-HSA-3274531,R-HSA-5668914,R-HSA-1643685,Glycogen storage disease type Ia (G6PC),Diseases of metabolism,Disease
R-HSA-3229133,R-HSA-5668914,R-HSA-1643685,Glycogen storage disease type Ib (SLC37A4),Diseases of metabolism,Disease
R-HSA-3814836,R-HSA-5668914,R-HSA-1643685,Glycogen storage disease type XV (GYG1),Diseases of metabolism,Disease
R-HSA-3229121,R-HSA-5668914,R-HSA-1643685,Glycogen storage diseases,Diseases of metabolism,Disease
R-HSA-3322077,R-HSA-71387,R-HSA-1430728,Glycogen synthesis,Metabolism of carbohydrates,Metabolism
R-HSA-70171,R-HSA-71387,R-HSA-1430728,Glycolysis,Metabolism of carbohydrates,Metabolism
R-HSA-209822,R-HSA-2980736,R-HSA-392499,Glycoprotein hormones,Peptide hormone metabolism,Metabolism of proteins
R-HSA-1630316,R-HSA-71387,R-HSA-1430728,Glycosaminoglycan metabolism,Metabolism of carbohydrates,Metabolism
R-HSA-1660662,R-HSA-556833,R-HSA-1430728,Glycosphingolipid metabolism,Metabolism of lipids,Metabolism
R-HSA-389661,R-HSA-71291,R-HSA-1430728,Glyoxylate metabolism and glycine degradation,Metabolism of amino acids and derivatives,Metabolism
R-HSA-432722,R-HSA-199991,R-HSA-5653656,Golgi Associated Vesicle Biogenesis,Membrane Trafficking,Vesicle-mediated transport
R-HSA-162658,R-HSA-69278,R-HSA-1640170,Golgi Cisternae Pericentriolar Stack Reorganization,"Cell Cycle, Mitotic",Cell Cycle
R-HSA-8856688,R-HSA-199991,R-HSA-5653656,Golgi-to-ER retrograde transport,Membrane Trafficking,Vesicle-mediated transport
R-HSA-982772,R-HSA-1280215,R-HSA-168256,Growth hormone receptor signaling,Cytokine Signaling in Immune system,Immune System
R-HSA-3214847,R-HSA-3247509,R-HSA-4839726,HATs acetylate histones,Chromatin modifying enzymes,Chromatin organization
R-HSA-9609690,R-HSA-5663205,R-HSA-1643685,HCMV Early Events,Infectious disease,Disease
R-HSA-9609646,R-HSA-5663205,R-HSA-1643685,HCMV Infection,Infectious disease,Disease
R-HSA-9610379,R-HSA-5663205,R-HSA-1643685,HCMV Late Events,Infectious disease,Disease
R-HSA-1296061,R-HSA-1296071,R-HSA-112316,HCN channels,Potassium Channels,Neuronal System
R-HSA-3214815,R-HSA-3247509,R-HSA-4839726,HDACs deacetylate histones,Chromatin modifying enzymes,Chromatin organization
R-HSA-8963896,R-HSA-174824,R-HSA-382551,HDL assembly,"Plasma lipoprotein assembly, remodeling, and clearance",Transport of small molecules
R-HSA-8964011,R-HSA-174824,R-HSA-382551,HDL clearance,"Plasma lipoprotein assembly, remodeling, and clearance",Transport of small molecules
R-HSA-8964058,R-HSA-174824,R-HSA-382551,HDL remodeling,"Plasma lipoprotein assembly, remodeling, and clearance",Transport of small molecules
R-HSA-3214842,R-HSA-3247509,R-HSA-4839726,HDMs demethylate histones,Chromatin modifying enzymes,Chromatin organization
R-HSA-5685942,R-HSA-5693532,R-HSA-73894,HDR through Homologous Recombination (HRR),DNA Double-Strand Break Repair,DNA Repair
R-HSA-5693567,R-HSA-5693532,R-HSA-73894,HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA),DNA Double-Strand Break Repair,DNA Repair
R-HSA-5685939,R-HSA-5693532,R-HSA-73894,HDR through MMEJ (alt-NHEJ),DNA Double-Strand Break Repair,DNA Repair
R-HSA-5685938,R-HSA-5693532,R-HSA-73894,HDR through Single Strand Annealing (SSA),DNA Double-Strand Break Repair,DNA Repair
R-HSA-5658034,R-HSA-5663202,R-HSA-1643685,HHAT G278V doesn't palmitoylate Hh-Np,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-162906,R-HSA-5663205,R-HSA-1643685,HIV Infection,Infectious disease,Disease
R-HSA-162587,R-HSA-5663205,R-HSA-1643685,HIV Life Cycle,Infectious disease,Disease
R-HSA-167169,R-HSA-5663205,R-HSA-1643685,HIV Transcription Elongation,Infectious disease,Disease
R-HSA-167161,R-HSA-5663205,R-HSA-1643685,HIV Transcription Initiation,Infectious disease,Disease
R-HSA-167287,R-HSA-5663205,R-HSA-1643685,HIV elongation arrest and recovery,Infectious disease,Disease
R-HSA-2022928,R-HSA-71387,R-HSA-1430728,HS-GAG biosynthesis,Metabolism of carbohydrates,Metabolism
R-HSA-2024096,R-HSA-71387,R-HSA-1430728,HS-GAG degradation,Metabolism of carbohydrates,Metabolism
R-HSA-3371511,R-HSA-2262752,R-HSA-8953897,HSF1 activation,Cellular responses to stress,Cellular responses to stimuli
R-HSA-3371571,R-HSA-2262752,R-HSA-8953897,HSF1-dependent transactivation,Cellular responses to stress,Cellular responses to stimuli
R-HSA-3371497,R-HSA-2262752,R-HSA-8953897,HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand,Cellular responses to stress,Cellular responses to stimuli
R-HSA-5610787,R-HSA-5358351,R-HSA-162582,Hedgehog 'off' state,Signaling by Hedgehog,Signal Transduction
R-HSA-5632684,R-HSA-5358351,R-HSA-162582,Hedgehog 'on' state,Signaling by Hedgehog,Signal Transduction
R-HSA-5358346,R-HSA-5358351,R-HSA-162582,Hedgehog ligand biogenesis,Signaling by Hedgehog,Signal Transduction
R-HSA-189451,R-HSA-189445,R-HSA-1430728,Heme biosynthesis,Metabolism of porphyrins,Metabolism
R-HSA-189483,R-HSA-189445,R-HSA-1430728,Heme degradation,Metabolism of porphyrins,Metabolism
R-HSA-9707616,R-HSA-2262752,R-HSA-8953897,Heme signaling,Cellular responses to stress,Cellular responses to stimuli
R-HSA-109582,R-HSA-109582,R-HSA-109582,Hemostasis,Hemostasis,Hemostasis
R-HSA-1638091,R-HSA-71387,R-HSA-1430728,Heparan sulfate/heparin (HS-GAG) metabolism,Metabolism of carbohydrates,Metabolism
R-HSA-5657560,R-HSA-5668914,R-HSA-1643685,Hereditary fructose intolerance,Diseases of metabolism,Disease
R-HSA-5387390,R-HSA-5663202,R-HSA-1643685,Hh mutants abrogate ligand secretion,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-5362768,R-HSA-5663202,R-HSA-1643685,Hh mutants are degraded by ERAD,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-629597,R-HSA-112315,R-HSA-112316,Highly calcium permeable nicotinic acetylcholine receptors,Transmission across Chemical Synapses,Neuronal System
R-HSA-629594,R-HSA-112315,R-HSA-112316,Highly calcium permeable postsynaptic nicotinic acetylcholine receptors,Transmission across Chemical Synapses,Neuronal System
R-HSA-629587,R-HSA-112315,R-HSA-112316,Highly sodium permeable postsynaptic acetylcholine nicotinic receptors,Transmission across Chemical Synapses,Neuronal System
R-HSA-629587,R-HSA-112315,R-HSA-112316,Highly sodium permeable postsynaptic acetylcholine nicotinic receptors,Transmission across Chemical Synapses,Neuronal System
R-HSA-390650,R-HSA-372790,R-HSA-162582,Histamine receptors,Signaling by GPCR,Signal Transduction
R-HSA-70921,R-HSA-71291,R-HSA-1430728,Histidine catabolism,Metabolism of amino acids and derivatives,Metabolism
R-HSA-5693579,R-HSA-5693532,R-HSA-73894,Homologous DNA Pairing and Strand Exchange,DNA Double-Strand Break Repair,DNA Repair
R-HSA-5693538,R-HSA-5693532,R-HSA-73894,Homology Directed Repair,DNA Double-Strand Break Repair,DNA Repair
R-HSA-375281,R-HSA-372790,R-HSA-162582,Hormone ligand-binding receptors,Signaling by GPCR,Signal Transduction
R-HSA-162909,R-HSA-5663205,R-HSA-1643685,Host Interactions of HIV factors,Infectious disease,Disease
R-HSA-450520,R-HSA-450531,R-HSA-8953854,HuR (ELAVL1) binds and stabilizes mRNA,Regulation of mRNA stability by proteins that bind AU-rich elements,Metabolism of RNA
R-HSA-2142850,R-HSA-71387,R-HSA-1430728,Hyaluronan biosynthesis and export,Metabolism of carbohydrates,Metabolism
R-HSA-2142845,R-HSA-71387,R-HSA-1430728,Hyaluronan metabolism,Metabolism of carbohydrates,Metabolism
R-HSA-2160916,R-HSA-71387,R-HSA-1430728,Hyaluronan uptake and degradation,Metabolism of carbohydrates,Metabolism
R-HSA-1483115,R-HSA-556833,R-HSA-1430728,Hydrolysis of LPC,Metabolism of lipids,Metabolism
R-HSA-1483152,R-HSA-556833,R-HSA-1430728,Hydrolysis of LPE,Metabolism of lipids,Metabolism
R-HSA-3296197,R-HSA-372790,R-HSA-162582,Hydroxycarboxylic acid-binding receptors,Signaling by GPCR,Signal Transduction
R-HSA-204626,R-HSA-597592,R-HSA-392499,Hypusine synthesis from eIF5A-lysine,Post-translational protein modification,Metabolism of proteins
R-HSA-2428924,R-HSA-9006934,R-HSA-162582,IGF1R signaling cascade,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-5602636,R-HSA-5260271,R-HSA-1643685,IKBKB deficiency causes SCID,Diseases of Immune System,Disease
R-HSA-5603027,R-HSA-5260271,R-HSA-1643685,IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR),Diseases of Immune System,Disease
R-HSA-937041,R-HSA-168249,R-HSA-168256,IKK complex recruitment mediated by RIP1,Innate Immune System,Immune System
R-HSA-6788467,R-HSA-1280215,R-HSA-168256,IL-6-type cytokine receptor ligand interactions,Cytokine Signaling in Immune system,Immune System
R-HSA-1855196,R-HSA-1483249,R-HSA-1430728,IP3 and IP4 transport between cytosol and nucleus,Inositol phosphate metabolism,Metabolism
R-HSA-1855229,R-HSA-1483249,R-HSA-1430728,IP6 and IP7 transport between cytosol and nucleus,Inositol phosphate metabolism,Metabolism
R-HSA-1855215,R-HSA-1483249,R-HSA-1430728,IPs transport between ER lumen and cytosol,Inositol phosphate metabolism,Metabolism
R-HSA-1855156,R-HSA-1483249,R-HSA-1430728,IPs transport between ER lumen and nucleus,Inositol phosphate metabolism,Metabolism
R-HSA-1855184,R-HSA-1483249,R-HSA-1430728,IPs transport between cytosol and ER lumen,Inositol phosphate metabolism,Metabolism
R-HSA-1855192,R-HSA-1483249,R-HSA-1430728,IPs transport between nucleus and ER lumen,Inositol phosphate metabolism,Metabolism
R-HSA-1855170,R-HSA-1483249,R-HSA-1430728,IPs transport between nucleus and cytosol,Inositol phosphate metabolism,Metabolism
R-HSA-937039,R-HSA-168249,R-HSA-168256,IRAK1 recruits IKK complex,Innate Immune System,Immune System
R-HSA-937039,R-HSA-168249,R-HSA-168256,IRAK1 recruits IKK complex,Innate Immune System,Immune System
R-HSA-937039,R-HSA-168249,R-HSA-168256,IRAK1 recruits IKK complex,Innate Immune System,Immune System
R-HSA-937039,R-HSA-168249,R-HSA-168256,IRAK1 recruits IKK complex,Innate Immune System,Immune System
R-HSA-937039,R-HSA-168249,R-HSA-168256,IRAK1 recruits IKK complex,Innate Immune System,Immune System
R-HSA-975144,R-HSA-168249,R-HSA-168256,IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation,Innate Immune System,Immune System
R-HSA-975144,R-HSA-168249,R-HSA-168256,IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation,Innate Immune System,Immune System
R-HSA-937042,R-HSA-168249,R-HSA-168256,IRAK2 mediated activation of TAK1 complex,Innate Immune System,Immune System
R-HSA-937042,R-HSA-168249,R-HSA-168256,IRAK2 mediated activation of TAK1 complex,Innate Immune System,Immune System
R-HSA-937042,R-HSA-168249,R-HSA-168256,IRAK2 mediated activation of TAK1 complex,Innate Immune System,Immune System
R-HSA-937042,R-HSA-168249,R-HSA-168256,IRAK2 mediated activation of TAK1 complex,Innate Immune System,Immune System
R-HSA-937042,R-HSA-168249,R-HSA-168256,IRAK2 mediated activation of TAK1 complex,Innate Immune System,Immune System
R-HSA-975163,R-HSA-168249,R-HSA-168256,IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation,Innate Immune System,Immune System
R-HSA-975163,R-HSA-168249,R-HSA-168256,IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation,Innate Immune System,Immune System
R-HSA-5603041,R-HSA-5260271,R-HSA-1643685,IRAK4 deficiency (TLR2/4),Diseases of Immune System,Disease
R-HSA-5603037,R-HSA-5260271,R-HSA-1643685,IRAK4 deficiency (TLR5),Diseases of Immune System,Disease
R-HSA-381070,R-HSA-2262752,R-HSA-8953897,IRE1alpha activates chaperones,Cellular responses to stress,Cellular responses to stimuli
R-HSA-1606341,R-HSA-168249,R-HSA-168256,IRF3 mediated activation of type 1 IFN,Innate Immune System,Immune System
R-HSA-3270619,R-HSA-168249,R-HSA-168256,IRF3-mediated induction of type I IFN,Innate Immune System,Immune System
R-HSA-74713,R-HSA-9006934,R-HSA-162582,IRS activation,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-112399,R-HSA-9006934,R-HSA-162582,IRS-mediated signalling,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-112399,R-HSA-9006934,R-HSA-162582,IRS-mediated signalling,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-2428928,R-HSA-9006934,R-HSA-162582,IRS-related events triggered by IGF1R,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-1169408,R-HSA-1280215,R-HSA-168256,ISG15 antiviral mechanism,Cytokine Signaling in Immune system,Immune System
R-HSA-5603029,R-HSA-5260271,R-HSA-1643685,IkBA variant leads to EDA-ID,Diseases of Immune System,Disease
R-HSA-9669917,R-HSA-5663202,R-HSA-1643685,Imatinib-resistant KIT mutants,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-9674396,R-HSA-5663202,R-HSA-1643685,Imatinib-resistant PDGFR mutants,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-168256,R-HSA-168256,R-HSA-168256,Immune System,Immune System,Immune System
R-HSA-198933,R-HSA-1280218,R-HSA-168256,Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell,Adaptive Immune System,Immune System
R-HSA-141430,R-HSA-69278,R-HSA-1640170,Inactivation of APC/C via direct inhibition of the APC/C complex,"Cell Cycle, Mitotic",Cell Cycle
R-HSA-141430,R-HSA-69620,R-HSA-1640170,Inactivation of APC/C via direct inhibition of the APC/C complex,Cell Cycle Checkpoints,Cell Cycle
R-HSA-428543,R-HSA-9675108,R-HSA-1266738,Inactivation of CDC42 and RAC1,Nervous system development,Developmental Biology
R-HSA-9705462,R-HSA-1280215,R-HSA-168256,Inactivation of CSF3 (G-CSF) signaling,Cytokine Signaling in Immune system,Immune System
R-HSA-2514859,R-HSA-2187338,R-HSA-9709957,"Inactivation, recovery and regulation of the phototransduction cascade",Visual phototransduction,Sensory Perception
R-HSA-400508,R-HSA-2980736,R-HSA-392499,"Incretin synthesis, secretion, and inactivation",Peptide hormone metabolism,Metabolism of proteins
R-HSA-9635486,R-HSA-5663205,R-HSA-1643685,Infection with Mycobacterium tuberculosis,Infectious disease,Disease
R-HSA-5663205,R-HSA-5663205,R-HSA-1643685,Infectious disease,Infectious disease,Disease
R-HSA-622312,R-HSA-168249,R-HSA-168256,Inflammasomes,Innate Immune System,Immune System
R-HSA-168255,R-HSA-5663205,R-HSA-1643685,Influenza Infection,Infectious disease,Disease
R-HSA-168273,R-HSA-5663205,R-HSA-1643685,Influenza Viral RNA Transcription and Replication,Infectious disease,Disease
R-HSA-168277,R-HSA-5663205,R-HSA-1643685,Influenza Virus Induced Apoptosis,Infectious disease,Disease
R-HSA-997272,R-HSA-112315,R-HSA-112316,Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits,Transmission across Chemical Synapses,Neuronal System
R-HSA-9670095,R-HSA-73886,R-HSA-1640170,Inhibition of DNA recombination at telomere,Chromosome Maintenance,Cell Cycle
R-HSA-168315,R-HSA-5663205,R-HSA-1643685,Inhibition of Host mRNA Processing and RNA Silencing,Infectious disease,Disease
R-HSA-168888,R-HSA-5663205,R-HSA-1643685,Inhibition of IFN-beta,Infectious disease,Disease
R-HSA-168305,R-HSA-5663205,R-HSA-1643685,Inhibition of Interferon Synthesis,Infectious disease,Disease
R-HSA-169131,R-HSA-5663205,R-HSA-1643685,Inhibition of PKR,Infectious disease,Disease
R-HSA-5638303,R-HSA-5663202,R-HSA-1643685,Inhibition of Signaling by Overexpressed EGFR,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-165181,R-HSA-165159,R-HSA-162582,Inhibition of TSC complex formation by PKB,MTOR signalling,Signal Transduction
R-HSA-9635644,R-HSA-5663205,R-HSA-1643685,Inhibition of membrane repair,Infectious disease,Disease
R-HSA-9636249,R-HSA-5663205,R-HSA-1643685,Inhibition of nitric oxide production,Infectious disease,Disease
R-HSA-113501,R-HSA-69278,R-HSA-1640170,Inhibition of replication initiation of damaged DNA by RB1/E2F1,"Cell Cycle, Mitotic",Cell Cycle
R-HSA-141405,R-HSA-69278,R-HSA-1640170,Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components,"Cell Cycle, Mitotic",Cell Cycle
R-HSA-141405,R-HSA-69620,R-HSA-1640170,Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components,Cell Cycle Checkpoints,Cell Cycle
R-HSA-166663,R-HSA-168249,R-HSA-168256,Initial triggering of complement,Innate Immune System,Immune System
R-HSA-2995383,R-HSA-69278,R-HSA-1640170,Initiation of Nuclear Envelope (NE) Reformation,"Cell Cycle, Mitotic",Cell Cycle
R-HSA-8876493,R-HSA-5663205,R-HSA-1643685,InlA-mediated entry of Listeria monocytogenes into host cells,Infectious disease,Disease
R-HSA-8875360,R-HSA-5663205,R-HSA-1643685,InlB-mediated entry of Listeria monocytogenes into host cell,Infectious disease,Disease
R-HSA-168249,R-HSA-168249,R-HSA-168256,Innate Immune System,Innate Immune System,Immune System
R-HSA-1483249,R-HSA-1483249,R-HSA-1430728,Inositol phosphate metabolism,Inositol phosphate metabolism,Metabolism
R-HSA-429593,R-HSA-425407,R-HSA-382551,Inositol transporters,SLC-mediated transmembrane transport,Transport of small molecules
R-HSA-9609523,R-HSA-9609523,R-HSA-9609507,Insertion of tail-anchored proteins into the endoplasmic reticulum membrane,Insertion of tail-anchored proteins into the endoplasmic reticulum membrane,Protein localization
R-HSA-163754,R-HSA-163685,R-HSA-1430728,Insulin effects increased synthesis of Xylulose-5-Phosphate,Integration of energy metabolism,Metabolism
R-HSA-264876,R-HSA-2980736,R-HSA-392499,Insulin processing,Peptide hormone metabolism,Metabolism of proteins
R-HSA-77387,R-HSA-9006934,R-HSA-162582,Insulin receptor recycling,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-74751,R-HSA-9006934,R-HSA-162582,Insulin receptor signalling cascade,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-428359,R-HSA-428359,R-HSA-8953854,Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA,Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA,Metabolism of RNA
R-HSA-163685,R-HSA-163685,R-HSA-1430728,Integration of energy metabolism,Integration of energy metabolism,Metabolism
R-HSA-162592,R-HSA-5663205,R-HSA-1643685,Integration of provirus,Infectious disease,Disease
R-HSA-175567,R-HSA-5663205,R-HSA-1643685,Integration of viral DNA into host genomic DNA,Infectious disease,Disease
R-HSA-216083,R-HSA-216083,R-HSA-1474244,Integrin cell surface interactions,Integrin cell surface interactions,Extracellular matrix organization
R-HSA-354192,R-HSA-354192,R-HSA-162582,Integrin signaling,Integrin signaling,Signal Transduction
R-HSA-354192,R-HSA-76002,R-HSA-109582,Integrin signaling,"Platelet activation, signaling and aggregation",Hemostasis
R-HSA-2534343,R-HSA-1187000,R-HSA-1474165,Interaction With Cumulus Cells And The Zona Pellucida,Fertilization,Reproduction
R-HSA-445095,R-HSA-9675108,R-HSA-1266738,Interaction between L1 and Ankyrins,Nervous system development,Developmental Biology
R-HSA-8854521,R-HSA-69278,R-HSA-1640170,Interaction between PHLDA1 and AURKA,"Cell Cycle, Mitotic",Cell Cycle
R-HSA-177243,R-HSA-5663205,R-HSA-1643685,Interactions of Rev with host cellular proteins,Infectious disease,Disease
R-HSA-176034,R-HSA-5663205,R-HSA-1643685,Interactions of Tat with host cellular proteins,Infectious disease,Disease
R-HSA-176033,R-HSA-5663205,R-HSA-1643685,Interactions of Vpr with host cellular proteins,Infectious disease,Disease
R-HSA-880009,R-HSA-1428517,R-HSA-1430728,Interconversion of 2-oxoglutarate and 2-hydroxyglutarate,The citric acid (TCA) cycle and respiratory electron transport,Metabolism
R-HSA-499943,R-HSA-15869,R-HSA-1430728,Interconversion of nucleotide di- and triphosphates,Metabolism of nucleotides,Metabolism
R-HSA-351200,R-HSA-71291,R-HSA-1430728,Interconversion of polyamines,Metabolism of amino acids and derivatives,Metabolism
R-HSA-913531,R-HSA-1280215,R-HSA-168256,Interferon Signaling,Cytokine Signaling in Immune system,Immune System
R-HSA-909733,R-HSA-1280215,R-HSA-168256,Interferon alpha/beta signaling,Cytokine Signaling in Immune system,Immune System
R-HSA-877300,R-HSA-1280215,R-HSA-168256,Interferon gamma signaling,Cytokine Signaling in Immune system,Immune System
R-HSA-912526,R-HSA-1280215,R-HSA-168256,Interleukin receptor SHC signaling,Cytokine Signaling in Immune system,Immune System
R-HSA-912526,R-HSA-1280215,R-HSA-168256,Interleukin receptor SHC signaling,Cytokine Signaling in Immune system,Immune System
R-HSA-446652,R-HSA-1280215,R-HSA-168256,Interleukin-1 family signaling,Cytokine Signaling in Immune system,Immune System
R-HSA-448706,R-HSA-1280215,R-HSA-168256,Interleukin-1 processing,Cytokine Signaling in Immune system,Immune System
R-HSA-9020702,R-HSA-1280215,R-HSA-168256,Interleukin-1 signaling,Cytokine Signaling in Immune system,Immune System
R-HSA-6783783,R-HSA-1280215,R-HSA-168256,Interleukin-10 signaling,Cytokine Signaling in Immune system,Immune System
R-HSA-447115,R-HSA-1280215,R-HSA-168256,Interleukin-12 family signaling,Cytokine Signaling in Immune system,Immune System
R-HSA-9020591,R-HSA-1280215,R-HSA-168256,Interleukin-12 signaling,Cytokine Signaling in Immune system,Immune System
R-HSA-8983432,R-HSA-1280215,R-HSA-168256,Interleukin-15 signaling,Cytokine Signaling in Immune system,Immune System
R-HSA-448424,R-HSA-1280215,R-HSA-168256,Interleukin-17 signaling,Cytokine Signaling in Immune system,Immune System
R-HSA-9012546,R-HSA-1280215,R-HSA-168256,Interleukin-18 signaling,Cytokine Signaling in Immune system,Immune System
R-HSA-451927,R-HSA-1280215,R-HSA-168256,Interleukin-2 family signaling,Cytokine Signaling in Immune system,Immune System
R-HSA-9020558,R-HSA-1280215,R-HSA-168256,Interleukin-2 signaling,Cytokine Signaling in Immune system,Immune System
R-HSA-8854691,R-HSA-1280215,R-HSA-168256,Interleukin-20 family signaling,Cytokine Signaling in Immune system,Immune System
R-HSA-9020958,R-HSA-1280215,R-HSA-168256,Interleukin-21 signaling,Cytokine Signaling in Immune system,Immune System
R-HSA-9020933,R-HSA-1280215,R-HSA-168256,Interleukin-23 signaling,Cytokine Signaling in Immune system,Immune System
R-HSA-9020956,R-HSA-1280215,R-HSA-168256,Interleukin-27 signaling,Cytokine Signaling in Immune system,Immune System
R-HSA-512988,R-HSA-1280215,R-HSA-168256,"Interleukin-3, Interleukin-5 and GM-CSF signaling",Cytokine Signaling in Immune system,Immune System
R-HSA-9014843,R-HSA-1280215,R-HSA-168256,Interleukin-33 signaling,Cytokine Signaling in Immune system,Immune System
R-HSA-8984722,R-HSA-1280215,R-HSA-168256,Interleukin-35 Signalling,Cytokine Signaling in Immune system,Immune System
R-HSA-9014826,R-HSA-1280215,R-HSA-168256,Interleukin-36 pathway,Cytokine Signaling in Immune system,Immune System
R-HSA-9008059,R-HSA-1280215,R-HSA-168256,Interleukin-37 signaling,Cytokine Signaling in Immune system,Immune System
R-HSA-9007892,R-HSA-1280215,R-HSA-168256,Interleukin-38 signaling,Cytokine Signaling in Immune system,Immune System
R-HSA-6785807,R-HSA-1280215,R-HSA-168256,Interleukin-4 and Interleukin-13 signaling,Cytokine Signaling in Immune system,Immune System
R-HSA-6783589,R-HSA-1280215,R-HSA-168256,Interleukin-6 family signaling,Cytokine Signaling in Immune system,Immune System
R-HSA-1059683,R-HSA-1280215,R-HSA-168256,Interleukin-6 signaling,Cytokine Signaling in Immune system,Immune System
R-HSA-1266695,R-HSA-1280215,R-HSA-168256,Interleukin-7 signaling,Cytokine Signaling in Immune system,Immune System
R-HSA-8985947,R-HSA-1280215,R-HSA-168256,Interleukin-9 signaling,Cytokine Signaling in Immune system,Immune System
R-HSA-8963676,R-HSA-8963676,R-HSA-8963743,Intestinal absorption,Intestinal absorption,Digestion and absorption
R-HSA-8981373,R-HSA-8963676,R-HSA-8963743,Intestinal hexose absorption,Intestinal absorption,Digestion and absorption
R-HSA-8942233,R-HSA-5663205,R-HSA-1643685,Intestinal infectious diseases,Infectious disease,Disease
R-HSA-8963678,R-HSA-8963676,R-HSA-8963743,Intestinal lipid absorption,Intestinal absorption,Digestion and absorption
R-HSA-5659898,R-HSA-5668914,R-HSA-1643685,Intestinal saccharidase deficiencies,Diseases of metabolism,Disease
R-HSA-6811442,R-HSA-199991,R-HSA-5653656,Intra-Golgi and retrograde Golgi-to-ER traffic,Membrane Trafficking,Vesicle-mediated transport
R-HSA-6811438,R-HSA-199991,R-HSA-5653656,Intra-Golgi traffic,Membrane Trafficking,Vesicle-mediated transport
R-HSA-434313,R-HSA-163685,R-HSA-1430728,Intracellular metabolism of fatty acids regulates insulin secretion,Integration of energy metabolism,Metabolism
R-HSA-8981607,R-HSA-8981607,R-HSA-382551,Intracellular oxygen transport,Intracellular oxygen transport,Transport of small molecules
R-HSA-9006925,R-HSA-9006925,R-HSA-162582,Intracellular signaling by second messengers,Intracellular signaling by second messengers,Signal Transduction
R-HSA-5620924,R-HSA-5617833,R-HSA-1852241,Intraflagellar transport,Cilium Assembly,Organelle biogenesis and maintenance
R-HSA-109606,R-HSA-109581,R-HSA-5357801,Intrinsic Pathway for Apoptosis,Apoptosis,Programmed Cell Death
R-HSA-140837,R-HSA-140877,R-HSA-109582,Intrinsic Pathway of Fibrin Clot Formation,Formation of Fibrin Clot (Clotting Cascade),Hemostasis
R-HSA-8941237,R-HSA-8941237,R-HSA-1474244,Invadopodia formation,Invadopodia formation,Extracellular matrix organization
R-HSA-1296065,R-HSA-1296071,R-HSA-112316,Inwardly rectifying K+ channels,Potassium Channels,Neuronal System
R-HSA-983712,R-HSA-983712,R-HSA-382551,Ion channel transport,Ion channel transport,Transport of small molecules
R-HSA-5578775,R-HSA-5576891,R-HSA-397014,Ion homeostasis,Cardiac conduction,Muscle contraction
R-HSA-6803544,R-HSA-168249,R-HSA-168256,Ion influx/efflux at host-pathogen interface,Innate Immune System,Immune System
R-HSA-936837,R-HSA-983712,R-HSA-382551,Ion transport by P-type ATPases,Ion channel transport,Transport of small molecules
R-HSA-451306,R-HSA-112315,R-HSA-112316,Ionotropic activity of kainate receptors,Transmission across Chemical Synapses,Neuronal System
R-HSA-917937,R-HSA-917937,R-HSA-382551,Iron uptake and transport,Iron uptake and transport,Transport of small molecules
R-HSA-450321,R-HSA-168249,R-HSA-168256,JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1,Innate Immune System,Immune System
R-HSA-450321,R-HSA-168249,R-HSA-168256,JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1,Innate Immune System,Immune System
R-HSA-450321,R-HSA-168249,R-HSA-168256,JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1,Innate Immune System,Immune System
R-HSA-450321,R-HSA-168249,R-HSA-168256,JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1,Innate Immune System,Immune System
R-HSA-450321,R-HSA-1280215,R-HSA-168256,JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1,Cytokine Signaling in Immune system,Immune System
R-HSA-450321,R-HSA-168249,R-HSA-168256,JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1,Innate Immune System,Immune System
R-HSA-450321,R-HSA-168249,R-HSA-168256,JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1,Innate Immune System,Immune System
R-HSA-450321,R-HSA-168249,R-HSA-168256,JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1,Innate Immune System,Immune System
R-HSA-450321,R-HSA-168249,R-HSA-168256,JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1,Innate Immune System,Immune System
R-HSA-450321,R-HSA-168249,R-HSA-168256,JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1,Innate Immune System,Immune System
R-HSA-5689877,R-HSA-597592,R-HSA-392499,Josephin domain DUBs,Post-translational protein modification,Metabolism of proteins
R-HSA-9669921,R-HSA-5663202,R-HSA-1643685,KIT mutants bind TKIs,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-450604,R-HSA-450531,R-HSA-8953854,KSRP (KHSRP) binds and destabilizes mRNA,Regulation of mRNA stability by proteins that bind AU-rich elements,Metabolism of RNA
R-HSA-9702569,R-HSA-5663202,R-HSA-1643685,KW2449-resistant FLT3 mutants,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-2022854,R-HSA-71387,R-HSA-1430728,Keratan sulfate biosynthesis,Metabolism of carbohydrates,Metabolism
R-HSA-2022857,R-HSA-71387,R-HSA-1430728,Keratan sulfate degradation,Metabolism of carbohydrates,Metabolism
R-HSA-1638074,R-HSA-71387,R-HSA-1430728,Keratan sulfate/keratin metabolism,Metabolism of carbohydrates,Metabolism
R-HSA-6805567,R-HSA-6805567,R-HSA-1266738,Keratinization,Keratinization,Developmental Biology
R-HSA-74182,R-HSA-556833,R-HSA-1430728,Ketone body metabolism,Metabolism of lipids,Metabolism
R-HSA-9664420,R-HSA-5663205,R-HSA-1643685,Killing mechanisms,Infectious disease,Disease
R-HSA-983189,R-HSA-983231,R-HSA-109582,Kinesins,Factors involved in megakaryocyte development and platelet production,Hemostasis
R-HSA-156827,R-HSA-72766,R-HSA-392499,L13a-mediated translational silencing of Ceruloplasmin expression,Translation,Metabolism of proteins
R-HSA-373760,R-HSA-9675108,R-HSA-1266738,L1CAM interactions,Nervous system development,Developmental Biology
R-HSA-8964038,R-HSA-174824,R-HSA-382551,LDL clearance,"Plasma lipoprotein assembly, remodeling, and clearance",Transport of small molecules
R-HSA-8964041,R-HSA-174824,R-HSA-382551,LDL remodeling,"Plasma lipoprotein assembly, remodeling, and clearance",Transport of small molecules
R-HSA-5682910,R-HSA-5682910,R-HSA-1266738,LGI-ADAM interactions,LGI-ADAM interactions,Developmental Biology
R-HSA-5340573,R-HSA-5663202,R-HSA-1643685,LGK974 inhibits PORCN,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-3134973,R-HSA-168249,R-HSA-168256,LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production,Innate Immune System,Immune System
R-HSA-9664535,R-HSA-5663205,R-HSA-1643685,LTC4-CYSLTR mediated IL4 production,Infectious disease,Disease
R-HSA-5653890,R-HSA-71387,R-HSA-1430728,Lactose synthesis,Metabolism of carbohydrates,Metabolism
R-HSA-69186,R-HSA-69278,R-HSA-1640170,Lagging Strand Synthesis,"Cell Cycle, Mitotic",Cell Cycle
R-HSA-69186,R-HSA-69239,R-HSA-69306,Lagging Strand Synthesis,Synthesis of DNA,DNA Replication
R-HSA-3000157,R-HSA-3000157,R-HSA-1474244,Laminin interactions,Laminin interactions,Extracellular matrix organization
R-HSA-162599,R-HSA-5663205,R-HSA-1643685,Late Phase of HIV Life Cycle,Infectious disease,Disease
R-HSA-9615710,R-HSA-9615710,R-HSA-9612973,Late endosomal microautophagy,Late endosomal microautophagy,Autophagy
R-HSA-1222499,R-HSA-5663205,R-HSA-1643685,Latent infection - Other responses of Mtb to phagocytosis,Infectious disease,Disease
R-HSA-69109,R-HSA-69278,R-HSA-1640170,Leading Strand Synthesis,"Cell Cycle, Mitotic",Cell Cycle
R-HSA-69109,R-HSA-69239,R-HSA-69306,Leading Strand Synthesis,Synthesis of DNA,DNA Replication
R-HSA-166662,R-HSA-168249,R-HSA-168256,Lectin pathway of complement activation,Innate Immune System,Immune System
R-HSA-9658195,R-HSA-5663205,R-HSA-1643685,Leishmania infection,Infectious disease,Disease
R-HSA-9664433,R-HSA-5663205,R-HSA-1643685,Leishmania parasite growth and survival,Infectious disease,Disease
R-HSA-9664417,R-HSA-5663205,R-HSA-1643685,Leishmania phagocytosis,Infectious disease,Disease
R-HSA-391906,R-HSA-372790,R-HSA-162582,Leukotriene receptors,Signaling by GPCR,Signal Transduction
R-HSA-9037629,R-HSA-71387,R-HSA-1430728,Lewis blood group biosynthesis,Metabolism of carbohydrates,Metabolism
R-HSA-5632681,R-HSA-5358351,R-HSA-162582,Ligand-receptor interactions,Signaling by Hedgehog,Signal Transduction
R-HSA-2046105,R-HSA-556833,R-HSA-1430728,Linoleic acid (LA) metabolism,Metabolism of lipids,Metabolism
R-HSA-8964572,R-HSA-556833,R-HSA-1430728,Lipid particle organization,Metabolism of lipids,Metabolism
R-HSA-9613354,R-HSA-1632852,R-HSA-9612973,Lipophagy,Macroautophagy,Autophagy
R-HSA-8876384,R-HSA-5663205,R-HSA-1643685,Listeria monocytogenes entry into host cells,Infectious disease,Disease
R-HSA-446343,R-HSA-446728,R-HSA-1500931,Localization of the PINCH-ILK-PARVIN complex to focal adhesions,Cell junction organization,Cell-Cell communication
R-HSA-9620244,R-HSA-112315,R-HSA-112316,Long-term potentiation,Transmission across Chemical Synapses,Neuronal System
R-HSA-2644607,R-HSA-5663202,R-HSA-1643685,Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-3304349,R-HSA-5663202,R-HSA-1643685,Loss of Function of SMAD2/3 in Cancer,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-3304347,R-HSA-5663202,R-HSA-1643685,Loss of Function of SMAD4 in Cancer,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-3656534,R-HSA-5663202,R-HSA-1643685,Loss of Function of TGFBR1 in Cancer,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-3642278,R-HSA-5663202,R-HSA-1643685,Loss of Function of TGFBR2 in Cancer,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-9723907,R-HSA-9645723,R-HSA-1643685,Loss of Function of TP53 in Cancer,Diseases of programmed cell death,Disease
R-HSA-9022534,R-HSA-9675151,R-HSA-1643685,Loss of MECP2 binding ability to 5hmC-DNA,Disorders of Developmental Biology,Disease
R-HSA-9022538,R-HSA-9675151,R-HSA-1643685,Loss of MECP2 binding ability to 5mC-DNA,Disorders of Developmental Biology,Disease
R-HSA-9022537,R-HSA-9675151,R-HSA-1643685,Loss of MECP2 binding ability to the NCoR/SMRT complex,Disorders of Developmental Biology,Disease
R-HSA-380259,R-HSA-69278,R-HSA-1640170,Loss of Nlp from mitotic centrosomes,"Cell Cycle, Mitotic",Cell Cycle
R-HSA-9005891,R-HSA-9675151,R-HSA-1643685,Loss of function of MECP2 in Rett syndrome,Disorders of Developmental Biology,Disease
R-HSA-9723905,R-HSA-9645723,R-HSA-1643685,Loss of function of TP53 in cancer due to loss of tetramerization ability,Diseases of programmed cell death,Disease
R-HSA-9022535,R-HSA-9675151,R-HSA-1643685,Loss of phosphorylation of MECP2 at T308,Disorders of Developmental Biology,Disease
R-HSA-380284,R-HSA-69278,R-HSA-1640170,Loss of proteins required for interphase microtubule organization from the centrosome,"Cell Cycle, Mitotic",Cell Cycle
R-HSA-71064,R-HSA-71291,R-HSA-1430728,Lysine catabolism,Metabolism of amino acids and derivatives,Metabolism
R-HSA-8853383,R-HSA-71387,R-HSA-1430728,Lysosomal oligosaccharide catabolism,Metabolism of carbohydrates,Metabolism
R-HSA-432720,R-HSA-199991,R-HSA-5653656,Lysosome Vesicle Biogenesis,Membrane Trafficking,Vesicle-mediated transport
R-HSA-419408,R-HSA-372790,R-HSA-162582,Lysosphingolipid and LPA receptors,Signaling by GPCR,Signal Transduction
R-HSA-68886,R-HSA-69278,R-HSA-1640170,M Phase,"Cell Cycle, Mitotic",Cell Cycle
R-HSA-450294,R-HSA-168249,R-HSA-168256,MAP kinase activation,Innate Immune System,Immune System
R-HSA-450294,R-HSA-168249,R-HSA-168256,MAP kinase activation,Innate Immune System,Immune System
R-HSA-450294,R-HSA-168249,R-HSA-168256,MAP kinase activation,Innate Immune System,Immune System
R-HSA-450294,R-HSA-168249,R-HSA-168256,MAP kinase activation,Innate Immune System,Immune System
R-HSA-450294,R-HSA-1280215,R-HSA-168256,MAP kinase activation,Cytokine Signaling in Immune system,Immune System
R-HSA-450294,R-HSA-168249,R-HSA-168256,MAP kinase activation,Innate Immune System,Immune System
R-HSA-450294,R-HSA-168249,R-HSA-168256,MAP kinase activation,Innate Immune System,Immune System
R-HSA-450294,R-HSA-168249,R-HSA-168256,MAP kinase activation,Innate Immune System,Immune System
R-HSA-450294,R-HSA-168249,R-HSA-168256,MAP kinase activation,Innate Immune System,Immune System
R-HSA-450294,R-HSA-168249,R-HSA-168256,MAP kinase activation,Innate Immune System,Immune System
R-HSA-5674135,R-HSA-5683057,R-HSA-162582,MAP2K and MAPK activation,MAPK family signaling cascades,Signal Transduction
R-HSA-5684264,R-HSA-168249,R-HSA-168256,MAP3K8 (TPL2)-dependent MAPK1/3 activation,Innate Immune System,Immune System
R-HSA-5684264,R-HSA-168249,R-HSA-168256,MAP3K8 (TPL2)-dependent MAPK1/3 activation,Innate Immune System,Immune System
R-HSA-5684264,R-HSA-168249,R-HSA-168256,MAP3K8 (TPL2)-dependent MAPK1/3 activation,Innate Immune System,Immune System
R-HSA-5684264,R-HSA-168249,R-HSA-168256,MAP3K8 (TPL2)-dependent MAPK1/3 activation,Innate Immune System,Immune System
R-HSA-5684264,R-HSA-1280215,R-HSA-168256,MAP3K8 (TPL2)-dependent MAPK1/3 activation,Cytokine Signaling in Immune system,Immune System
R-HSA-5684264,R-HSA-168249,R-HSA-168256,MAP3K8 (TPL2)-dependent MAPK1/3 activation,Innate Immune System,Immune System
R-HSA-5684264,R-HSA-168249,R-HSA-168256,MAP3K8 (TPL2)-dependent MAPK1/3 activation,Innate Immune System,Immune System
R-HSA-5684264,R-HSA-168249,R-HSA-168256,MAP3K8 (TPL2)-dependent MAPK1/3 activation,Innate Immune System,Immune System
R-HSA-5684264,R-HSA-168249,R-HSA-168256,MAP3K8 (TPL2)-dependent MAPK1/3 activation,Innate Immune System,Immune System
R-HSA-5684264,R-HSA-168249,R-HSA-168256,MAP3K8 (TPL2)-dependent MAPK1/3 activation,Innate Immune System,Immune System
R-HSA-5684264,R-HSA-1280215,R-HSA-168256,MAP3K8 (TPL2)-dependent MAPK1/3 activation,Cytokine Signaling in Immune system,Immune System
R-HSA-5683057,R-HSA-5683057,R-HSA-162582,MAPK family signaling cascades,MAPK family signaling cascades,Signal Transduction
R-HSA-450282,R-HSA-168249,R-HSA-168256,MAPK targets/ Nuclear events mediated by MAP kinases,Innate Immune System,Immune System
R-HSA-450282,R-HSA-168249,R-HSA-168256,MAPK targets/ Nuclear events mediated by MAP kinases,Innate Immune System,Immune System
R-HSA-450282,R-HSA-168249,R-HSA-168256,MAPK targets/ Nuclear events mediated by MAP kinases,Innate Immune System,Immune System
R-HSA-450282,R-HSA-168249,R-HSA-168256,MAPK targets/ Nuclear events mediated by MAP kinases,Innate Immune System,Immune System
R-HSA-450282,R-HSA-1280215,R-HSA-168256,MAPK targets/ Nuclear events mediated by MAP kinases,Cytokine Signaling in Immune system,Immune System
R-HSA-450282,R-HSA-168249,R-HSA-168256,MAPK targets/ Nuclear events mediated by MAP kinases,Innate Immune System,Immune System
R-HSA-450282,R-HSA-168249,R-HSA-168256,MAPK targets/ Nuclear events mediated by MAP kinases,Innate Immune System,Immune System
R-HSA-450282,R-HSA-168249,R-HSA-168256,MAPK targets/ Nuclear events mediated by MAP kinases,Innate Immune System,Immune System
R-HSA-450282,R-HSA-168249,R-HSA-168256,MAPK targets/ Nuclear events mediated by MAP kinases,Innate Immune System,Immune System
R-HSA-450282,R-HSA-168249,R-HSA-168256,MAPK targets/ Nuclear events mediated by MAP kinases,Innate Immune System,Immune System
R-HSA-112411,R-HSA-5683057,R-HSA-162582,MAPK1 (ERK2) activation,MAPK family signaling cascades,Signal Transduction
R-HSA-5684996,R-HSA-5683057,R-HSA-162582,MAPK1/MAPK3 signaling,MAPK family signaling cascades,Signal Transduction
R-HSA-110056,R-HSA-5683057,R-HSA-162582,MAPK3 (ERK1) activation,MAPK family signaling cascades,Signal Transduction
R-HSA-5687128,R-HSA-5683057,R-HSA-162582,MAPK6/MAPK4 signaling,MAPK family signaling cascades,Signal Transduction
R-HSA-2465910,R-HSA-69278,R-HSA-1640170,MASTL Facilitates Mitotic Progression,"Cell Cycle, Mitotic",Cell Cycle
R-HSA-9022699,R-HSA-73857,R-HSA-74160,MECP2 regulates neuronal receptors and channels,RNA Polymerase II Transcription,Gene expression (Transcription)
R-HSA-9022707,R-HSA-73857,R-HSA-74160,MECP2 regulates transcription factors,RNA Polymerase II Transcription,Gene expression (Transcription)
R-HSA-9022927,R-HSA-73857,R-HSA-74160,MECP2 regulates transcription of genes involved in GABA signaling,RNA Polymerase II Transcription,Gene expression (Transcription)
R-HSA-9022702,R-HSA-73857,R-HSA-74160,MECP2 regulates transcription of neuronal ligands,RNA Polymerase II Transcription,Gene expression (Transcription)
R-HSA-6806942,R-HSA-9006934,R-HSA-162582,MET Receptor Activation,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-8851907,R-HSA-9006934,R-HSA-162582,MET activates PI3K/AKT signaling,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-8874081,R-HSA-9006934,R-HSA-162582,MET activates PTK2 signaling,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-8865999,R-HSA-9006934,R-HSA-162582,MET activates PTPN11,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-8875555,R-HSA-9006934,R-HSA-162582,MET activates RAP1 and RAC1,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-8851805,R-HSA-9006934,R-HSA-162582,MET activates RAS signaling,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-8875791,R-HSA-9006934,R-HSA-162582,MET activates STAT3,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-8875513,R-HSA-9006934,R-HSA-162582,MET interacts with TNS proteins,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-8875878,R-HSA-9006934,R-HSA-162582,MET promotes cell motility,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-8875656,R-HSA-9006934,R-HSA-162582,MET receptor recycling,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-5657655,R-HSA-73942,R-HSA-73894,MGMT-mediated DNA damage reversal,DNA Damage Reversal,DNA Repair
R-HSA-2132295,R-HSA-1280218,R-HSA-168256,MHC class II antigen presentation,Adaptive Immune System,Immune System
R-HSA-2206302,R-HSA-5668914,R-HSA-1643685,MPS I - Hurler syndrome,Diseases of metabolism,Disease
R-HSA-2206296,R-HSA-5668914,R-HSA-1643685,MPS II - Hunter syndrome,Diseases of metabolism,Disease
R-HSA-2206307,R-HSA-5668914,R-HSA-1643685,MPS IIIA - Sanfilippo syndrome A,Diseases of metabolism,Disease
R-HSA-2206282,R-HSA-5668914,R-HSA-1643685,MPS IIIB - Sanfilippo syndrome B,Diseases of metabolism,Disease
R-HSA-2206291,R-HSA-5668914,R-HSA-1643685,MPS IIIC - Sanfilippo syndrome C,Diseases of metabolism,Disease
R-HSA-2206305,R-HSA-5668914,R-HSA-1643685,MPS IIID - Sanfilippo syndrome D,Diseases of metabolism,Disease
R-HSA-2206290,R-HSA-5668914,R-HSA-1643685,MPS IV - Morquio syndrome A,Diseases of metabolism,Disease
R-HSA-2206308,R-HSA-5668914,R-HSA-1643685,MPS IV - Morquio syndrome B,Diseases of metabolism,Disease
R-HSA-2206280,R-HSA-5668914,R-HSA-1643685,MPS IX - Natowicz syndrome,Diseases of metabolism,Disease
R-HSA-2206285,R-HSA-5668914,R-HSA-1643685,MPS VI - Maroteaux-Lamy syndrome,Diseases of metabolism,Disease
R-HSA-2206292,R-HSA-5668914,R-HSA-1643685,MPS VII - Sly syndrome,Diseases of metabolism,Disease
R-HSA-5660489,R-HSA-5660526,R-HSA-8953897,MTF1 activates gene expression,Response to metal ions,Cellular responses to stimuli
R-HSA-165159,R-HSA-165159,R-HSA-162582,MTOR signalling,MTOR signalling,Signal Transduction
R-HSA-1632852,R-HSA-1632852,R-HSA-9612973,Macroautophagy,Macroautophagy,Autophagy
R-HSA-6791226,R-HSA-72312,R-HSA-8953854,Major pathway of rRNA processing in the nucleolus and cytosol,rRNA processing,Metabolism of RNA
R-HSA-9636667,R-HSA-5663205,R-HSA-1643685,Manipulation of host energy metabolism,Infectious disease,Disease
R-HSA-9669924,R-HSA-5663202,R-HSA-1643685,Masitinib-resistant KIT mutants,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-9683610,R-HSA-5663205,R-HSA-1643685,Maturation of nucleoprotein,Infectious disease,Disease
R-HSA-9694631,R-HSA-5663205,R-HSA-1643685,Maturation of nucleoprotein,Infectious disease,Disease
R-HSA-9683673,R-HSA-5663205,R-HSA-1643685,Maturation of protein 3a,Infectious disease,Disease
R-HSA-9694719,R-HSA-5663205,R-HSA-1643685,Maturation of protein 3a,Infectious disease,Disease
R-HSA-9683683,R-HSA-5663205,R-HSA-1643685,Maturation of protein E,Infectious disease,Disease
R-HSA-9694493,R-HSA-5663205,R-HSA-1643685,Maturation of protein E,Infectious disease,Disease
R-HSA-9683612,R-HSA-5663205,R-HSA-1643685,Maturation of protein M,Infectious disease,Disease
R-HSA-9694594,R-HSA-5663205,R-HSA-1643685,Maturation of protein M,Infectious disease,Disease
R-HSA-9684325,R-HSA-5663205,R-HSA-1643685,Maturation of replicase proteins,Infectious disease,Disease
R-HSA-9694301,R-HSA-5663205,R-HSA-1643685,Maturation of replicase proteins,Infectious disease,Disease
R-HSA-9683686,R-HSA-5663205,R-HSA-1643685,Maturation of spike protein,Infectious disease,Disease
R-HSA-9694548,R-HSA-5663205,R-HSA-1643685,Maturation of spike protein,Infectious disease,Disease
R-HSA-1500620,R-HSA-1500620,R-HSA-1474165,Meiosis,Meiosis,Reproduction
R-HSA-1500620,R-HSA-1500620,R-HSA-1640170,Meiosis,Meiosis,Cell Cycle
R-HSA-912446,R-HSA-1500620,R-HSA-1474165,Meiotic recombination,Meiosis,Reproduction
R-HSA-912446,R-HSA-1500620,R-HSA-1640170,Meiotic recombination,Meiosis,Cell Cycle
R-HSA-1221632,R-HSA-1500620,R-HSA-1474165,Meiotic synapsis,Meiosis,Reproduction
R-HSA-1221632,R-HSA-1500620,R-HSA-1640170,Meiotic synapsis,Meiosis,Cell Cycle
R-HSA-5662702,R-HSA-71291,R-HSA-1430728,Melanin biosynthesis,Metabolism of amino acids and derivatives,Metabolism
R-HSA-199991,R-HSA-199991,R-HSA-5653656,Membrane Trafficking,Membrane Trafficking,Vesicle-mediated transport
R-HSA-174490,R-HSA-5663205,R-HSA-1643685,Membrane binding and targetting of GAG proteins,Infectious disease,Disease
R-HSA-5579029,R-HSA-5668914,R-HSA-1643685,Metabolic disorders of biological oxidation enzymes,Diseases of metabolism,Disease
R-HSA-1430728,R-HSA-1430728,R-HSA-1430728,Metabolism,Metabolism,Metabolism
R-HSA-2022377,R-HSA-2980736,R-HSA-392499,Metabolism of Angiotensinogen to Angiotensins,Peptide hormone metabolism,Metabolism of proteins
R-HSA-8953854,R-HSA-8953854,R-HSA-8953854,Metabolism of RNA,Metabolism of RNA,Metabolism of RNA
R-HSA-209776,R-HSA-71291,R-HSA-1430728,Metabolism of amine-derived hormones,Metabolism of amino acids and derivatives,Metabolism
R-HSA-71291,R-HSA-71291,R-HSA-1430728,Metabolism of amino acids and derivatives,Metabolism of amino acids and derivatives,Metabolism
R-HSA-71387,R-HSA-71387,R-HSA-1430728,Metabolism of carbohydrates,Metabolism of carbohydrates,Metabolism
R-HSA-8978934,R-HSA-196854,R-HSA-1430728,Metabolism of cofactors,Metabolism of vitamins and cofactors,Metabolism
R-HSA-6806667,R-HSA-196854,R-HSA-1430728,Metabolism of fat-soluble vitamins,Metabolism of vitamins and cofactors,Metabolism
R-HSA-196757,R-HSA-196854,R-HSA-1430728,Metabolism of folate and pterines,Metabolism of vitamins and cofactors,Metabolism
R-HSA-2408550,R-HSA-71291,R-HSA-1430728,Metabolism of ingested H2SeO4 and H2SeO3 into H2Se,Metabolism of amino acids and derivatives,Metabolism
R-HSA-5263617,R-HSA-71291,R-HSA-1430728,Metabolism of ingested MeSeO2H into MeSeH,Metabolism of amino acids and derivatives,Metabolism
R-HSA-2408508,R-HSA-71291,R-HSA-1430728,"Metabolism of ingested SeMet, Sec, MeSec into H2Se",Metabolism of amino acids and derivatives,Metabolism
R-HSA-556833,R-HSA-556833,R-HSA-1430728,Metabolism of lipids,Metabolism of lipids,Metabolism
R-HSA-202131,R-HSA-202131,R-HSA-1430728,Metabolism of nitric oxide: NOS3 activation and regulation,Metabolism of nitric oxide: NOS3 activation and regulation,Metabolism
R-HSA-194441,R-HSA-194441,R-HSA-8953854,Metabolism of non-coding RNA,Metabolism of non-coding RNA,Metabolism of RNA
R-HSA-15869,R-HSA-15869,R-HSA-1430728,Metabolism of nucleotides,Metabolism of nucleotides,Metabolism
R-HSA-351202,R-HSA-71291,R-HSA-1430728,Metabolism of polyamines,Metabolism of amino acids and derivatives,Metabolism
R-HSA-189445,R-HSA-189445,R-HSA-1430728,Metabolism of porphyrins,Metabolism of porphyrins,Metabolism
R-HSA-392499,R-HSA-392499,R-HSA-392499,Metabolism of proteins,Metabolism of proteins,Metabolism of proteins
R-HSA-380612,R-HSA-112315,R-HSA-112316,Metabolism of serotonin,Transmission across Chemical Synapses,Neuronal System
R-HSA-196071,R-HSA-556833,R-HSA-1430728,Metabolism of steroid hormones,Metabolism of lipids,Metabolism
R-HSA-8957322,R-HSA-556833,R-HSA-1430728,Metabolism of steroids,Metabolism of lipids,Metabolism
R-HSA-6806664,R-HSA-196854,R-HSA-1430728,Metabolism of vitamin K,Metabolism of vitamins and cofactors,Metabolism
R-HSA-196854,R-HSA-196854,R-HSA-1430728,Metabolism of vitamins and cofactors,Metabolism of vitamins and cofactors,Metabolism
R-HSA-196849,R-HSA-196854,R-HSA-1430728,Metabolism of water-soluble vitamins and cofactors,Metabolism of vitamins and cofactors,Metabolism
R-HSA-425410,R-HSA-425407,R-HSA-382551,Metal ion SLC transporters,SLC-mediated transmembrane transport,Transport of small molecules
R-HSA-6799990,R-HSA-168249,R-HSA-168256,Metal sequestration by antimicrobial proteins,Innate Immune System,Immune System
R-HSA-5689901,R-HSA-597592,R-HSA-392499,Metalloprotease DUBs,Post-translational protein modification,Metabolism of proteins
R-HSA-5661231,R-HSA-5660526,R-HSA-8953897,Metallothioneins bind metals,Response to metal ions,Cellular responses to stimuli
R-HSA-1237112,R-HSA-71291,R-HSA-1430728,Methionine salvage pathway,Metabolism of amino acids and derivatives,Metabolism
R-HSA-156581,R-HSA-211859,R-HSA-1430728,Methylation,Biological oxidations,Metabolism
R-HSA-2408552,R-HSA-71291,R-HSA-1430728,Methylation of MeSeH for excretion,Metabolism of amino acids and derivatives,Metabolism
R-HSA-203927,R-HSA-211000,R-HSA-74160,MicroRNA (miRNA) biogenesis,Gene Silencing by RNA,Gene expression (Transcription)
R-HSA-9686347,R-HSA-5218859,R-HSA-5357801,Microbial modulation of RIPK1-mediated regulated necrosis,Regulated Necrosis,Programmed Cell Death
R-HSA-190840,R-HSA-199991,R-HSA-5653656,Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane,Membrane Trafficking,Vesicle-mediated transport
R-HSA-193993,R-HSA-556833,R-HSA-1430728,Mineralocorticoid biosynthesis,Metabolism of lipids,Metabolism
R-HSA-164516,R-HSA-5663205,R-HSA-1643685,Minus-strand DNA synthesis,Infectious disease,Disease
R-HSA-9715370,R-HSA-9716542,R-HSA-162582,Miro GTPase Cycle,"Signaling by Rho GTPases, Miro GTPases and RHOBTB3",Signal Transduction
R-HSA-211958,R-HSA-211859,R-HSA-1430728,Miscellaneous substrates,Biological oxidations,Metabolism
R-HSA-5223345,R-HSA-5223345,R-HSA-382551,Miscellaneous transport and binding events,Miscellaneous transport and binding events,Transport of small molecules
R-HSA-5358508,R-HSA-5358508,R-HSA-73894,Mismatch Repair,Mismatch Repair,DNA Repair
R-HSA-5358606,R-HSA-5358508,R-HSA-73894,Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta),Mismatch Repair,DNA Repair
R-HSA-5358565,R-HSA-5358508,R-HSA-73894,Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha),Mismatch Repair,DNA Repair
R-HSA-1369007,R-HSA-382556,R-HSA-382551,Mitochondrial ABC transporters,ABC-family proteins mediated transport,Transport of small molecules
R-HSA-77289,R-HSA-556833,R-HSA-1430728,Mitochondrial Fatty Acid Beta-Oxidation,Metabolism of lipids,Metabolism
R-HSA-166187,R-HSA-1428517,R-HSA-1430728,Mitochondrial Uncoupling,The citric acid (TCA) cycle and respiratory electron transport,Metabolism
R-HSA-1592230,R-HSA-1592230,R-HSA-1852241,Mitochondrial biogenesis,Mitochondrial biogenesis,Organelle biogenesis and maintenance
R-HSA-8949215,R-HSA-8949215,R-HSA-382551,Mitochondrial calcium ion transport,Mitochondrial calcium ion transport,Transport of small molecules
R-HSA-1362409,R-HSA-1362409,R-HSA-1430728,Mitochondrial iron-sulfur cluster biogenesis,Mitochondrial iron-sulfur cluster biogenesis,Metabolism
R-HSA-1268020,R-HSA-1268020,R-HSA-9609507,Mitochondrial protein import,Mitochondrial protein import,Protein localization
R-HSA-379726,R-HSA-72766,R-HSA-392499,Mitochondrial tRNA aminoacylation,Translation,Metabolism of proteins
R-HSA-163282,R-HSA-75944,R-HSA-74160,Mitochondrial transcription initiation,Transcription from mitochondrial promoters,Gene expression (Transcription)
R-HSA-163316,R-HSA-75944,R-HSA-74160,Mitochondrial transcription termination,Transcription from mitochondrial promoters,Gene expression (Transcription)
R-HSA-5368287,R-HSA-72766,R-HSA-392499,Mitochondrial translation,Translation,Metabolism of proteins
R-HSA-5389840,R-HSA-72766,R-HSA-392499,Mitochondrial translation elongation,Translation,Metabolism of proteins
R-HSA-5368286,R-HSA-72766,R-HSA-392499,Mitochondrial translation initiation,Translation,Metabolism of proteins
R-HSA-5419276,R-HSA-72766,R-HSA-392499,Mitochondrial translation termination,Translation,Metabolism of proteins
R-HSA-5205647,R-HSA-1632852,R-HSA-9612973,Mitophagy,Macroautophagy,Autophagy
R-HSA-68882,R-HSA-69278,R-HSA-1640170,Mitotic Anaphase,"Cell Cycle, Mitotic",Cell Cycle
R-HSA-453279,R-HSA-69278,R-HSA-1640170,Mitotic G1 phase and G1/S transition,"Cell Cycle, Mitotic",Cell Cycle
R-HSA-453274,R-HSA-69278,R-HSA-1640170,Mitotic G2-G2/M phases,"Cell Cycle, Mitotic",Cell Cycle
R-HSA-2555396,R-HSA-69278,R-HSA-1640170,Mitotic Metaphase and Anaphase,"Cell Cycle, Mitotic",Cell Cycle
R-HSA-68881,R-HSA-69278,R-HSA-1640170,Mitotic Metaphase/Anaphase Transition,"Cell Cycle, Mitotic",Cell Cycle
R-HSA-68877,R-HSA-69278,R-HSA-1640170,Mitotic Prometaphase,"Cell Cycle, Mitotic",Cell Cycle
R-HSA-68875,R-HSA-69278,R-HSA-1640170,Mitotic Prophase,"Cell Cycle, Mitotic",Cell Cycle
R-HSA-69618,R-HSA-69620,R-HSA-1640170,Mitotic Spindle Checkpoint,Cell Cycle Checkpoints,Cell Cycle
R-HSA-68884,R-HSA-69278,R-HSA-1640170,Mitotic Telophase/Cytokinesis,"Cell Cycle, Mitotic",Cell Cycle
R-HSA-9637628,R-HSA-5663205,R-HSA-1643685,Modulation by Mtb of host immune system,Infectious disease,Disease
R-HSA-2129379,R-HSA-1566948,R-HSA-1474244,Molecules associated with elastic fibres,Elastic fibre formation,Extracellular matrix organization
R-HSA-947581,R-HSA-196854,R-HSA-1430728,Molybdenum cofactor biosynthesis,Metabolism of vitamins and cofactors,Metabolism
R-HSA-1222449,R-HSA-5663205,R-HSA-1643685,Mtb iron assimilation by chelation,Infectious disease,Disease
R-HSA-2206281,R-HSA-5668914,R-HSA-1643685,Mucopolysaccharidoses,Diseases of metabolism,Disease
R-HSA-427601,R-HSA-425407,R-HSA-382551,Multifunctional anion exchangers,SLC-mediated transmembrane transport,Transport of small molecules
R-HSA-390648,R-HSA-372790,R-HSA-162582,Muscarinic acetylcholine receptors,Signaling by GPCR,Signal Transduction
R-HSA-397014,R-HSA-397014,R-HSA-397014,Muscle contraction,Muscle contraction,Muscle contraction
R-HSA-975871,R-HSA-168249,R-HSA-168256,MyD88 cascade initiated on plasma membrane,Innate Immune System,Immune System
R-HSA-975871,R-HSA-168249,R-HSA-168256,MyD88 cascade initiated on plasma membrane,Innate Immune System,Immune System
R-HSA-5602498,R-HSA-5260271,R-HSA-1643685,MyD88 deficiency (TLR2/4),Diseases of Immune System,Disease
R-HSA-5602680,R-HSA-5260271,R-HSA-1643685,MyD88 deficiency (TLR5),Diseases of Immune System,Disease
R-HSA-975155,R-HSA-168249,R-HSA-168256,MyD88 dependent cascade initiated on endosome,Innate Immune System,Immune System
R-HSA-975155,R-HSA-168249,R-HSA-168256,MyD88 dependent cascade initiated on endosome,Innate Immune System,Immune System
R-HSA-166166,R-HSA-168249,R-HSA-168256,MyD88-independent TLR4 cascade,Innate Immune System,Immune System
R-HSA-166058,R-HSA-168249,R-HSA-168256,MyD88:MAL(TIRAP) cascade initiated on plasma membrane,Innate Immune System,Immune System
R-HSA-166058,R-HSA-168249,R-HSA-168256,MyD88:MAL(TIRAP) cascade initiated on plasma membrane,Innate Immune System,Immune System
R-HSA-166058,R-HSA-168249,R-HSA-168256,MyD88:MAL(TIRAP) cascade initiated on plasma membrane,Innate Immune System,Immune System
R-HSA-3785653,R-HSA-5668914,R-HSA-1643685,Myoclonic epilepsy of Lafora,Diseases of metabolism,Disease
R-HSA-525793,R-HSA-525793,R-HSA-1266738,Myogenesis,Myogenesis,Developmental Biology
R-HSA-975577,R-HSA-597592,R-HSA-392499,N-Glycan antennae elongation,Post-translational protein modification,Metabolism of proteins
R-HSA-975576,R-HSA-597592,R-HSA-392499,N-glycan antennae elongation in the medial/trans-Golgi,Post-translational protein modification,Metabolism of proteins
R-HSA-964739,R-HSA-597592,R-HSA-392499,N-glycan trimming and elongation in the cis-Golgi,Post-translational protein modification,Metabolism of proteins
R-HSA-532668,R-HSA-597592,R-HSA-392499,N-glycan trimming in the ER and Calnexin/Calreticulin cycle,Post-translational protein modification,Metabolism of proteins
R-HSA-205025,R-HSA-73887,R-HSA-162582,NADE modulates death signalling,Death Receptor Signalling,Signal Transduction
R-HSA-389542,R-HSA-196854,R-HSA-1430728,NADPH regeneration,Metabolism of vitamins and cofactors,Metabolism
R-HSA-375165,R-HSA-9675108,R-HSA-1266738,NCAM signaling for neurite out-growth,Nervous system development,Developmental Biology
R-HSA-419037,R-HSA-9675108,R-HSA-1266738,NCAM1 interactions,Nervous system development,Developmental Biology
R-HSA-9636003,R-HSA-73884,R-HSA-73894,NEIL3-mediated resolution of ICLs,Base Excision Repair,DNA Repair
R-HSA-168333,R-HSA-5663205,R-HSA-1643685,NEP/NS2 Interacts with the Cellular Export Machinery,Infectious disease,Disease
R-HSA-933543,R-HSA-168249,R-HSA-168256,NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10,Innate Immune System,Immune System
R-HSA-209560,R-HSA-73887,R-HSA-162582,NF-kB is activated and signals survival,Death Receptor Signalling,Signal Transduction
R-HSA-205017,R-HSA-73887,R-HSA-162582,NFG and proNGF binds to p75NTR,Death Receptor Signalling,Signal Transduction
R-HSA-167060,R-HSA-9006934,R-HSA-162582,NGF processing,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-187024,R-HSA-9006934,R-HSA-162582,NGF-independant TRKA activation,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-9031628,R-HSA-9006934,R-HSA-162582,NGF-stimulated transcription,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-5676590,R-HSA-1280215,R-HSA-168256,NIK-->noncanonical NF-kB signaling,Cytokine Signaling in Immune system,Immune System
R-HSA-168638,R-HSA-168249,R-HSA-168256,NOD1/2 Signaling Pathway,Innate Immune System,Immune System
R-HSA-203754,R-HSA-202131,R-HSA-1430728,NOSIP mediated eNOS trafficking,Metabolism of nitric oxide: NOS3 activation and regulation,Metabolism
R-HSA-203641,R-HSA-202131,R-HSA-1430728,NOSTRIN mediated eNOS trafficking,Metabolism of nitric oxide: NOS3 activation and regulation,Metabolism
R-HSA-2122947,R-HSA-157118,R-HSA-162582,NOTCH1 Intracellular Domain Regulates Transcription,Signaling by NOTCH,Signal Transduction
R-HSA-2979096,R-HSA-157118,R-HSA-162582,NOTCH2 Activation and Transmission of Signal to the Nucleus,Signaling by NOTCH,Signal Transduction
R-HSA-2197563,R-HSA-157118,R-HSA-162582,NOTCH2 intracellular domain regulates transcription,Signaling by NOTCH,Signal Transduction
R-HSA-9013507,R-HSA-157118,R-HSA-162582,NOTCH3 Activation and Transmission of Signal to the Nucleus,Signaling by NOTCH,Signal Transduction
R-HSA-9013508,R-HSA-157118,R-HSA-162582,NOTCH3 Intracellular Domain Regulates Transcription,Signaling by NOTCH,Signal Transduction
R-HSA-9013700,R-HSA-157118,R-HSA-162582,NOTCH4 Activation and Transmission of Signal to the Nucleus,Signaling by NOTCH,Signal Transduction
R-HSA-9013695,R-HSA-157118,R-HSA-162582,NOTCH4 Intracellular Domain Regulates Transcription,Signaling by NOTCH,Signal Transduction
R-HSA-1368071,R-HSA-1368071,R-HSA-400253,NR1D1 (REV-ERBA) represses gene expression,NR1D1 (REV-ERBA) represses gene expression,Circadian Clock
R-HSA-9632974,R-HSA-9006931,R-HSA-162582,NR1H2 & NR1H3 regulate gene expression linked to gluconeogenesis,Signaling by Nuclear Receptors,Signal Transduction
R-HSA-9029558,R-HSA-9006931,R-HSA-162582,NR1H2 & NR1H3 regulate gene expression linked to lipogenesis,Signaling by Nuclear Receptors,Signal Transduction
R-HSA-9031528,R-HSA-9006931,R-HSA-162582,NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose,Signaling by Nuclear Receptors,Signal Transduction
R-HSA-9623433,R-HSA-9006931,R-HSA-162582,NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis,Signaling by Nuclear Receptors,Signal Transduction
R-HSA-9031525,R-HSA-9006931,R-HSA-162582,NR1H2 & NR1H3 regulate gene expression to limit cholesterol uptake,Signaling by Nuclear Receptors,Signal Transduction
R-HSA-9024446,R-HSA-9006931,R-HSA-162582,NR1H2 and NR1H3-mediated signaling,Signaling by Nuclear Receptors,Signal Transduction
R-HSA-9029569,R-HSA-9006931,R-HSA-162582,NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux,Signaling by Nuclear Receptors,Signal Transduction
R-HSA-193648,R-HSA-73887,R-HSA-162582,NRAGE signals death through JNK,Death Receptor Signalling,Signal Transduction
R-HSA-205043,R-HSA-73887,R-HSA-162582,NRIF signals cell death from the nucleus,Death Receptor Signalling,Signal Transduction
R-HSA-168276,R-HSA-5663205,R-HSA-1643685,NS1 Mediated Effects on Host Pathways,Infectious disease,Disease
R-HSA-9025046,R-HSA-9006934,R-HSA-162582,NTF3 activates NTRK2 (TRKB) signaling,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-9034013,R-HSA-9006934,R-HSA-162582,NTF3 activates NTRK3 signaling,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-9026357,R-HSA-9006934,R-HSA-162582,NTF4 activates NTRK2 (TRKB) signaling,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-9032759,R-HSA-9006934,R-HSA-162582,NTRK2 activates RAC1,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-9603505,R-HSA-9006934,R-HSA-162582,NTRK3 as a dependence receptor,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-9717301,R-HSA-5663202,R-HSA-1643685,NVP-TAE684-resistant ALK mutants,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-442660,R-HSA-425407,R-HSA-382551,Na+/Cl- dependent neurotransmitter transporters,SLC-mediated transmembrane transport,Transport of small molecules
R-HSA-420597,R-HSA-446728,R-HSA-1500931,Nectin/Necl  trans heterodimerization,Cell junction organization,Cell-Cell communication
R-HSA-8951664,R-HSA-597592,R-HSA-392499,Neddylation,Post-translational protein modification,Metabolism of proteins
R-HSA-167590,R-HSA-5663205,R-HSA-1643685,Nef Mediated CD4 Down-regulation,Infectious disease,Disease
R-HSA-182218,R-HSA-5663205,R-HSA-1643685,Nef Mediated CD8 Down-regulation,Infectious disease,Disease
R-HSA-164944,R-HSA-5663205,R-HSA-1643685,Nef and signal transduction,Infectious disease,Disease
R-HSA-164939,R-HSA-5663205,R-HSA-1643685,Nef mediated downregulation of CD28 cell surface expression,Infectious disease,Disease
R-HSA-164940,R-HSA-5663205,R-HSA-1643685,Nef mediated downregulation of MHC class I complex cell surface expression,Infectious disease,Disease
R-HSA-164938,R-HSA-5663205,R-HSA-1643685,Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters,Infectious disease,Disease
R-HSA-5250941,R-HSA-212165,R-HSA-74160,Negative epigenetic regulation of rRNA expression,Epigenetic regulation of gene expression,Gene expression (Transcription)
R-HSA-5674499,R-HSA-5683057,R-HSA-162582,Negative feedback regulation of MAPK pathway,MAPK family signaling cascades,Signal Transduction
R-HSA-5654726,R-HSA-9006934,R-HSA-162582,Negative regulation of FGFR1 signaling,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-5654727,R-HSA-9006934,R-HSA-162582,Negative regulation of FGFR2 signaling,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-5654732,R-HSA-9006934,R-HSA-162582,Negative regulation of FGFR3 signaling,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-5654733,R-HSA-9006934,R-HSA-162582,Negative regulation of FGFR4 signaling,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-9706369,R-HSA-1280215,R-HSA-168256,Negative regulation of FLT3,Cytokine Signaling in Immune system,Immune System
R-HSA-5675221,R-HSA-5683057,R-HSA-162582,Negative regulation of MAPK pathway,MAPK family signaling cascades,Signal Transduction
R-HSA-6807004,R-HSA-9006934,R-HSA-162582,Negative regulation of MET activity,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-9617324,R-HSA-112315,R-HSA-112316,Negative regulation of NMDA receptor-mediated neuronal transmission,Transmission across Chemical Synapses,Neuronal System
R-HSA-9604323,R-HSA-157118,R-HSA-162582,Negative regulation of NOTCH4 signaling,Signaling by NOTCH,Signal Transduction
R-HSA-5368598,R-HSA-195721,R-HSA-162582,Negative regulation of TCF-dependent signaling by DVL-interacting proteins,Signaling by WNT,Signal Transduction
R-HSA-3772470,R-HSA-195721,R-HSA-162582,Negative regulation of TCF-dependent signaling by WNT ligand antagonists,Signaling by WNT,Signal Transduction
R-HSA-8866904,R-HSA-73857,R-HSA-74160,Negative regulation of activity of TFAP2 (AP-2) family transcription factors,RNA Polymerase II Transcription,Gene expression (Transcription)
R-HSA-199418,R-HSA-9006925,R-HSA-162582,Negative regulation of the PI3K/AKT network,Intracellular signaling by second messengers,Signal Transduction
R-HSA-936440,R-HSA-168249,R-HSA-168256,Negative regulators of DDX58/IFIH1 signaling,Innate Immune System,Immune System
R-HSA-373753,R-HSA-373753,R-HSA-1500931,Nephrin family interactions,Nephrin family interactions,Cell-Cell communication
R-HSA-9675108,R-HSA-9675108,R-HSA-1266738,Nervous system development,Nervous system development,Developmental Biology
R-HSA-418886,R-HSA-9675108,R-HSA-1266738,Netrin mediated repulsion signals,Nervous system development,Developmental Biology
R-HSA-373752,R-HSA-9675108,R-HSA-1266738,Netrin-1 signaling,Nervous system development,Developmental Biology
R-HSA-6794361,R-HSA-6794362,R-HSA-112316,Neurexins and neuroligins,Protein-protein interactions at synapses,Neuronal System
R-HSA-8863678,R-HSA-9645723,R-HSA-1643685,Neurodegenerative Diseases,Diseases of programmed cell death,Disease
R-HSA-447043,R-HSA-9675108,R-HSA-1266738,Neurofascin interactions,Nervous system development,Developmental Biology
R-HSA-112316,R-HSA-112316,R-HSA-112316,Neuronal System,Neuronal System,Neuronal System
R-HSA-194306,R-HSA-9006934,R-HSA-162582,Neurophilin interactions with VEGF and VEGFR,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-168799,R-HSA-5663205,R-HSA-1643685,Neurotoxicity of clostridium toxins,Infectious disease,Disease
R-HSA-112311,R-HSA-112315,R-HSA-112316,Neurotransmitter clearance,Transmission across Chemical Synapses,Neuronal System
R-HSA-112314,R-HSA-112315,R-HSA-112316,Neurotransmitter receptors and postsynaptic signal transmission,Transmission across Chemical Synapses,Neuronal System
R-HSA-112310,R-HSA-112315,R-HSA-112316,Neurotransmitter release cycle,Transmission across Chemical Synapses,Neuronal System
R-HSA-112313,R-HSA-112315,R-HSA-112316,Neurotransmitter uptake and metabolism In glial cells,Transmission across Chemical Synapses,Neuronal System
R-HSA-6798695,R-HSA-168249,R-HSA-168256,Neutrophil degranulation,Innate Immune System,Immune System
R-HSA-197264,R-HSA-196854,R-HSA-1430728,Nicotinamide salvaging,Metabolism of vitamins and cofactors,Metabolism
R-HSA-196807,R-HSA-196854,R-HSA-1430728,Nicotinate metabolism,Metabolism of vitamins and cofactors,Metabolism
R-HSA-9669926,R-HSA-5663202,R-HSA-1643685,Nilotinib-resistant KIT mutants,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-392154,R-HSA-418346,R-HSA-109582,Nitric oxide stimulates guanylate cyclase,Platelet homeostasis,Hemostasis
R-HSA-427413,R-HSA-212165,R-HSA-74160,NoRC negatively regulates rRNA expression,Epigenetic regulation of gene expression,Gene expression (Transcription)
R-HSA-3000171,R-HSA-3000171,R-HSA-1474244,Non-integrin membrane-ECM interactions,Non-integrin membrane-ECM interactions,Extracellular matrix organization
R-HSA-9017802,R-HSA-157118,R-HSA-162582,Noncanonical activation of NOTCH3,Signaling by NOTCH,Signal Transduction
R-HSA-5693571,R-HSA-5693532,R-HSA-73894,Nonhomologous End-Joining (NHEJ),DNA Double-Strand Break Repair,DNA Repair
R-HSA-975957,R-HSA-927802,R-HSA-8953854,Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC),Nonsense-Mediated Decay (NMD),Metabolism of RNA
R-HSA-975956,R-HSA-927802,R-HSA-8953854,Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),Nonsense-Mediated Decay (NMD),Metabolism of RNA
R-HSA-927802,R-HSA-927802,R-HSA-8953854,Nonsense-Mediated Decay (NMD),Nonsense-Mediated Decay (NMD),Metabolism of RNA
R-HSA-181430,R-HSA-112315,R-HSA-112316,Norepinephrine Neurotransmitter Release Cycle,Transmission across Chemical Synapses,Neuronal System
R-HSA-350054,R-HSA-73857,R-HSA-74160,Notch-HLH transcription pathway,RNA Polymerase II Transcription,Gene expression (Transcription)
R-HSA-447038,R-HSA-9675108,R-HSA-1266738,NrCAM interactions,Nervous system development,Developmental Biology
R-HSA-2995410,R-HSA-69278,R-HSA-1640170,Nuclear Envelope (NE) Reassembly,"Cell Cycle, Mitotic",Cell Cycle
R-HSA-2980766,R-HSA-69278,R-HSA-1640170,Nuclear Envelope Breakdown,"Cell Cycle, Mitotic",Cell Cycle
R-HSA-198725,R-HSA-9006934,R-HSA-162582,Nuclear Events (kinase and transcription factor activation),Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-3301854,R-HSA-69278,R-HSA-1640170,Nuclear Pore Complex (NPC) Disassembly,"Cell Cycle, Mitotic",Cell Cycle
R-HSA-383280,R-HSA-73857,R-HSA-74160,Nuclear Receptor transcription pathway,RNA Polymerase II Transcription,Gene expression (Transcription)
R-HSA-9725371,R-HSA-5663202,R-HSA-1643685,Nuclear events stimulated by ALK signaling in cancer,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-180746,R-HSA-5663205,R-HSA-1643685,Nuclear import of Rev protein,Infectious disease,Disease
R-HSA-1251985,R-HSA-9006934,R-HSA-162582,Nuclear signaling by ERBB4,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-8956320,R-HSA-15869,R-HSA-1430728,Nucleobase biosynthesis,Metabolism of nucleotides,Metabolism
R-HSA-8956319,R-HSA-15869,R-HSA-1430728,Nucleobase catabolism,Metabolism of nucleotides,Metabolism
R-HSA-774815,R-HSA-73886,R-HSA-1640170,Nucleosome assembly,Chromosome Maintenance,Cell Cycle
R-HSA-5696398,R-HSA-5696398,R-HSA-73894,Nucleotide Excision Repair,Nucleotide Excision Repair,DNA Repair
R-HSA-8956321,R-HSA-15869,R-HSA-1430728,Nucleotide salvage,Metabolism of nucleotides,Metabolism
R-HSA-168643,R-HSA-168249,R-HSA-168256,"Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways",Innate Immune System,Immune System
R-HSA-418038,R-HSA-372790,R-HSA-162582,Nucleotide-like (purinergic) receptors,Signaling by GPCR,Signal Transduction
R-HSA-5173214,R-HSA-597592,R-HSA-392499,O-glycosylation of TSR domain-containing proteins,Post-translational protein modification,Metabolism of proteins
R-HSA-5173105,R-HSA-597592,R-HSA-392499,O-linked glycosylation,Post-translational protein modification,Metabolism of proteins
R-HSA-913709,R-HSA-597592,R-HSA-392499,O-linked glycosylation of mucins,Post-translational protein modification,Metabolism of proteins
R-HSA-1480926,R-HSA-1480926,R-HSA-382551,O2/CO2 exchange in erythrocytes,O2/CO2 exchange in erythrocytes,Transport of small molecules
R-HSA-8983711,R-HSA-1280215,R-HSA-168256,OAS antiviral response,Cytokine Signaling in Immune system,Immune System
R-HSA-9673163,R-HSA-1428517,R-HSA-1430728,Oleoyl-phe metabolism,The citric acid (TCA) cycle and respiratory electron transport,Metabolism
R-HSA-381753,R-HSA-381753,R-HSA-9709957,Olfactory Signaling Pathway,Olfactory Signaling Pathway,Sensory Perception
R-HSA-190704,R-HSA-199991,R-HSA-5653656,Oligomerization of connexins into connexons,Membrane Trafficking,Vesicle-mediated transport
R-HSA-2559585,R-HSA-2262752,R-HSA-8953897,Oncogene Induced Senescence,Cellular responses to stress,Cellular responses to stimuli
R-HSA-6802957,R-HSA-5663202,R-HSA-1643685,Oncogenic MAPK signaling,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-111885,R-HSA-372790,R-HSA-162582,Opioid Signalling,Signaling by GPCR,Signal Transduction
R-HSA-419771,R-HSA-372790,R-HSA-162582,Opsins,Signaling by GPCR,Signal Transduction
R-HSA-68949,R-HSA-69278,R-HSA-1640170,Orc1 removal from chromatin,"Cell Cycle, Mitotic",Cell Cycle
R-HSA-68949,R-HSA-69239,R-HSA-69306,Orc1 removal from chromatin,Synthesis of DNA,DNA Replication
R-HSA-389397,R-HSA-372790,R-HSA-162582,Orexin and neuropeptides FF and QRFP bind to their respective receptors,Signaling by GPCR,Signal Transduction
R-HSA-1852241,R-HSA-1852241,R-HSA-1852241,Organelle biogenesis and maintenance,Organelle biogenesis and maintenance,Organelle biogenesis and maintenance
R-HSA-561048,R-HSA-425407,R-HSA-382551,Organic anion transport,SLC-mediated transmembrane transport,Transport of small molecules
R-HSA-428643,R-HSA-425407,R-HSA-382551,Organic anion transporters,SLC-mediated transmembrane transport,Transport of small molecules
R-HSA-549127,R-HSA-425407,R-HSA-382551,Organic cation transport,SLC-mediated transmembrane transport,Transport of small molecules
R-HSA-549132,R-HSA-425407,R-HSA-382551,Organic cation/anion/zwitterion transport,SLC-mediated transmembrane transport,Transport of small molecules
R-HSA-449836,R-HSA-1280215,R-HSA-168256,Other interleukin signaling,Cytokine Signaling in Immune system,Immune System
R-HSA-416700,R-HSA-9675108,R-HSA-1266738,Other semaphorin interactions,Nervous system development,Developmental Biology
R-HSA-5689896,R-HSA-597592,R-HSA-392499,Ovarian tumor domain proteases,Post-translational protein modification,Metabolism of proteins
R-HSA-2559580,R-HSA-2262752,R-HSA-8953897,Oxidative Stress Induced Senescence,Cellular responses to stress,Cellular responses to stimuli
R-HSA-1234176,R-HSA-2262752,R-HSA-8953897,Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha,Cellular responses to stress,Cellular responses to stimuli
R-HSA-417957,R-HSA-372790,R-HSA-162582,P2Y receptors,Signaling by GPCR,Signal Transduction
R-HSA-141334,R-HSA-211859,R-HSA-1430728,PAOs oxidise polyamines to amines,Biological oxidations,Metabolism
R-HSA-5651801,R-HSA-73884,R-HSA-73894,PCNA-Dependent Long Patch Base Excision Repair,Base Excision Repair,DNA Repair
R-HSA-4086400,R-HSA-195721,R-HSA-162582,PCP/CE pathway,Signaling by WNT,Signal Transduction
R-HSA-389948,R-HSA-1280218,R-HSA-168256,PD-1 signaling,Adaptive Immune System,Immune System
R-HSA-165160,R-HSA-9006934,R-HSA-162582,PDE3B signalling,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-165160,R-HSA-9006934,R-HSA-162582,PDE3B signalling,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-9674428,R-HSA-5663202,R-HSA-1643685,PDGFR mutants bind TKIs,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-210990,R-HSA-202733,R-HSA-109582,PECAM1 interactions,Cell surface interactions at the vascular wall,Hemostasis
R-HSA-381042,R-HSA-2262752,R-HSA-8953897,PERK regulates gene expression,Cellular responses to stress,Cellular responses to stimuli
R-HSA-1483255,R-HSA-556833,R-HSA-1430728,PI Metabolism,Metabolism of lipids,Metabolism
R-HSA-1483196,R-HSA-556833,R-HSA-1430728,PI and PC transport between ER and Golgi membranes,Metabolism of lipids,Metabolism
R-HSA-1483196,R-HSA-556833,R-HSA-1430728,PI and PC transport between ER and Golgi membranes,Metabolism of lipids,Metabolism
R-HSA-5654689,R-HSA-9006934,R-HSA-162582,PI-3K cascade:FGFR1,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-5654695,R-HSA-9006934,R-HSA-162582,PI-3K cascade:FGFR2,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-5654710,R-HSA-9006934,R-HSA-162582,PI-3K cascade:FGFR3,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-5654720,R-HSA-9006934,R-HSA-162582,PI-3K cascade:FGFR4,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-109704,R-HSA-9006934,R-HSA-162582,PI3K Cascade,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-109704,R-HSA-9006934,R-HSA-162582,PI3K Cascade,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-1963642,R-HSA-9006934,R-HSA-162582,PI3K events in ERBB2 signaling,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-1250342,R-HSA-9006934,R-HSA-162582,PI3K events in ERBB4 signaling,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-2219528,R-HSA-5663202,R-HSA-1643685,PI3K/AKT Signaling in Cancer,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-198203,R-HSA-9006934,R-HSA-162582,PI3K/AKT activation,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-6811555,R-HSA-73857,R-HSA-74160,PI5P Regulates TP53 Acetylation,RNA Polymerase II Transcription,Gene expression (Transcription)
R-HSA-6811558,R-HSA-9006925,R-HSA-162582,"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling",Intracellular signaling by second messengers,Signal Transduction
R-HSA-5205685,R-HSA-1632852,R-HSA-9612973,PINK1-PRKN Mediated Mitophagy,Macroautophagy,Autophagy
R-HSA-1257604,R-HSA-9006925,R-HSA-162582,PIP3 activates AKT signaling,Intracellular signaling by second messengers,Signal Transduction
R-HSA-1660510,R-HSA-556833,R-HSA-1430728,PIPs transport between Golgi and plasma membranes,Metabolism of lipids,Metabolism
R-HSA-1660502,R-HSA-556833,R-HSA-1430728,PIPs transport between early and late endosome membranes,Metabolism of lipids,Metabolism
R-HSA-1660537,R-HSA-556833,R-HSA-1430728,PIPs transport between early endosome and Golgi membranes,Metabolism of lipids,Metabolism
R-HSA-1660508,R-HSA-556833,R-HSA-1430728,PIPs transport between late endosome and Golgi membranes,Metabolism of lipids,Metabolism
R-HSA-1660524,R-HSA-556833,R-HSA-1430728,PIPs transport between plasma and early endosome membranes,Metabolism of lipids,Metabolism
R-HSA-5601884,R-HSA-211000,R-HSA-74160,PIWI-interacting RNA (piRNA) biogenesis,Gene Silencing by RNA,Gene expression (Transcription)
R-HSA-163615,R-HSA-372790,R-HSA-162582,PKA activation,Signaling by GPCR,Signal Transduction
R-HSA-163615,R-HSA-9006925,R-HSA-162582,PKA activation,Intracellular signaling by second messengers,Signal Transduction
R-HSA-164378,R-HSA-163685,R-HSA-1430728,PKA activation in glucagon signalling,Integration of energy metabolism,Metabolism
R-HSA-111931,R-HSA-372790,R-HSA-162582,PKA-mediated phosphorylation of CREB,Signaling by GPCR,Signal Transduction
R-HSA-111931,R-HSA-9006925,R-HSA-162582,PKA-mediated phosphorylation of CREB,Intracellular signaling by second messengers,Signal Transduction
R-HSA-163358,R-HSA-163685,R-HSA-1430728,PKA-mediated phosphorylation of key metabolic factors,Integration of energy metabolism,Metabolism
R-HSA-109703,R-HSA-9006934,R-HSA-162582,PKB-mediated events,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-109703,R-HSA-9006934,R-HSA-162582,PKB-mediated events,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-3214841,R-HSA-3247509,R-HSA-4839726,PKMTs methylate histone lysines,Chromatin modifying enzymes,Chromatin organization
R-HSA-112043,R-HSA-372790,R-HSA-162582,PLC beta mediated events,Signaling by GPCR,Signal Transduction
R-HSA-167021,R-HSA-9006934,R-HSA-162582,PLC-gamma1 signalling,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-1251932,R-HSA-9006934,R-HSA-162582,PLCG1 events in ERBB2 signaling,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-110362,R-HSA-73884,R-HSA-73894,POLB-Dependent Long Patch Base Excision Repair,Base Excision Repair,DNA Repair
R-HSA-2892247,R-HSA-452723,R-HSA-1266738,"POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation",Transcriptional regulation of pluripotent stem cells,Developmental Biology
R-HSA-2892245,R-HSA-452723,R-HSA-1266738,"POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation",Transcriptional regulation of pluripotent stem cells,Developmental Biology
R-HSA-163767,R-HSA-163685,R-HSA-1430728,PP2A-mediated dephosphorylation of key metabolic factors,Integration of energy metabolism,Metabolism
R-HSA-1989781,R-HSA-556833,R-HSA-1430728,PPARA activates gene expression,Metabolism of lipids,Metabolism
R-HSA-212300,R-HSA-212165,R-HSA-74160,PRC2 methylates histones and DNA,Epigenetic regulation of gene expression,Gene expression (Transcription)
R-HSA-5674404,R-HSA-5663202,R-HSA-1643685,PTEN Loss of Function in Cancer,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-6807070,R-HSA-9006925,R-HSA-162582,PTEN Regulation,Intracellular signaling by second messengers,Signal Transduction
R-HSA-8849474,R-HSA-9006927,R-HSA-162582,PTK6 Activates STAT3,Signaling by Non-Receptor Tyrosine Kinases,Signal Transduction
R-HSA-8849472,R-HSA-9006927,R-HSA-162582,PTK6 Down-Regulation,Signaling by Non-Receptor Tyrosine Kinases,Signal Transduction
R-HSA-8849473,R-HSA-9006927,R-HSA-162582,PTK6 Expression,Signaling by Non-Receptor Tyrosine Kinases,Signal Transduction
R-HSA-8849470,R-HSA-9006927,R-HSA-162582,PTK6 Regulates Cell Cycle,Signaling by Non-Receptor Tyrosine Kinases,Signal Transduction
R-HSA-8849468,R-HSA-9006927,R-HSA-162582,PTK6 Regulates Proteins Involved in RNA Processing,Signaling by Non-Receptor Tyrosine Kinases,Signal Transduction
R-HSA-8849471,R-HSA-9006927,R-HSA-162582,"PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases",Signaling by Non-Receptor Tyrosine Kinases,Signal Transduction
R-HSA-8849469,R-HSA-9006927,R-HSA-162582,PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1,Signaling by Non-Receptor Tyrosine Kinases,Signal Transduction
R-HSA-8857538,R-HSA-9006927,R-HSA-162582,PTK6 promotes HIF1A stabilization,Signaling by Non-Receptor Tyrosine Kinases,Signal Transduction
R-HSA-171306,R-HSA-73886,R-HSA-1640170,Packaging Of Telomere Ends,Chromosome Maintenance,Cell Cycle
R-HSA-168303,R-HSA-5663205,R-HSA-1643685,Packaging of Eight RNA Segments,Infectious disease,Disease
R-HSA-6802955,R-HSA-5663202,R-HSA-1643685,Paradoxical activation of RAF signaling by kinase inactive BRAF,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-9664407,R-HSA-5663205,R-HSA-1643685,Parasite infection,Infectious disease,Disease
R-HSA-432047,R-HSA-445717,R-HSA-382551,Passive transport by Aquaporins,Aquaporin-mediated transport,Transport of small molecules
R-HSA-167290,R-HSA-5663205,R-HSA-1643685,Pausing and recovery of HIV elongation,Infectious disease,Disease
R-HSA-167238,R-HSA-5663205,R-HSA-1643685,Pausing and recovery of Tat-mediated HIV elongation,Infectious disease,Disease
R-HSA-71336,R-HSA-71387,R-HSA-1430728,Pentose phosphate pathway,Metabolism of carbohydrates,Metabolism
R-HSA-6791465,R-HSA-5668914,R-HSA-1643685,Pentose phosphate pathway disease,Diseases of metabolism,Disease
R-HSA-156902,R-HSA-72766,R-HSA-392499,Peptide chain elongation,Translation,Metabolism of proteins
R-HSA-209952,R-HSA-2980736,R-HSA-392499,Peptide hormone biosynthesis,Peptide hormone metabolism,Metabolism of proteins
R-HSA-2980736,R-HSA-2980736,R-HSA-392499,Peptide hormone metabolism,Peptide hormone metabolism,Metabolism of proteins
R-HSA-375276,R-HSA-372790,R-HSA-162582,Peptide ligand-binding receptors,Signaling by GPCR,Signal Transduction
R-HSA-390918,R-HSA-556833,R-HSA-1430728,Peroxisomal lipid metabolism,Metabolism of lipids,Metabolism
R-HSA-9033241,R-HSA-9033241,R-HSA-9609507,Peroxisomal protein import,Peroxisomal protein import,Protein localization
R-HSA-9005895,R-HSA-9675151,R-HSA-1643685,Pervasive developmental disorders,Disorders of Developmental Biology,Disease
R-HSA-9664873,R-HSA-1632852,R-HSA-9612973,Pexophagy,Macroautophagy,Autophagy
R-HSA-9637698,R-HSA-5663205,R-HSA-1643685,Phagocyte cell death caused by cytosolic Mtb,Infectious disease,Disease
R-HSA-5576892,R-HSA-5576891,R-HSA-397014,Phase 0 - rapid depolarisation,Cardiac conduction,Muscle contraction
R-HSA-5576894,R-HSA-5576891,R-HSA-397014,Phase 1 - inactivation of fast Na+ channels,Cardiac conduction,Muscle contraction
R-HSA-5576893,R-HSA-5576891,R-HSA-397014,Phase 2 - plateau phase,Cardiac conduction,Muscle contraction
R-HSA-5576890,R-HSA-5576891,R-HSA-397014,Phase 3 - rapid repolarisation,Cardiac conduction,Muscle contraction
R-HSA-5576886,R-HSA-5576891,R-HSA-397014,Phase 4 - resting membrane potential,Cardiac conduction,Muscle contraction
R-HSA-211945,R-HSA-211859,R-HSA-1430728,Phase I - Functionalization of compounds,Biological oxidations,Metabolism
R-HSA-156580,R-HSA-211859,R-HSA-1430728,Phase II - Conjugation of compounds,Biological oxidations,Metabolism
R-HSA-8963691,R-HSA-71291,R-HSA-1430728,Phenylalanine and tyrosine metabolism,Metabolism of amino acids and derivatives,Metabolism
R-HSA-8964208,R-HSA-71291,R-HSA-1430728,Phenylalanine metabolism,Metabolism of amino acids and derivatives,Metabolism
R-HSA-2160456,R-HSA-5668914,R-HSA-1643685,Phenylketonuria,Diseases of metabolism,Disease
R-HSA-8850843,R-HSA-15869,R-HSA-1430728,Phosphate bond hydrolysis by NTPDase proteins,Metabolism of nucleotides,Metabolism
R-HSA-2393930,R-HSA-15869,R-HSA-1430728,Phosphate bond hydrolysis by NUDT proteins,Metabolism of nucleotides,Metabolism
R-HSA-5654219,R-HSA-9006934,R-HSA-162582,Phospholipase C-mediated cascade: FGFR1,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-5654221,R-HSA-9006934,R-HSA-162582,Phospholipase C-mediated cascade; FGFR2,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-5654227,R-HSA-9006934,R-HSA-162582,Phospholipase C-mediated cascade; FGFR3,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-5654228,R-HSA-9006934,R-HSA-162582,Phospholipase C-mediated cascade; FGFR4,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-1483257,R-HSA-556833,R-HSA-1430728,Phospholipid metabolism,Metabolism of lipids,Metabolism
R-HSA-202427,R-HSA-1280218,R-HSA-168256,Phosphorylation of CD3 and TCR zeta chains,Adaptive Immune System,Immune System
R-HSA-176417,R-HSA-69278,R-HSA-1640170,Phosphorylation of Emi1,"Cell Cycle, Mitotic",Cell Cycle
R-HSA-69200,R-HSA-69278,R-HSA-1640170,Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes,"Cell Cycle, Mitotic",Cell Cycle
R-HSA-170145,R-HSA-69278,R-HSA-1640170,Phosphorylation of proteins involved in the G2/M transition by Cyclin A:Cdc2 complexes,"Cell Cycle, Mitotic",Cell Cycle
R-HSA-176412,R-HSA-69278,R-HSA-1640170,Phosphorylation of the APC/C,"Cell Cycle, Mitotic",Cell Cycle
R-HSA-5578768,R-HSA-5576891,R-HSA-397014,Physiological factors,Cardiac conduction,Muscle contraction
R-HSA-8963898,R-HSA-174824,R-HSA-382551,Plasma lipoprotein assembly,"Plasma lipoprotein assembly, remodeling, and clearance",Transport of small molecules
R-HSA-174824,R-HSA-174824,R-HSA-382551,"Plasma lipoprotein assembly, remodeling, and clearance","Plasma lipoprotein assembly, remodeling, and clearance",Transport of small molecules
R-HSA-8964043,R-HSA-174824,R-HSA-382551,Plasma lipoprotein clearance,"Plasma lipoprotein assembly, remodeling, and clearance",Transport of small molecules
R-HSA-8963899,R-HSA-174824,R-HSA-382551,Plasma lipoprotein remodeling,"Plasma lipoprotein assembly, remodeling, and clearance",Transport of small molecules
R-HSA-75896,R-HSA-556833,R-HSA-1430728,Plasmalogen biosynthesis,Metabolism of lipids,Metabolism
R-HSA-75892,R-HSA-75892,R-HSA-109582,Platelet Adhesion to exposed collagen,Platelet Adhesion to exposed collagen,Hemostasis
R-HSA-76009,R-HSA-76002,R-HSA-109582,Platelet Aggregation (Plug Formation),"Platelet activation, signaling and aggregation",Hemostasis
R-HSA-76002,R-HSA-76002,R-HSA-109582,"Platelet activation, signaling and aggregation","Platelet activation, signaling and aggregation",Hemostasis
R-HSA-418360,R-HSA-418346,R-HSA-109582,Platelet calcium homeostasis,Platelet homeostasis,Hemostasis
R-HSA-114608,R-HSA-76002,R-HSA-109582,Platelet degranulation,"Platelet activation, signaling and aggregation",Hemostasis
R-HSA-418346,R-HSA-418346,R-HSA-109582,Platelet homeostasis,Platelet homeostasis,Hemostasis
R-HSA-432142,R-HSA-418346,R-HSA-109582,Platelet sensitization by LDL,Platelet homeostasis,Hemostasis
R-HSA-164525,R-HSA-5663205,R-HSA-1643685,Plus-strand DNA synthesis,Infectious disease,Disease
R-HSA-156711,R-HSA-69278,R-HSA-1640170,Polo-like kinase mediated events,"Cell Cycle, Mitotic",Cell Cycle
R-HSA-69091,R-HSA-69278,R-HSA-1640170,Polymerase switching,"Cell Cycle, Mitotic",Cell Cycle
R-HSA-69091,R-HSA-69239,R-HSA-69306,Polymerase switching,Synthesis of DNA,DNA Replication
R-HSA-69091,R-HSA-69278,R-HSA-1640170,Polymerase switching,"Cell Cycle, Mitotic",Cell Cycle
R-HSA-69091,R-HSA-69239,R-HSA-69306,Polymerase switching,Synthesis of DNA,DNA Replication
R-HSA-174411,R-HSA-73886,R-HSA-1640170,Polymerase switching on the C-strand of the telomere,Chromosome Maintenance,Cell Cycle
R-HSA-5250913,R-HSA-212165,R-HSA-74160,Positive epigenetic regulation of rRNA expression,Epigenetic regulation of gene expression,Gene expression (Transcription)
R-HSA-438064,R-HSA-112315,R-HSA-112316,Post NMDA receptor activation events,Transmission across Chemical Synapses,Neuronal System
R-HSA-389977,R-HSA-391251,R-HSA-392499,Post-chaperonin tubulin folding pathway,Protein folding,Metabolism of proteins
R-HSA-426496,R-HSA-211000,R-HSA-74160,Post-transcriptional silencing by small RNAs,Gene Silencing by RNA,Gene expression (Transcription)
R-HSA-163125,R-HSA-597592,R-HSA-392499,Post-translational modification: synthesis of GPI-anchored proteins,Post-translational protein modification,Metabolism of proteins
R-HSA-597592,R-HSA-597592,R-HSA-392499,Post-translational protein modification,Post-translational protein modification,Metabolism of proteins
R-HSA-8957275,R-HSA-597592,R-HSA-392499,Post-translational protein phosphorylation,Post-translational protein modification,Metabolism of proteins
R-HSA-9615933,R-HSA-69278,R-HSA-1640170,Postmitotic nuclear pore complex (NPC) reformation,"Cell Cycle, Mitotic",Cell Cycle
R-HSA-622327,R-HSA-112315,R-HSA-112316,Postsynaptic nicotinic acetylcholine receptors,Transmission across Chemical Synapses,Neuronal System
R-HSA-1296071,R-HSA-1296071,R-HSA-112316,Potassium Channels,Potassium Channels,Neuronal System
R-HSA-1296067,R-HSA-1296071,R-HSA-112316,Potassium transport channels,Potassium Channels,Neuronal System
R-HSA-9679191,R-HSA-5663205,R-HSA-1643685,Potential therapeutics for SARS,Infectious disease,Disease
R-HSA-1912422,R-HSA-157118,R-HSA-162582,Pre-NOTCH Expression and Processing,Signaling by NOTCH,Signal Transduction
R-HSA-1912420,R-HSA-157118,R-HSA-162582,Pre-NOTCH Processing in Golgi,Signaling by NOTCH,Signal Transduction
R-HSA-1912399,R-HSA-157118,R-HSA-162582,Pre-NOTCH Processing in the Endoplasmic Reticulum,Signaling by NOTCH,Signal Transduction
R-HSA-1912408,R-HSA-157118,R-HSA-162582,Pre-NOTCH Transcription and Translation,Signaling by NOTCH,Signal Transduction
R-HSA-389957,R-HSA-391251,R-HSA-392499,Prefoldin mediated transfer of substrate  to CCT/TriC,Protein folding,Metabolism of proteins
R-HSA-196108,R-HSA-556833,R-HSA-1430728,Pregnenolone biosynthesis,Metabolism of lipids,Metabolism
R-HSA-112308,R-HSA-112315,R-HSA-112316,Presynaptic depolarization and calcium channel opening,Transmission across Chemical Synapses,Neuronal System
R-HSA-500657,R-HSA-112315,R-HSA-112316,Presynaptic function of Kainate receptors,Transmission across Chemical Synapses,Neuronal System
R-HSA-622323,R-HSA-112315,R-HSA-112316,Presynaptic nicotinic acetylcholine receptors,Transmission across Chemical Synapses,Neuronal System
R-HSA-5693616,R-HSA-5693532,R-HSA-73894,Presynaptic phase of homologous DNA pairing and strand exchange,DNA Double-Strand Break Repair,DNA Repair
R-HSA-9636383,R-HSA-5663205,R-HSA-1643685,Prevention of phagosomal-lysosomal fusion,Infectious disease,Disease
R-HSA-3215018,R-HSA-597592,R-HSA-392499,Processing and activation of SUMO,Post-translational protein modification,Metabolism of proteins
R-HSA-72203,R-HSA-72203,R-HSA-8953854,Processing of Capped Intron-Containing Pre-mRNA,Processing of Capped Intron-Containing Pre-mRNA,Metabolism of RNA
R-HSA-75067,R-HSA-75067,R-HSA-8953854,Processing of Capped Intronless Pre-mRNA,Processing of Capped Intronless Pre-mRNA,Metabolism of RNA
R-HSA-5693607,R-HSA-5693532,R-HSA-73894,Processing of DNA double-strand break ends,DNA Double-Strand Break Repair,DNA Repair
R-HSA-77595,R-HSA-75067,R-HSA-8953854,Processing of Intronless Pre-mRNAs,Processing of Capped Intronless Pre-mRNA,Metabolism of RNA
R-HSA-8949664,R-HSA-8949215,R-HSA-382551,Processing of SMDT1,Mitochondrial calcium ion transport,Transport of small molecules
R-HSA-174414,R-HSA-73886,R-HSA-1640170,Processive synthesis on the C-strand of the telomere,Chromosome Maintenance,Cell Cycle
R-HSA-69183,R-HSA-69278,R-HSA-1640170,Processive synthesis on the lagging strand,"Cell Cycle, Mitotic",Cell Cycle
R-HSA-69183,R-HSA-69239,R-HSA-69306,Processive synthesis on the lagging strand,Synthesis of DNA,DNA Replication
R-HSA-5357801,R-HSA-5357801,R-HSA-5357801,Programmed Cell Death,Programmed Cell Death,Programmed Cell Death
R-HSA-964827,R-HSA-597592,R-HSA-392499,"Progressive trimming of alpha-1,2-linked mannose residues from Man9/8/7GlcNAc2 to produce Man5GlcNAc2",Post-translational protein modification,Metabolism of proteins
R-HSA-1170546,R-HSA-1280215,R-HSA-168256,Prolactin receptor signaling,Cytokine Signaling in Immune system,Immune System
R-HSA-70688,R-HSA-71291,R-HSA-1430728,Proline catabolism,Metabolism of amino acids and derivatives,Metabolism
R-HSA-169893,R-HSA-9006934,R-HSA-162582,Prolonged ERK activation events,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-71032,R-HSA-556833,R-HSA-1430728,Propionyl-CoA catabolism,Metabolism of lipids,Metabolism
R-HSA-392851,R-HSA-418346,R-HSA-109582,Prostacyclin signalling through prostacyclin receptor,Platelet homeostasis,Hemostasis
R-HSA-391908,R-HSA-372790,R-HSA-162582,Prostanoid ligand receptors,Signaling by GPCR,Signal Transduction
R-HSA-391251,R-HSA-391251,R-HSA-392499,Protein folding,Protein folding,Metabolism of proteins
R-HSA-9609507,R-HSA-9609507,R-HSA-9609507,Protein localization,Protein localization,Protein localization
R-HSA-8876725,R-HSA-597592,R-HSA-392499,Protein methylation,Post-translational protein modification,Metabolism of proteins
R-HSA-5676934,R-HSA-5676934,R-HSA-392499,Protein repair,Protein repair,Metabolism of proteins
R-HSA-8852135,R-HSA-597592,R-HSA-392499,Protein ubiquitination,Post-translational protein modification,Metabolism of proteins
R-HSA-6794362,R-HSA-6794362,R-HSA-112316,Protein-protein interactions at synapses,Protein-protein interactions at synapses,Neuronal System
R-HSA-433692,R-HSA-425407,R-HSA-382551,Proton-coupled monocarboxylate transport,SLC-mediated transmembrane transport,Transport of small molecules
R-HSA-428559,R-HSA-425407,R-HSA-382551,Proton-coupled neutral amino acid transporters,SLC-mediated transmembrane transport,Transport of small molecules
R-HSA-427975,R-HSA-425407,R-HSA-382551,Proton/oligopeptide cotransporters,SLC-mediated transmembrane transport,Transport of small molecules
R-HSA-74259,R-HSA-15869,R-HSA-1430728,Purine catabolism,Metabolism of nucleotides,Metabolism
R-HSA-73817,R-HSA-15869,R-HSA-1430728,Purine ribonucleoside monophosphate biosynthesis,Metabolism of nucleotides,Metabolism
R-HSA-74217,R-HSA-15869,R-HSA-1430728,Purine salvage,Metabolism of nucleotides,Metabolism
R-HSA-9660826,R-HSA-5663205,R-HSA-1643685,Purinergic signaling in leishmaniasis infection,Infectious disease,Disease
R-HSA-500753,R-HSA-15869,R-HSA-1430728,Pyrimidine biosynthesis,Metabolism of nucleotides,Metabolism
R-HSA-73621,R-HSA-15869,R-HSA-1430728,Pyrimidine catabolism,Metabolism of nucleotides,Metabolism
R-HSA-73614,R-HSA-15869,R-HSA-1430728,Pyrimidine salvage,Metabolism of nucleotides,Metabolism
R-HSA-71737,R-HSA-71737,R-HSA-1430728,Pyrophosphate hydrolysis,Pyrophosphate hydrolysis,Metabolism
R-HSA-5620971,R-HSA-5218859,R-HSA-5357801,Pyroptosis,Regulated Necrosis,Programmed Cell Death
R-HSA-70268,R-HSA-1428517,R-HSA-1430728,Pyruvate metabolism,The citric acid (TCA) cycle and respiratory electron transport,Metabolism
R-HSA-71406,R-HSA-1428517,R-HSA-1430728,Pyruvate metabolism and Citric Acid (TCA) cycle,The citric acid (TCA) cycle and respiratory electron transport,Metabolism
R-HSA-5365859,R-HSA-9006931,R-HSA-162582,RA biosynthesis pathway,Signaling by Nuclear Receptors,Signal Transduction
R-HSA-8876198,R-HSA-199991,R-HSA-5653656,RAB GEFs exchange GTP for GDP on RABs,Membrane Trafficking,Vesicle-mediated transport
R-HSA-8873719,R-HSA-597592,R-HSA-392499,RAB geranylgeranylation,Post-translational protein modification,Metabolism of proteins
R-HSA-9013149,R-HSA-9716542,R-HSA-162582,RAC1 GTPase cycle,"Signaling by Rho GTPases, Miro GTPases and RHOBTB3",Signal Transduction
R-HSA-9013404,R-HSA-9716542,R-HSA-162582,RAC2 GTPase cycle,"Signaling by Rho GTPases, Miro GTPases and RHOBTB3",Signal Transduction
R-HSA-9013423,R-HSA-9716542,R-HSA-162582,RAC3 GTPase cycle,"Signaling by Rho GTPases, Miro GTPases and RHOBTB3",Signal Transduction
R-HSA-5673000,R-HSA-5683057,R-HSA-162582,RAF activation,MAPK family signaling cascades,Signal Transduction
R-HSA-112409,R-HSA-5683057,R-HSA-162582,RAF-independent MAPK1/3 activation,MAPK family signaling cascades,Signal Transduction
R-HSA-5673001,R-HSA-5683057,R-HSA-162582,RAF/MAP kinase cascade,MAPK family signaling cascades,Signal Transduction
R-HSA-9649913,R-HSA-5663202,R-HSA-1643685,RAS GTPase cycle mutants,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-9648002,R-HSA-5683057,R-HSA-162582,RAS processing,MAPK family signaling cascades,Signal Transduction
R-HSA-6802953,R-HSA-5663202,R-HSA-1643685,RAS signaling downstream of NF1 loss-of-function variants,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-8853659,R-HSA-9675108,R-HSA-1266738,RET signaling,Nervous system development,Developmental Biology
R-HSA-195258,R-HSA-9716542,R-HSA-162582,RHO GTPase Effectors,"Signaling by Rho GTPases, Miro GTPases and RHOBTB3",Signal Transduction
R-HSA-9012999,R-HSA-9716542,R-HSA-162582,RHO GTPase cycle,"Signaling by Rho GTPases, Miro GTPases and RHOBTB3",Signal Transduction
R-HSA-5663220,R-HSA-9716542,R-HSA-162582,RHO GTPases Activate Formins,"Signaling by Rho GTPases, Miro GTPases and RHOBTB3",Signal Transduction
R-HSA-5668599,R-HSA-9716542,R-HSA-162582,RHO GTPases Activate NADPH Oxidases,"Signaling by Rho GTPases, Miro GTPases and RHOBTB3",Signal Transduction
R-HSA-5627117,R-HSA-9716542,R-HSA-162582,RHO GTPases Activate ROCKs,"Signaling by Rho GTPases, Miro GTPases and RHOBTB3",Signal Transduction
R-HSA-5666185,R-HSA-9716542,R-HSA-162582,RHO GTPases Activate Rhotekin and Rhophilins,"Signaling by Rho GTPases, Miro GTPases and RHOBTB3",Signal Transduction
R-HSA-5663213,R-HSA-9716542,R-HSA-162582,RHO GTPases Activate WASPs and WAVEs,"Signaling by Rho GTPases, Miro GTPases and RHOBTB3",Signal Transduction
R-HSA-5625900,R-HSA-9716542,R-HSA-162582,RHO GTPases activate CIT,"Signaling by Rho GTPases, Miro GTPases and RHOBTB3",Signal Transduction
R-HSA-5626467,R-HSA-9716542,R-HSA-162582,RHO GTPases activate IQGAPs,"Signaling by Rho GTPases, Miro GTPases and RHOBTB3",Signal Transduction
R-HSA-5625970,R-HSA-9716542,R-HSA-162582,RHO GTPases activate KTN1,"Signaling by Rho GTPases, Miro GTPases and RHOBTB3",Signal Transduction
R-HSA-5627123,R-HSA-9716542,R-HSA-162582,RHO GTPases activate PAKs,"Signaling by Rho GTPases, Miro GTPases and RHOBTB3",Signal Transduction
R-HSA-5625740,R-HSA-9716542,R-HSA-162582,RHO GTPases activate PKNs,"Signaling by Rho GTPases, Miro GTPases and RHOBTB3",Signal Transduction
R-HSA-5627083,R-HSA-9716542,R-HSA-162582,RHO GTPases regulate CFTR trafficking,"Signaling by Rho GTPases, Miro GTPases and RHOBTB3",Signal Transduction
R-HSA-8980692,R-HSA-9716542,R-HSA-162582,RHOA GTPase cycle,"Signaling by Rho GTPases, Miro GTPases and RHOBTB3",Signal Transduction
R-HSA-9013026,R-HSA-9716542,R-HSA-162582,RHOB GTPase cycle,"Signaling by Rho GTPases, Miro GTPases and RHOBTB3",Signal Transduction
R-HSA-9706574,R-HSA-9716542,R-HSA-162582,RHOBTB GTPase Cycle,"Signaling by Rho GTPases, Miro GTPases and RHOBTB3",Signal Transduction
R-HSA-9013422,R-HSA-9716542,R-HSA-162582,RHOBTB1 GTPase cycle,"Signaling by Rho GTPases, Miro GTPases and RHOBTB3",Signal Transduction
R-HSA-9013418,R-HSA-9716542,R-HSA-162582,RHOBTB2 GTPase cycle,"Signaling by Rho GTPases, Miro GTPases and RHOBTB3",Signal Transduction
R-HSA-9706019,R-HSA-9716542,R-HSA-162582,RHOBTB3 ATPase cycle,"Signaling by Rho GTPases, Miro GTPases and RHOBTB3",Signal Transduction
R-HSA-9013106,R-HSA-9716542,R-HSA-162582,RHOC GTPase cycle,"Signaling by Rho GTPases, Miro GTPases and RHOBTB3",Signal Transduction
R-HSA-9013405,R-HSA-9716542,R-HSA-162582,RHOD GTPase cycle,"Signaling by Rho GTPases, Miro GTPases and RHOBTB3",Signal Transduction
R-HSA-9035034,R-HSA-9716542,R-HSA-162582,RHOF GTPase cycle,"Signaling by Rho GTPases, Miro GTPases and RHOBTB3",Signal Transduction
R-HSA-9013408,R-HSA-9716542,R-HSA-162582,RHOG GTPase cycle,"Signaling by Rho GTPases, Miro GTPases and RHOBTB3",Signal Transduction
R-HSA-9013407,R-HSA-9716542,R-HSA-162582,RHOH GTPase cycle,"Signaling by Rho GTPases, Miro GTPases and RHOBTB3",Signal Transduction
R-HSA-9013409,R-HSA-9716542,R-HSA-162582,RHOJ GTPase cycle,"Signaling by Rho GTPases, Miro GTPases and RHOBTB3",Signal Transduction
R-HSA-9013406,R-HSA-9716542,R-HSA-162582,RHOQ GTPase cycle,"Signaling by Rho GTPases, Miro GTPases and RHOBTB3",Signal Transduction
R-HSA-9013425,R-HSA-9716542,R-HSA-162582,RHOT1 GTPase cycle,"Signaling by Rho GTPases, Miro GTPases and RHOBTB3",Signal Transduction
R-HSA-9013419,R-HSA-9716542,R-HSA-162582,RHOT2 GTPase cycle,"Signaling by Rho GTPases, Miro GTPases and RHOBTB3",Signal Transduction
R-HSA-9013420,R-HSA-9716542,R-HSA-162582,RHOU GTPase cycle,"Signaling by Rho GTPases, Miro GTPases and RHOBTB3",Signal Transduction
R-HSA-9013424,R-HSA-9716542,R-HSA-162582,RHOV GTPase cycle,"Signaling by Rho GTPases, Miro GTPases and RHOBTB3",Signal Transduction
R-HSA-1810476,R-HSA-168249,R-HSA-168256,RIP-mediated NFkB activation via ZBP1,Innate Immune System,Immune System
R-HSA-5213460,R-HSA-5218859,R-HSA-5357801,RIPK1-mediated regulated necrosis,Regulated Necrosis,Programmed Cell Death
R-HSA-3214858,R-HSA-3247509,R-HSA-4839726,RMTs methylate histone arginines,Chromatin modifying enzymes,Chromatin organization
R-HSA-77075,R-HSA-73857,R-HSA-74160,RNA Pol II CTD phosphorylation and interaction with CE,RNA Polymerase II Transcription,Gene expression (Transcription)
R-HSA-167160,R-HSA-5663205,R-HSA-1643685,RNA Pol II CTD phosphorylation and interaction with CE during HIV infection,Infectious disease,Disease
R-HSA-73854,R-HSA-73864,R-HSA-74160,RNA Polymerase I Promoter Clearance,RNA Polymerase I Transcription,Gene expression (Transcription)
R-HSA-73772,R-HSA-73864,R-HSA-74160,RNA Polymerase I Promoter Escape,RNA Polymerase I Transcription,Gene expression (Transcription)
R-HSA-73728,R-HSA-73864,R-HSA-74160,RNA Polymerase I Promoter Opening,RNA Polymerase I Transcription,Gene expression (Transcription)
R-HSA-73864,R-HSA-73864,R-HSA-74160,RNA Polymerase I Transcription,RNA Polymerase I Transcription,Gene expression (Transcription)
R-HSA-73762,R-HSA-73864,R-HSA-74160,RNA Polymerase I Transcription Initiation,RNA Polymerase I Transcription,Gene expression (Transcription)
R-HSA-73863,R-HSA-73864,R-HSA-74160,RNA Polymerase I Transcription Termination,RNA Polymerase I Transcription,Gene expression (Transcription)
R-HSA-167162,R-HSA-5663205,R-HSA-1643685,RNA Polymerase II HIV Promoter Escape,Infectious disease,Disease
R-HSA-674695,R-HSA-73857,R-HSA-74160,RNA Polymerase II Pre-transcription Events,RNA Polymerase II Transcription,Gene expression (Transcription)
R-HSA-73776,R-HSA-73857,R-HSA-74160,RNA Polymerase II Promoter Escape,RNA Polymerase II Transcription,Gene expression (Transcription)
R-HSA-73857,R-HSA-73857,R-HSA-74160,RNA Polymerase II Transcription,RNA Polymerase II Transcription,Gene expression (Transcription)
R-HSA-75955,R-HSA-73857,R-HSA-74160,RNA Polymerase II Transcription Elongation,RNA Polymerase II Transcription,Gene expression (Transcription)
R-HSA-75953,R-HSA-73857,R-HSA-74160,RNA Polymerase II Transcription Initiation,RNA Polymerase II Transcription,Gene expression (Transcription)
R-HSA-76042,R-HSA-73857,R-HSA-74160,RNA Polymerase II Transcription Initiation And Promoter Clearance,RNA Polymerase II Transcription,Gene expression (Transcription)
R-HSA-73779,R-HSA-73857,R-HSA-74160,RNA Polymerase II Transcription Pre-Initiation And Promoter Opening,RNA Polymerase II Transcription,Gene expression (Transcription)
R-HSA-73856,R-HSA-73857,R-HSA-74160,RNA Polymerase II Transcription Termination,RNA Polymerase II Transcription,Gene expression (Transcription)
R-HSA-749476,R-HSA-74158,R-HSA-74160,RNA Polymerase III Abortive And Retractive Initiation,RNA Polymerase III Transcription,Gene expression (Transcription)
R-HSA-73780,R-HSA-74158,R-HSA-74160,RNA Polymerase III Chain Elongation,RNA Polymerase III Transcription,Gene expression (Transcription)
R-HSA-74158,R-HSA-74158,R-HSA-74160,RNA Polymerase III Transcription,RNA Polymerase III Transcription,Gene expression (Transcription)
R-HSA-76046,R-HSA-74158,R-HSA-74160,RNA Polymerase III Transcription Initiation,RNA Polymerase III Transcription,Gene expression (Transcription)
R-HSA-76061,R-HSA-74158,R-HSA-74160,RNA Polymerase III Transcription Initiation From Type 1 Promoter,RNA Polymerase III Transcription,Gene expression (Transcription)
R-HSA-76066,R-HSA-74158,R-HSA-74160,RNA Polymerase III Transcription Initiation From Type 2 Promoter,RNA Polymerase III Transcription,Gene expression (Transcription)
R-HSA-76071,R-HSA-74158,R-HSA-74160,RNA Polymerase III Transcription Initiation From Type 3 Promoter,RNA Polymerase III Transcription,Gene expression (Transcription)
R-HSA-73980,R-HSA-74158,R-HSA-74160,RNA Polymerase III Transcription Termination,RNA Polymerase III Transcription,Gene expression (Transcription)
R-HSA-6807505,R-HSA-73857,R-HSA-74160,RNA polymerase II transcribes snRNA genes,RNA Polymerase II Transcription,Gene expression (Transcription)
R-HSA-9696273,R-HSA-9716542,R-HSA-162582,RND1 GTPase cycle,"Signaling by Rho GTPases, Miro GTPases and RHOBTB3",Signal Transduction
R-HSA-9696270,R-HSA-9716542,R-HSA-162582,RND2 GTPase cycle,"Signaling by Rho GTPases, Miro GTPases and RHOBTB3",Signal Transduction
R-HSA-9696264,R-HSA-9716542,R-HSA-162582,RND3 GTPase cycle,"Signaling by Rho GTPases, Miro GTPases and RHOBTB3",Signal Transduction
R-HSA-9010642,R-HSA-9675108,R-HSA-1266738,ROBO receptors bind AKAP5,Nervous system development,Developmental Biology
R-HSA-1368082,R-HSA-1368082,R-HSA-400253,RORA activates gene expression,RORA activates gene expression,Circadian Clock
R-HSA-1222556,R-HSA-168249,R-HSA-168256,ROS and RNS production in phagocytes,Innate Immune System,Immune System
R-HSA-8932339,R-HSA-2262752,R-HSA-8953897,ROS sensing by NFE2L2,Cellular responses to stress,Cellular responses to stimuli
R-HSA-5659996,R-HSA-5668914,R-HSA-1643685,RPIA deficiency: failed conversion of R5P to RU5P,Diseases of metabolism,Disease
R-HSA-6791461,R-HSA-5668914,R-HSA-1643685,RPIA deficiency: failed conversion of RU5P to R5P,Diseases of metabolism,Disease
R-HSA-444257,R-HSA-112315,R-HSA-112316,RSK activation,Transmission across Chemical Synapses,Neuronal System
R-HSA-8877330,R-HSA-73857,R-HSA-74160,RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs),RNA Polymerase II Transcription,Gene expression (Transcription)
R-HSA-8939243,R-HSA-73857,R-HSA-74160,RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known,RNA Polymerase II Transcription,Gene expression (Transcription)
R-HSA-8931987,R-HSA-73857,R-HSA-74160,RUNX1 regulates estrogen receptor mediated transcription,RNA Polymerase II Transcription,Gene expression (Transcription)
R-HSA-8935964,R-HSA-73857,R-HSA-74160,RUNX1 regulates expression of components of tight junctions,RNA Polymerase II Transcription,Gene expression (Transcription)
R-HSA-8936459,R-HSA-73857,R-HSA-74160,RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function,RNA Polymerase II Transcription,Gene expression (Transcription)
R-HSA-8939245,R-HSA-73857,R-HSA-74160,RUNX1 regulates transcription of genes involved in BCR signaling,RNA Polymerase II Transcription,Gene expression (Transcription)
R-HSA-8939256,R-HSA-73857,R-HSA-74160,RUNX1 regulates transcription of genes involved in WNT signaling,RNA Polymerase II Transcription,Gene expression (Transcription)
R-HSA-8939236,R-HSA-73857,R-HSA-74160,RUNX1 regulates transcription of genes involved in differentiation of HSCs,RNA Polymerase II Transcription,Gene expression (Transcription)
R-HSA-8939242,R-HSA-73857,R-HSA-74160,RUNX1 regulates transcription of genes involved in differentiation of keratinocytes,RNA Polymerase II Transcription,Gene expression (Transcription)
R-HSA-8939246,R-HSA-73857,R-HSA-74160,RUNX1 regulates transcription of genes involved in differentiation of myeloid cells,RNA Polymerase II Transcription,Gene expression (Transcription)
R-HSA-8939247,R-HSA-73857,R-HSA-74160,RUNX1 regulates transcription of genes involved in interleukin signaling,RNA Polymerase II Transcription,Gene expression (Transcription)
R-HSA-8941326,R-HSA-73857,R-HSA-74160,RUNX2 regulates bone development,RNA Polymerase II Transcription,Gene expression (Transcription)
R-HSA-8941284,R-HSA-73857,R-HSA-74160,RUNX2 regulates chondrocyte maturation,RNA Polymerase II Transcription,Gene expression (Transcription)
R-HSA-8941332,R-HSA-73857,R-HSA-74160,RUNX2 regulates genes involved in cell migration,RNA Polymerase II Transcription,Gene expression (Transcription)
R-HSA-8941333,R-HSA-73857,R-HSA-74160,RUNX2 regulates genes involved in differentiation of myeloid cells,RNA Polymerase II Transcription,Gene expression (Transcription)
R-HSA-8940973,R-HSA-73857,R-HSA-74160,RUNX2 regulates osteoblast differentiation,RNA Polymerase II Transcription,Gene expression (Transcription)
R-HSA-8949275,R-HSA-73857,R-HSA-74160,RUNX3 Regulates Immune Response and Cell Migration,RNA Polymerase II Transcription,Gene expression (Transcription)
R-HSA-8952158,R-HSA-73857,R-HSA-74160,RUNX3 regulates BCL2L11 (BIM) transcription,RNA Polymerase II Transcription,Gene expression (Transcription)
R-HSA-8941855,R-HSA-73857,R-HSA-74160,RUNX3 regulates CDKN1A transcription,RNA Polymerase II Transcription,Gene expression (Transcription)
R-HSA-8941856,R-HSA-73857,R-HSA-74160,RUNX3 regulates NOTCH signaling,RNA Polymerase II Transcription,Gene expression (Transcription)
R-HSA-8951911,R-HSA-73857,R-HSA-74160,RUNX3 regulates RUNX1-mediated transcription,RNA Polymerase II Transcription,Gene expression (Transcription)
R-HSA-8951430,R-HSA-73857,R-HSA-74160,RUNX3 regulates WNT signaling,RNA Polymerase II Transcription,Gene expression (Transcription)
R-HSA-8951671,R-HSA-73857,R-HSA-74160,RUNX3 regulates YAP1-mediated transcription,RNA Polymerase II Transcription,Gene expression (Transcription)
R-HSA-8951936,R-HSA-73857,R-HSA-74160,RUNX3 regulates p14-ARF,RNA Polymerase II Transcription,Gene expression (Transcription)
R-HSA-9007101,R-HSA-199991,R-HSA-5653656,Rab regulation of trafficking,Membrane Trafficking,Vesicle-mediated transport
R-HSA-392517,R-HSA-1280218,R-HSA-168256,Rap1 signalling,Adaptive Immune System,Immune System
R-HSA-442982,R-HSA-112315,R-HSA-112316,Ras activation upon Ca2+ influx through NMDA receptor,Transmission across Chemical Synapses,Neuronal System
R-HSA-975578,R-HSA-597592,R-HSA-392499,Reactions specific to the complex N-glycan synthesis pathway,Post-translational protein modification,Metabolism of proteins
R-HSA-975574,R-HSA-597592,R-HSA-392499,Reactions specific to the hybrid N-glycan synthesis pathway,Post-translational protein modification,Metabolism of proteins
R-HSA-8934903,R-HSA-1632852,R-HSA-9612973,Receptor Mediated Mitophagy,Macroautophagy,Autophagy
R-HSA-388844,R-HSA-6794362,R-HSA-112316,Receptor-type tyrosine-protein phosphatases,Protein-protein interactions at synapses,Neuronal System
R-HSA-110330,R-HSA-73884,R-HSA-73894,Recognition and association of DNA glycosylase with site containing an affected purine,Base Excision Repair,DNA Repair
R-HSA-110328,R-HSA-73884,R-HSA-73894,Recognition and association of DNA glycosylase with site containing an affected pyrimidine,Base Excision Repair,DNA Repair
R-HSA-110314,R-HSA-73893,R-HSA-73894,Recognition of DNA damage by PCNA-containing replication complex,DNA Damage Bypass,DNA Repair
R-HSA-5693565,R-HSA-5693532,R-HSA-73894,Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks,DNA Double-Strand Break Repair,DNA Repair
R-HSA-380320,R-HSA-69278,R-HSA-1640170,Recruitment of NuMA to mitotic centrosomes,"Cell Cycle, Mitotic",Cell Cycle
R-HSA-380270,R-HSA-69278,R-HSA-1640170,Recruitment of mitotic centrosome proteins and complexes,"Cell Cycle, Mitotic",Cell Cycle
R-HSA-159418,R-HSA-556833,R-HSA-1430728,Recycling of bile acids and salts,Metabolism of lipids,Metabolism
R-HSA-72731,R-HSA-72766,R-HSA-392499,Recycling of eIF2:GDP,Translation,Metabolism of proteins
R-HSA-437239,R-HSA-9675108,R-HSA-1266738,Recycling pathway of L1,Nervous system development,Developmental Biology
R-HSA-418359,R-HSA-418346,R-HSA-109582,Reduction of cytosolic Ca++ levels,Platelet homeostasis,Hemostasis
R-HSA-8866376,R-HSA-9675108,R-HSA-1266738,Reelin signalling pathway,Nervous system development,Developmental Biology
R-HSA-9669929,R-HSA-5663202,R-HSA-1643685,Regorafenib-resistant KIT mutants,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-9674403,R-HSA-5663202,R-HSA-1643685,Regorafenib-resistant PDGFR mutants,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-5218859,R-HSA-5218859,R-HSA-5357801,Regulated Necrosis,Regulated Necrosis,Programmed Cell Death
R-HSA-193692,R-HSA-73887,R-HSA-162582,Regulated proteolysis of p75NTR,Death Receptor Signalling,Signal Transduction
R-HSA-3248023,R-HSA-168249,R-HSA-168256,Regulation by TREX1,Innate Immune System,Immune System
R-HSA-3371378,R-HSA-109581,R-HSA-5357801,Regulation by c-FLIP,Apoptosis,Programmed Cell Death
R-HSA-176408,R-HSA-69278,R-HSA-1640170,Regulation of APC/C activators between G1/S and early anaphase,"Cell Cycle, Mitotic",Cell Cycle
R-HSA-169911,R-HSA-109581,R-HSA-5357801,Regulation of Apoptosis,Apoptosis,Programmed Cell Death
R-HSA-9708530,R-HSA-2262752,R-HSA-8953897,Regulation of BACH1 activity,Cellular responses to stress,Cellular responses to stimuli
R-HSA-977606,R-HSA-168249,R-HSA-168256,Regulation of Complement cascade,Innate Immune System,Immune System
R-HSA-9617629,R-HSA-73857,R-HSA-74160,Regulation of FOXO transcriptional activity by acetylation,RNA Polymerase II Transcription,Gene expression (Transcription)
R-HSA-4641263,R-HSA-195721,R-HSA-162582,Regulation of FZD by ubiquitination,Signaling by WNT,Signal Transduction
R-HSA-170822,R-HSA-71387,R-HSA-1430728,Regulation of Glucokinase by Glucokinase Regulatory Protein,Metabolism of carbohydrates,Metabolism
R-HSA-9707587,R-HSA-2262752,R-HSA-8953897,Regulation of HMOX1 expression and activity,Cellular responses to stress,Cellular responses to stimuli
R-HSA-3371453,R-HSA-2262752,R-HSA-8953897,Regulation of HSF1-mediated heat shock response,Cellular responses to stress,Cellular responses to stimuli
R-HSA-912694,R-HSA-1280215,R-HSA-168256,Regulation of IFNA signaling,Cytokine Signaling in Immune system,Immune System
R-HSA-877312,R-HSA-1280215,R-HSA-168256,Regulation of IFNG signaling,Cytokine Signaling in Immune system,Immune System
R-HSA-381426,R-HSA-381426,R-HSA-392499,Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs),Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs),Metabolism of proteins
R-HSA-1433559,R-HSA-9006934,R-HSA-162582,Regulation of KIT signaling,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-9022692,R-HSA-73857,R-HSA-74160,Regulation of MECP2 expression and activity,RNA Polymerase II Transcription,Gene expression (Transcription)
R-HSA-211728,R-HSA-109581,R-HSA-5357801,Regulation of PAK-2p34 activity by PS-GAP/RHG10,Apoptosis,Programmed Cell Death
R-HSA-2565942,R-HSA-69278,R-HSA-1640170,Regulation of PLK1 Activity at G2/M Transition,"Cell Cycle, Mitotic",Cell Cycle
R-HSA-8943724,R-HSA-9006925,R-HSA-162582,Regulation of PTEN gene transcription,Intracellular signaling by second messengers,Signal Transduction
R-HSA-8948747,R-HSA-9006925,R-HSA-162582,Regulation of PTEN localization,Intracellular signaling by second messengers,Signal Transduction
R-HSA-8943723,R-HSA-9006925,R-HSA-162582,Regulation of PTEN mRNA translation,Intracellular signaling by second messengers,Signal Transduction
R-HSA-8948751,R-HSA-9006925,R-HSA-162582,Regulation of PTEN stability and activity,Intracellular signaling by second messengers,Signal Transduction
R-HSA-5658442,R-HSA-5683057,R-HSA-162582,Regulation of RAS by GAPs,MAPK family signaling cascades,Signal Transduction
R-HSA-8934593,R-HSA-73857,R-HSA-74160,Regulation of RUNX1 Expression and Activity,RNA Polymerase II Transcription,Gene expression (Transcription)
R-HSA-8939902,R-HSA-73857,R-HSA-74160,Regulation of RUNX2 expression and activity,RNA Polymerase II Transcription,Gene expression (Transcription)
R-HSA-8941858,R-HSA-73857,R-HSA-74160,Regulation of RUNX3 expression and activity,RNA Polymerase II Transcription,Gene expression (Transcription)
R-HSA-5686938,R-HSA-168249,R-HSA-168256,Regulation of TLR by endogenous ligand,Innate Immune System,Immune System
R-HSA-5357905,R-HSA-73887,R-HSA-162582,Regulation of TNFR1 signaling,Death Receptor Signalling,Signal Transduction
R-HSA-5633007,R-HSA-73857,R-HSA-74160,Regulation of TP53 Activity,RNA Polymerase II Transcription,Gene expression (Transcription)
R-HSA-6804758,R-HSA-73857,R-HSA-74160,Regulation of TP53 Activity through Acetylation,RNA Polymerase II Transcription,Gene expression (Transcription)
R-HSA-6804759,R-HSA-73857,R-HSA-74160,Regulation of TP53 Activity through Association with Co-factors,RNA Polymerase II Transcription,Gene expression (Transcription)
R-HSA-6804760,R-HSA-73857,R-HSA-74160,Regulation of TP53 Activity through Methylation,RNA Polymerase II Transcription,Gene expression (Transcription)
R-HSA-6804756,R-HSA-73857,R-HSA-74160,Regulation of TP53 Activity through Phosphorylation,RNA Polymerase II Transcription,Gene expression (Transcription)
R-HSA-6804757,R-HSA-73857,R-HSA-74160,Regulation of TP53 Degradation,RNA Polymerase II Transcription,Gene expression (Transcription)
R-HSA-6804754,R-HSA-73857,R-HSA-74160,Regulation of TP53 Expression,RNA Polymerase II Transcription,Gene expression (Transcription)
R-HSA-6806003,R-HSA-73857,R-HSA-74160,Regulation of TP53 Expression and Degradation,RNA Polymerase II Transcription,Gene expression (Transcription)
R-HSA-2029482,R-HSA-168249,R-HSA-168256,Regulation of actin dynamics for phagocytic cup formation,Innate Immune System,Immune System
R-HSA-211733,R-HSA-109581,R-HSA-5357801,Regulation of activated PAK-2p34 by proteasome mediated degradation,Apoptosis,Programmed Cell Death
R-HSA-186712,R-HSA-186712,R-HSA-1266738,Regulation of beta-cell development,Regulation of beta-cell development,Developmental Biology
R-HSA-1655829,R-HSA-556833,R-HSA-1430728,Regulation of cholesterol biosynthesis by SREBP (SREBF),Metabolism of lipids,Metabolism
R-HSA-428542,R-HSA-9675108,R-HSA-1266738,Regulation of commissural axon pathfinding by SLIT and ROBO,Nervous system development,Developmental Biology
R-HSA-8985801,R-HSA-9675108,R-HSA-1266738,Regulation of cortical dendrite branching,Nervous system development,Developmental Biology
R-HSA-446388,R-HSA-446728,R-HSA-1500931,Regulation of cytoskeletal remodeling and cell spreading by IPP complex components,Cell junction organization,Cell-Cell communication
R-HSA-9010553,R-HSA-9675108,R-HSA-1266738,Regulation of expression of SLITs and ROBOs,Nervous system development,Developmental Biology
R-HSA-191650,R-HSA-199991,R-HSA-5653656,Regulation of gap junction activity,Membrane Trafficking,Vesicle-mediated transport
R-HSA-1234158,R-HSA-2262752,R-HSA-8953897,Regulation of gene expression by Hypoxia-inducible Factor,Cellular responses to stress,Cellular responses to stimuli
R-HSA-210745,R-HSA-186712,R-HSA-1266738,Regulation of gene expression in beta cells,Regulation of beta-cell development,Developmental Biology
R-HSA-210747,R-HSA-186712,R-HSA-1266738,Regulation of gene expression in early pancreatic precursor cells,Regulation of beta-cell development,Developmental Biology
R-HSA-210746,R-HSA-186712,R-HSA-1266738,Regulation of gene expression in endocrine-committed (NEUROG3+) progenitor cells,Regulation of beta-cell development,Developmental Biology
R-HSA-210744,R-HSA-186712,R-HSA-1266738,Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells,Regulation of beta-cell development,Developmental Biology
R-HSA-9634600,R-HSA-71387,R-HSA-1430728,"Regulation of glycolysis by fructose 2,6-bisphosphate metabolism",Metabolism of carbohydrates,Metabolism
R-HSA-3134975,R-HSA-168249,R-HSA-168256,Regulation of innate immune responses to cytosolic DNA,Innate Immune System,Immune System
R-HSA-422356,R-HSA-163685,R-HSA-1430728,Regulation of insulin secretion,Integration of energy metabolism,Metabolism
R-HSA-400206,R-HSA-556833,R-HSA-1430728,Regulation of lipid metabolism by PPARalpha,Metabolism of lipids,Metabolism
R-HSA-9614399,R-HSA-73857,R-HSA-74160,Regulation of localization of FOXO transcription factors,RNA Polymerase II Transcription,Gene expression (Transcription)
R-HSA-450531,R-HSA-450531,R-HSA-8953854,Regulation of mRNA stability by proteins that bind AU-rich elements,Regulation of mRNA stability by proteins that bind AU-rich elements,Metabolism of RNA
R-HSA-453276,R-HSA-69278,R-HSA-1640170,Regulation of mitotic cell cycle,"Cell Cycle, Mitotic",Cell Cycle
R-HSA-5675482,R-HSA-5218859,R-HSA-5357801,Regulation of necroptotic cell death,Regulated Necrosis,Programmed Cell Death
R-HSA-350562,R-HSA-71291,R-HSA-1430728,Regulation of ornithine decarboxylase (ODC),Metabolism of amino acids and derivatives,Metabolism
R-HSA-204174,R-HSA-1428517,R-HSA-1430728,Regulation of pyruvate dehydrogenase (PDH) complex,The citric acid (TCA) cycle and respiratory electron transport,Metabolism
R-HSA-912631,R-HSA-1280215,R-HSA-168256,Regulation of signaling by CBL,Cytokine Signaling in Immune system,Immune System
R-HSA-1433617,R-HSA-1181150,R-HSA-1266738,Regulation of signaling by NODAL,Signaling by NODAL,Developmental Biology
R-HSA-9627069,R-HSA-109581,R-HSA-5357801,Regulation of the apoptosome activity,Apoptosis,Programmed Cell Death
R-HSA-350864,R-HSA-71291,R-HSA-1430728,Regulation of thyroid hormone activity,Metabolism of amino acids and derivatives,Metabolism
R-HSA-444821,R-HSA-372790,R-HSA-162582,Relaxin receptors,Signaling by GPCR,Signal Transduction
R-HSA-168298,R-HSA-5663205,R-HSA-1643685,Release,Infectious disease,Disease
R-HSA-5362798,R-HSA-5358351,R-HSA-162582,Release of Hh-Np from the secreting cell,Signaling by Hedgehog,Signal Transduction
R-HSA-111457,R-HSA-109581,R-HSA-5357801,Release of apoptotic factors from the mitochondria,Apoptosis,Programmed Cell Death
R-HSA-159782,R-HSA-597592,R-HSA-392499,Removal of aminoterminal propeptides from gamma-carboxylated proteins,Post-translational protein modification,Metabolism of proteins
R-HSA-69166,R-HSA-69278,R-HSA-1640170,Removal of the Flap Intermediate,"Cell Cycle, Mitotic",Cell Cycle
R-HSA-69166,R-HSA-69239,R-HSA-69306,Removal of the Flap Intermediate,Synthesis of DNA,DNA Replication
R-HSA-174437,R-HSA-73886,R-HSA-1640170,Removal of the Flap Intermediate from the C-strand,Chromosome Maintenance,Cell Cycle
R-HSA-9682706,R-HSA-5663205,R-HSA-1643685,Replication of the SARS-CoV-1 genome,Infectious disease,Disease
R-HSA-9694686,R-HSA-5663205,R-HSA-1643685,Replication of the SARS-CoV-2 genome,Infectious disease,Disease
R-HSA-4641265,R-HSA-195721,R-HSA-162582,Repression of WNT target genes,Signaling by WNT,Signal Transduction
R-HSA-1474165,R-HSA-1474165,R-HSA-1474165,Reproduction,Reproduction,Reproduction
R-HSA-9665250,R-HSA-5663202,R-HSA-1643685,Resistance of ERBB2 KD mutants to AEE788,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-9665249,R-HSA-5663202,R-HSA-1643685,Resistance of ERBB2 KD mutants to afatinib,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-9665251,R-HSA-5663202,R-HSA-1643685,Resistance of ERBB2 KD mutants to lapatinib,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-9665246,R-HSA-5663202,R-HSA-1643685,Resistance of ERBB2 KD mutants to neratinib,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-9665247,R-HSA-5663202,R-HSA-1643685,Resistance of ERBB2 KD mutants to osimertinib,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-9665244,R-HSA-5663202,R-HSA-1643685,Resistance of ERBB2 KD mutants to sapitinib,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-9665245,R-HSA-5663202,R-HSA-1643685,Resistance of ERBB2 KD mutants to tesevatinib,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-9665233,R-HSA-5663202,R-HSA-1643685,Resistance of ERBB2 KD mutants to trastuzumab,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-110373,R-HSA-73884,R-HSA-73894,Resolution of AP sites via the multiple-nucleotide patch replacement pathway,Base Excision Repair,DNA Repair
R-HSA-110381,R-HSA-73884,R-HSA-73894,Resolution of AP sites via the single-nucleotide replacement pathway,Base Excision Repair,DNA Repair
R-HSA-73933,R-HSA-73884,R-HSA-73894,Resolution of Abasic Sites (AP sites),Base Excision Repair,DNA Repair
R-HSA-5693537,R-HSA-5693532,R-HSA-73894,Resolution of D-Loop Structures,DNA Double-Strand Break Repair,DNA Repair
R-HSA-5693568,R-HSA-5693532,R-HSA-73894,Resolution of D-loop Structures through Holliday Junction Intermediates,DNA Double-Strand Break Repair,DNA Repair
R-HSA-5693554,R-HSA-5693532,R-HSA-73894,Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA),DNA Double-Strand Break Repair,DNA Repair
R-HSA-2500257,R-HSA-69278,R-HSA-1640170,Resolution of Sister Chromatid Cohesion,"Cell Cycle, Mitotic",Cell Cycle
R-HSA-611105,R-HSA-1428517,R-HSA-1430728,Respiratory electron transport,The citric acid (TCA) cycle and respiratory electron transport,Metabolism
R-HSA-163200,R-HSA-1428517,R-HSA-1430728,"Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.",The citric acid (TCA) cycle and respiratory electron transport,Metabolism
R-HSA-9648895,R-HSA-2262752,R-HSA-8953897,Response of EIF2AK1 (HRI) to heme deficiency,Cellular responses to stress,Cellular responses to stimuli
R-HSA-9633012,R-HSA-2262752,R-HSA-8953897,Response of EIF2AK4 (GCN2) to amino acid deficiency,Cellular responses to stress,Cellular responses to stimuli
R-HSA-9637690,R-HSA-5663205,R-HSA-1643685,Response of Mtb to phagocytosis,Infectious disease,Disease
R-HSA-76005,R-HSA-76002,R-HSA-109582,Response to elevated platelet cytosolic Ca2+,"Platelet activation, signaling and aggregation",Hemostasis
R-HSA-5660526,R-HSA-5660526,R-HSA-8953897,Response to metal ions,Response to metal ions,Cellular responses to stimuli
R-HSA-2453864,R-HSA-9675143,R-HSA-1643685,Retinoid cycle disease events,Diseases of the neuronal system,Disease
R-HSA-975634,R-HSA-2187338,R-HSA-9709957,Retinoid metabolism and transport,Visual phototransduction,Sensory Perception
R-HSA-975634,R-HSA-196854,R-HSA-1430728,Retinoid metabolism and transport,Metabolism of vitamins and cofactors,Metabolism
R-HSA-6809583,R-HSA-9675143,R-HSA-1643685,Retinoid metabolism disease events,Diseases of the neuronal system,Disease
R-HSA-177504,R-HSA-9006934,R-HSA-162582,Retrograde neurotrophin signalling,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-6811440,R-HSA-199991,R-HSA-5653656,Retrograde transport at the Trans-Golgi-Network,Membrane Trafficking,Vesicle-mediated transport
R-HSA-888593,R-HSA-112315,R-HSA-112316,Reuptake of GABA,Transmission across Chemical Synapses,Neuronal System
R-HSA-165054,R-HSA-5663205,R-HSA-1643685,Rev-mediated nuclear export of HIV RNA,Infectious disease,Disease
R-HSA-165054,R-HSA-5663205,R-HSA-1643685,Rev-mediated nuclear export of HIV RNA,Infectious disease,Disease
R-HSA-73943,R-HSA-73942,R-HSA-73894,Reversal of alkylation damage by DNA dioxygenases,DNA Damage Reversal,DNA Repair
R-HSA-162589,R-HSA-5663205,R-HSA-1643685,Reverse Transcription of HIV RNA,Infectious disease,Disease
R-HSA-1475029,R-HSA-1475029,R-HSA-1430728,Reversible hydration of carbon dioxide,Reversible hydration of carbon dioxide,Metabolism
R-HSA-9037628,R-HSA-71387,R-HSA-1430728,Rhesus blood group biosynthesis,Metabolism of carbohydrates,Metabolism
R-HSA-444411,R-HSA-425407,R-HSA-382551,Rhesus glycoproteins mediate ammonium transport.,SLC-mediated transmembrane transport,Transport of small molecules
R-HSA-72702,R-HSA-72766,R-HSA-392499,Ribosomal scanning and start codon recognition,Translation,Metabolism of proteins
R-HSA-428890,R-HSA-9675108,R-HSA-1266738,Role of ABL in ROBO-SLIT signaling,Nervous system development,Developmental Biology
R-HSA-2730905,R-HSA-168249,R-HSA-168256,Role of LAT2/NTAL/LAB on calcium mobilization,Innate Immune System,Immune System
R-HSA-2029485,R-HSA-168249,R-HSA-168256,Role of phospholipids in phagocytosis,Innate Immune System,Immune System
R-HSA-418890,R-HSA-9675108,R-HSA-1266738,Role of second messengers in netrin-1 signaling,Nervous system development,Developmental Biology
R-HSA-69242,R-HSA-69278,R-HSA-1640170,S Phase,"Cell Cycle, Mitotic",Cell Cycle
R-HSA-5358747,R-HSA-5663202,R-HSA-1643685,S33 mutants of beta-catenin aren't phosphorylated,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-5358749,R-HSA-5663202,R-HSA-1643685,S37 mutants of beta-catenin aren't phosphorylated,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-5358751,R-HSA-5663202,R-HSA-1643685,S45 mutants of beta-catenin aren't phosphorylated,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-9679506,R-HSA-5663205,R-HSA-1643685,SARS-CoV Infections,Infectious disease,Disease
R-HSA-9679514,R-HSA-5663205,R-HSA-1643685,SARS-CoV-1 Genome Replication and Transcription,Infectious disease,Disease
R-HSA-9678108,R-HSA-5663205,R-HSA-1643685,SARS-CoV-1 Infection,Infectious disease,Disease
R-HSA-9694682,R-HSA-5663205,R-HSA-1643685,SARS-CoV-2 Genome Replication and Transcription,Infectious disease,Disease
R-HSA-9694516,R-HSA-5663205,R-HSA-1643685,SARS-CoV-2 Infection,Infectious disease,Disease
R-HSA-187577,R-HSA-69278,R-HSA-1640170,SCF(Skp2)-mediated degradation of p27/p21,"Cell Cycle, Mitotic",Cell Cycle
R-HSA-187577,R-HSA-69278,R-HSA-1640170,SCF(Skp2)-mediated degradation of p27/p21,"Cell Cycle, Mitotic",Cell Cycle
R-HSA-174113,R-HSA-69278,R-HSA-1640170,SCF-beta-TrCP mediated degradation of Emi1,"Cell Cycle, Mitotic",Cell Cycle
R-HSA-373756,R-HSA-446728,R-HSA-1500931,SDK interactions,Cell junction organization,Cell-Cell communication
R-HSA-399955,R-HSA-9675108,R-HSA-1266738,SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion,Nervous system development,Developmental Biology
R-HSA-5654688,R-HSA-9006934,R-HSA-162582,SHC-mediated cascade:FGFR1,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-5654699,R-HSA-9006934,R-HSA-162582,SHC-mediated cascade:FGFR2,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-5654704,R-HSA-9006934,R-HSA-162582,SHC-mediated cascade:FGFR3,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-5654719,R-HSA-9006934,R-HSA-162582,SHC-mediated cascade:FGFR4,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-2428933,R-HSA-9006934,R-HSA-162582,SHC-related events triggered by IGF1R,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-180336,R-HSA-9006934,R-HSA-162582,SHC1 events in EGFR signaling,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-1250196,R-HSA-9006934,R-HSA-162582,SHC1 events in ERBB2 signaling,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-1250347,R-HSA-9006934,R-HSA-162582,SHC1 events in ERBB4 signaling,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-9726840,R-HSA-5663202,R-HSA-1643685,SHOC2 M1731 mutant abolishes MRAS complex function,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-427359,R-HSA-212165,R-HSA-74160,SIRT1 negatively regulates rRNA expression,Epigenetic regulation of gene expression,Gene expression (Transcription)
R-HSA-77588,R-HSA-75067,R-HSA-8953854,SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs,Processing of Capped Intronless Pre-mRNA,Metabolism of RNA
R-HSA-111367,R-HSA-75067,R-HSA-8953854,SLBP independent Processing of Histone Pre-mRNAs,Processing of Capped Intronless Pre-mRNA,Metabolism of RNA
R-HSA-5619102,R-HSA-5619115,R-HSA-1643685,SLC transporter disorders,Disorders of transmembrane transporters,Disease
R-HSA-425407,R-HSA-425407,R-HSA-382551,SLC-mediated transmembrane transport,SLC-mediated transmembrane transport,Transport of small molecules
R-HSA-8985586,R-HSA-9675108,R-HSA-1266738,SLIT2:ROBO1 increases RHOA activity,Nervous system development,Developmental Biology
R-HSA-111463,R-HSA-109581,R-HSA-5357801,SMAC (DIABLO) binds to IAPs,Apoptosis,Programmed Cell Death
R-HSA-111464,R-HSA-109581,R-HSA-5357801,SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes,Apoptosis,Programmed Cell Death
R-HSA-111469,R-HSA-109581,R-HSA-5357801,"SMAC, XIAP-regulated apoptotic response",Apoptosis,Programmed Cell Death
R-HSA-3315487,R-HSA-5663202,R-HSA-1643685,SMAD2/3 MH2 Domain Mutants in Cancer,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-3304356,R-HSA-5663202,R-HSA-1643685,SMAD2/3 Phosphorylation Motif Mutants in Cancer,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-2173796,R-HSA-9006936,R-HSA-162582,SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription,Signaling by TGFB family members,Signal Transduction
R-HSA-2173796,R-HSA-73857,R-HSA-74160,SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription,RNA Polymerase II Transcription,Gene expression (Transcription)
R-HSA-3311021,R-HSA-5663202,R-HSA-1643685,SMAD4 MH2 Domain Mutants in Cancer,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-112412,R-HSA-9006934,R-HSA-162582,SOS-mediated signalling,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-112412,R-HSA-9006934,R-HSA-162582,SOS-mediated signalling,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-1799339,R-HSA-72766,R-HSA-392499,SRP-dependent cotranslational protein targeting to membrane,Translation,Metabolism of proteins
R-HSA-9701898,R-HSA-9006934,R-HSA-162582,STAT3 nuclear events downstream of ALK signaling,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-9645135,R-HSA-1280215,R-HSA-168256,STAT5 Activation,Cytokine Signaling in Immune system,Immune System
R-HSA-9702518,R-HSA-5663202,R-HSA-1643685,STAT5 activation downstream of FLT3 ITD mutants,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-3249367,R-HSA-168249,R-HSA-168256,STAT6-mediated induction of chemokines,Innate Immune System,Immune System
R-HSA-1834941,R-HSA-168249,R-HSA-168256,STING mediated induction of host immune responses,Innate Immune System,Immune System
R-HSA-3108232,R-HSA-597592,R-HSA-392499,SUMO E3 ligases SUMOylate target proteins,Post-translational protein modification,Metabolism of proteins
R-HSA-3065676,R-HSA-597592,R-HSA-392499,SUMO is conjugated to E1 (UBA2:SAE1),Post-translational protein modification,Metabolism of proteins
R-HSA-3065679,R-HSA-597592,R-HSA-392499,SUMO is proteolytically processed,Post-translational protein modification,Metabolism of proteins
R-HSA-3065678,R-HSA-597592,R-HSA-392499,"SUMO is transferred from E1 to E2 (UBE2I, UBC9)",Post-translational protein modification,Metabolism of proteins
R-HSA-2990846,R-HSA-597592,R-HSA-392499,SUMOylation,Post-translational protein modification,Metabolism of proteins
R-HSA-3108214,R-HSA-597592,R-HSA-392499,SUMOylation of DNA damage response and repair proteins,Post-translational protein modification,Metabolism of proteins
R-HSA-4655427,R-HSA-597592,R-HSA-392499,SUMOylation of DNA methylation proteins,Post-translational protein modification,Metabolism of proteins
R-HSA-4615885,R-HSA-597592,R-HSA-392499,SUMOylation of DNA replication proteins,Post-translational protein modification,Metabolism of proteins
R-HSA-4570464,R-HSA-597592,R-HSA-392499,SUMOylation of RNA binding proteins,Post-translational protein modification,Metabolism of proteins
R-HSA-4085377,R-HSA-597592,R-HSA-392499,SUMOylation of SUMOylation proteins,Post-translational protein modification,Metabolism of proteins
R-HSA-4551638,R-HSA-597592,R-HSA-392499,SUMOylation of chromatin organization proteins,Post-translational protein modification,Metabolism of proteins
R-HSA-4755510,R-HSA-597592,R-HSA-392499,SUMOylation of immune response proteins,Post-translational protein modification,Metabolism of proteins
R-HSA-4090294,R-HSA-597592,R-HSA-392499,SUMOylation of intracellular receptors,Post-translational protein modification,Metabolism of proteins
R-HSA-3899300,R-HSA-597592,R-HSA-392499,SUMOylation of transcription cofactors,Post-translational protein modification,Metabolism of proteins
R-HSA-3232118,R-HSA-597592,R-HSA-392499,SUMOylation of transcription factors,Post-translational protein modification,Metabolism of proteins
R-HSA-3232142,R-HSA-597592,R-HSA-392499,SUMOylation of ubiquitinylation proteins,Post-translational protein modification,Metabolism of proteins
R-HSA-3000480,R-HSA-2173782,R-HSA-5653656,Scavenging by Class A Receptors,Binding and Uptake of Ligands by Scavenger Receptors,Vesicle-mediated transport
R-HSA-3000471,R-HSA-2173782,R-HSA-5653656,Scavenging by Class B Receptors,Binding and Uptake of Ligands by Scavenger Receptors,Vesicle-mediated transport
R-HSA-3000484,R-HSA-2173782,R-HSA-5653656,Scavenging by Class F Receptors,Binding and Uptake of Ligands by Scavenger Receptors,Vesicle-mediated transport
R-HSA-3000497,R-HSA-2173782,R-HSA-5653656,Scavenging by Class H Receptors,Binding and Uptake of Ligands by Scavenger Receptors,Vesicle-mediated transport
R-HSA-2168880,R-HSA-2173782,R-HSA-5653656,Scavenging of heme from plasma,Binding and Uptake of Ligands by Scavenger Receptors,Vesicle-mediated transport
R-HSA-9668328,R-HSA-69278,R-HSA-1640170,Sealing of the nuclear envelope (NE) by ESCRT-III,"Cell Cycle, Mitotic",Cell Cycle
R-HSA-9663891,R-HSA-1632852,R-HSA-9612973,Selective autophagy,Macroautophagy,Autophagy
R-HSA-2408522,R-HSA-71291,R-HSA-1430728,Selenoamino acid metabolism,Metabolism of amino acids and derivatives,Metabolism
R-HSA-2408557,R-HSA-71291,R-HSA-1430728,Selenocysteine synthesis,Metabolism of amino acids and derivatives,Metabolism
R-HSA-399954,R-HSA-9675108,R-HSA-1266738,Sema3A PAK dependent Axon repulsion,Nervous system development,Developmental Biology
R-HSA-400685,R-HSA-9675108,R-HSA-1266738,Sema4D in semaphorin signaling,Nervous system development,Developmental Biology
R-HSA-416572,R-HSA-9675108,R-HSA-1266738,Sema4D induced cell migration and growth-cone collapse,Nervous system development,Developmental Biology
R-HSA-416550,R-HSA-9675108,R-HSA-1266738,Sema4D mediated inhibition of cell attachment and migration,Nervous system development,Developmental Biology
R-HSA-373755,R-HSA-9675108,R-HSA-1266738,Semaphorin interactions,Nervous system development,Developmental Biology
R-HSA-2559582,R-HSA-2262752,R-HSA-8953897,Senescence-Associated Secretory Phenotype (SASP),Cellular responses to stress,Cellular responses to stimuli
R-HSA-5693548,R-HSA-5693532,R-HSA-73894,Sensing of DNA Double Strand Breaks,DNA Double-Strand Break Repair,DNA Repair
R-HSA-9709957,R-HSA-9709957,R-HSA-9709957,Sensory Perception,Sensory Perception,Sensory Perception
R-HSA-9659379,R-HSA-9659379,R-HSA-9709957,Sensory processing of sound,Sensory processing of sound,Sensory Perception
R-HSA-9662360,R-HSA-9659379,R-HSA-9709957,Sensory processing of sound by inner hair cells of the cochlea,Sensory processing of sound,Sensory Perception
R-HSA-9662361,R-HSA-9659379,R-HSA-9709957,Sensory processing of sound by outer hair cells of the cochlea,Sensory processing of sound,Sensory Perception
R-HSA-2467813,R-HSA-69278,R-HSA-1640170,Separation of Sister Chromatids,"Cell Cycle, Mitotic",Cell Cycle
R-HSA-977347,R-HSA-71291,R-HSA-1430728,Serine biosynthesis,Metabolism of amino acids and derivatives,Metabolism
R-HSA-181429,R-HSA-112315,R-HSA-112316,Serotonin Neurotransmitter Release Cycle,Transmission across Chemical Synapses,Neuronal System
R-HSA-209931,R-HSA-71291,R-HSA-1430728,Serotonin and melatonin biosynthesis,Metabolism of amino acids and derivatives,Metabolism
R-HSA-380615,R-HSA-112315,R-HSA-112316,Serotonin clearance from the synaptic cleft,Transmission across Chemical Synapses,Neuronal System
R-HSA-390666,R-HSA-372790,R-HSA-162582,Serotonin receptors,Signaling by GPCR,Signal Transduction
R-HSA-3282872,R-HSA-5668914,R-HSA-1643685,Severe congenital neutropenia type 4 (G6PC3),Diseases of metabolism,Disease
R-HSA-4085001,R-HSA-597592,R-HSA-392499,Sialic acid metabolism,Post-translational protein modification,Metabolism of proteins
R-HSA-162582,R-HSA-162582,R-HSA-162582,Signal Transduction,Signal Transduction,Signal Transduction
R-HSA-392518,R-HSA-76002,R-HSA-109582,Signal amplification,"Platelet activation, signaling and aggregation",Hemostasis
R-HSA-74749,R-HSA-9006934,R-HSA-162582,Signal attenuation,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-391160,R-HSA-391160,R-HSA-1500931,Signal regulatory protein family interactions,Signal regulatory protein family interactions,Cell-Cell communication
R-HSA-445144,R-HSA-9675108,R-HSA-1266738,Signal transduction by L1,Nervous system development,Developmental Biology
R-HSA-201556,R-HSA-9006934,R-HSA-162582,Signaling by ALK,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-9725370,R-HSA-5663202,R-HSA-1643685,Signaling by ALK fusions and activated point mutants,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-9700206,R-HSA-5663202,R-HSA-1643685,Signaling by ALK in cancer,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-4839748,R-HSA-5663202,R-HSA-1643685,Signaling by AMER1 mutants,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-4839744,R-HSA-5663202,R-HSA-1643685,Signaling by APC mutants,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-4839735,R-HSA-5663202,R-HSA-1643685,Signaling by AXIN mutants,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-1502540,R-HSA-9006936,R-HSA-162582,Signaling by Activin,Signaling by TGFB family members,Signal Transduction
R-HSA-201451,R-HSA-9006936,R-HSA-162582,Signaling by BMP,Signaling by TGFB family members,Signal Transduction
R-HSA-6802952,R-HSA-5663202,R-HSA-1643685,Signaling by BRAF and RAF1 fusions,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-9674555,R-HSA-1280215,R-HSA-168256,Signaling by CSF3 (G-CSF),Cytokine Signaling in Immune system,Immune System
R-HSA-4839743,R-HSA-5663202,R-HSA-1643685,Signaling by CTNNB1 phospho-site mutants,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-177929,R-HSA-9006934,R-HSA-162582,Signaling by EGFR,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-1643713,R-HSA-5663202,R-HSA-1643685,Signaling by EGFR in Cancer,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-5637812,R-HSA-5663202,R-HSA-1643685,Signaling by EGFRvIII in Cancer,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-1227986,R-HSA-9006934,R-HSA-162582,Signaling by ERBB2,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-9665348,R-HSA-5663202,R-HSA-1643685,Signaling by ERBB2 ECD mutants,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-9664565,R-HSA-5663202,R-HSA-1643685,Signaling by ERBB2 KD Mutants,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-9665686,R-HSA-5663202,R-HSA-1643685,Signaling by ERBB2 TMD/JMD mutants,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-1227990,R-HSA-5663202,R-HSA-1643685,Signaling by ERBB2 in Cancer,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-1236394,R-HSA-9006934,R-HSA-162582,Signaling by ERBB4,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-9006335,R-HSA-9006335,R-HSA-162582,Signaling by Erythropoietin,Signaling by Erythropoietin,Signal Transduction
R-HSA-190236,R-HSA-9006934,R-HSA-162582,Signaling by FGFR,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-1226099,R-HSA-5663202,R-HSA-1643685,Signaling by FGFR in disease,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-5654736,R-HSA-9006934,R-HSA-162582,Signaling by FGFR1,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-1839120,R-HSA-5663202,R-HSA-1643685,Signaling by FGFR1 amplification mutants,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-5655302,R-HSA-5663202,R-HSA-1643685,Signaling by FGFR1 in disease,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-5654738,R-HSA-9006934,R-HSA-162582,Signaling by FGFR2,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-8851708,R-HSA-5663202,R-HSA-1643685,Signaling by FGFR2 IIIa TM,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-2023837,R-HSA-5663202,R-HSA-1643685,Signaling by FGFR2 amplification mutants,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-8853333,R-HSA-5663202,R-HSA-1643685,Signaling by FGFR2 fusions,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-5655253,R-HSA-5663202,R-HSA-1643685,Signaling by FGFR2 in disease,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-5654741,R-HSA-9006934,R-HSA-162582,Signaling by FGFR3,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-8853334,R-HSA-5663202,R-HSA-1643685,Signaling by FGFR3 fusions in cancer,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-5655332,R-HSA-5663202,R-HSA-1643685,Signaling by FGFR3 in disease,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-8853338,R-HSA-5663202,R-HSA-1643685,Signaling by FGFR3 point mutants in cancer,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-5654743,R-HSA-9006934,R-HSA-162582,Signaling by FGFR4,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-5655291,R-HSA-5663202,R-HSA-1643685,Signaling by FGFR4 in disease,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-9703648,R-HSA-5663202,R-HSA-1643685,Signaling by FLT3 ITD and TKD mutants,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-9703465,R-HSA-5663202,R-HSA-1643685,Signaling by FLT3 fusion proteins,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-372790,R-HSA-372790,R-HSA-162582,Signaling by GPCR,Signaling by GPCR,Signal Transduction
R-HSA-5339716,R-HSA-5663202,R-HSA-1643685,Signaling by GSK3beta mutants,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-5358351,R-HSA-5358351,R-HSA-162582,Signaling by Hedgehog,Signaling by Hedgehog,Signal Transduction
R-HSA-2028269,R-HSA-2028269,R-HSA-162582,Signaling by Hippo,Signaling by Hippo,Signal Transduction
R-HSA-74752,R-HSA-9006934,R-HSA-162582,Signaling by Insulin receptor,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-449147,R-HSA-1280215,R-HSA-168256,Signaling by Interleukins,Cytokine Signaling in Immune system,Immune System
R-HSA-9669938,R-HSA-5663202,R-HSA-1643685,Signaling by KIT in disease,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-5339717,R-HSA-5663202,R-HSA-1643685,Signaling by LRP5 mutants,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-2586552,R-HSA-2586552,R-HSA-162582,Signaling by Leptin,Signaling by Leptin,Signal Transduction
R-HSA-5637815,R-HSA-5663202,R-HSA-1643685,Signaling by Ligand-Responsive EGFR Variants in Cancer,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-9652169,R-HSA-5663202,R-HSA-1643685,Signaling by MAP2K mutants,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-9652817,R-HSA-5663202,R-HSA-1643685,Signaling by MAPK mutants,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-6806834,R-HSA-9006934,R-HSA-162582,Signaling by MET,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-9660537,R-HSA-5663202,R-HSA-1643685,Signaling by MRAS-complex mutants,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-8852405,R-HSA-9006934,R-HSA-162582,Signaling by MST1,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-1181150,R-HSA-1181150,R-HSA-1266738,Signaling by NODAL,Signaling by NODAL,Developmental Biology
R-HSA-157118,R-HSA-157118,R-HSA-162582,Signaling by NOTCH,Signaling by NOTCH,Signal Transduction
R-HSA-1980143,R-HSA-157118,R-HSA-162582,Signaling by NOTCH1,Signaling by NOTCH,Signal Transduction
R-HSA-2691230,R-HSA-5663202,R-HSA-1643685,Signaling by NOTCH1 HD Domain Mutants in Cancer,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-2894858,R-HSA-5663202,R-HSA-1643685,Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-2644602,R-HSA-5663202,R-HSA-1643685,Signaling by NOTCH1 PEST Domain Mutants in Cancer,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-2644603,R-HSA-5663202,R-HSA-1643685,Signaling by NOTCH1 in Cancer,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-2660825,R-HSA-5663202,R-HSA-1643685,Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-1980145,R-HSA-157118,R-HSA-162582,Signaling by NOTCH2,Signaling by NOTCH,Signal Transduction
R-HSA-9012852,R-HSA-157118,R-HSA-162582,Signaling by NOTCH3,Signaling by NOTCH,Signal Transduction
R-HSA-9013694,R-HSA-157118,R-HSA-162582,Signaling by NOTCH4,Signaling by NOTCH,Signal Transduction
R-HSA-187037,R-HSA-9006934,R-HSA-162582,Signaling by NTRK1 (TRKA),Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-9006115,R-HSA-9006934,R-HSA-162582,Signaling by NTRK2 (TRKB),Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-9034015,R-HSA-9006934,R-HSA-162582,Signaling by NTRK3 (TRKC),Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-166520,R-HSA-9006934,R-HSA-162582,Signaling by NTRKs,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-9006927,R-HSA-9006927,R-HSA-162582,Signaling by Non-Receptor Tyrosine Kinases,Signaling by Non-Receptor Tyrosine Kinases,Signal Transduction
R-HSA-9006931,R-HSA-9006931,R-HSA-162582,Signaling by Nuclear Receptors,Signaling by Nuclear Receptors,Signal Transduction
R-HSA-5638302,R-HSA-5663202,R-HSA-1643685,Signaling by Overexpressed Wild-Type EGFR in Cancer,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-186797,R-HSA-9006934,R-HSA-162582,Signaling by PDGF,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-9671555,R-HSA-5663202,R-HSA-1643685,Signaling by PDGFR in disease,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-9673770,R-HSA-5663202,R-HSA-1643685,Signaling by PDGFRA extracellular domain mutants,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-9673767,R-HSA-5663202,R-HSA-1643685,"Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants",Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-8848021,R-HSA-9006927,R-HSA-162582,Signaling by PTK6,Signaling by Non-Receptor Tyrosine Kinases,Signal Transduction
R-HSA-9656223,R-HSA-5663202,R-HSA-1643685,Signaling by RAF1 mutants,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-6802949,R-HSA-5663202,R-HSA-1643685,Signaling by RAS mutants,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-5340588,R-HSA-5663202,R-HSA-1643685,Signaling by RNF43 mutants,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-376176,R-HSA-9675108,R-HSA-1266738,Signaling by ROBO receptors,Nervous system development,Developmental Biology
R-HSA-9006934,R-HSA-9006934,R-HSA-162582,Signaling by Receptor Tyrosine Kinases,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-5362517,R-HSA-9006931,R-HSA-162582,Signaling by Retinoic Acid,Signaling by Nuclear Receptors,Signal Transduction
R-HSA-194315,R-HSA-9716542,R-HSA-162582,Signaling by Rho GTPases,"Signaling by Rho GTPases, Miro GTPases and RHOBTB3",Signal Transduction
R-HSA-9716542,R-HSA-9716542,R-HSA-162582,"Signaling by Rho GTPases, Miro GTPases and RHOBTB3","Signaling by Rho GTPases, Miro GTPases and RHOBTB3",Signal Transduction
R-HSA-1433557,R-HSA-9006934,R-HSA-162582,Signaling by SCF-KIT,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-5339700,R-HSA-5663202,R-HSA-1643685,Signaling by TCF7L2 mutants,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-170834,R-HSA-9006936,R-HSA-162582,Signaling by TGF-beta Receptor Complex,Signaling by TGFB family members,Signal Transduction
R-HSA-3304351,R-HSA-5663202,R-HSA-1643685,Signaling by TGF-beta Receptor Complex in Cancer,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-9006936,R-HSA-9006936,R-HSA-162582,Signaling by TGFB family members,Signaling by TGFB family members,Signal Transduction
R-HSA-2404192,R-HSA-9006934,R-HSA-162582,Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R),Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-194138,R-HSA-9006934,R-HSA-162582,Signaling by VEGF,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-195721,R-HSA-195721,R-HSA-162582,Signaling by WNT,Signaling by WNT,Signal Transduction
R-HSA-4791275,R-HSA-5663202,R-HSA-1643685,Signaling by WNT in cancer,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-1839122,R-HSA-5663202,R-HSA-1643685,Signaling by activated point mutants of FGFR1,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-1839130,R-HSA-5663202,R-HSA-1643685,Signaling by activated point mutants of FGFR3,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-1839117,R-HSA-5663202,R-HSA-1643685,Signaling by cytosolic FGFR1 fusion mutants,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-9673766,R-HSA-5663202,R-HSA-1643685,Signaling by cytosolic PDGFRA and PDGFRB fusion proteins,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-9680187,R-HSA-5663202,R-HSA-1643685,Signaling by extracellular domain mutants of KIT,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-6802948,R-HSA-5663202,R-HSA-1643685,Signaling by high-kinase activity BRAF mutants,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-9669935,R-HSA-5663202,R-HSA-1643685,Signaling by juxtamembrane domain KIT mutants,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-9669933,R-HSA-5663202,R-HSA-1643685,Signaling by kinase domain mutants of KIT,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-9673768,R-HSA-5663202,R-HSA-1643685,Signaling by membrane-tethered fusions of PDGFRA or PDGFRB,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-6802946,R-HSA-5663202,R-HSA-1643685,Signaling by moderate kinase activity BRAF mutants,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-9670439,R-HSA-5663202,R-HSA-1643685,"Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants",Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-8853336,R-HSA-5663202,R-HSA-1643685,Signaling by plasma membrane FGFR1 fusions,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-983705,R-HSA-1280218,R-HSA-168256,Signaling by the B Cell Receptor (BCR),Adaptive Immune System,Immune System
R-HSA-9649948,R-HSA-5663202,R-HSA-1643685,Signaling downstream of RAS mutants,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-198765,R-HSA-9006934,R-HSA-162582,Signalling to ERK5,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-187687,R-HSA-9006934,R-HSA-162582,Signalling to ERKs,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-167044,R-HSA-9006934,R-HSA-162582,Signalling to RAS,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-198745,R-HSA-9006934,R-HSA-162582,Signalling to STAT3,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-187706,R-HSA-9006934,R-HSA-162582,Signalling to p38 via RIT and RIN,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-426486,R-HSA-211000,R-HSA-74160,Small interfering RNA (siRNA) biogenesis,Gene Silencing by RNA,Gene expression (Transcription)
R-HSA-445355,R-HSA-445355,R-HSA-397014,Smooth Muscle Contraction,Smooth Muscle Contraction,Muscle contraction
R-HSA-427652,R-HSA-425407,R-HSA-382551,Sodium-coupled phosphate cotransporters,SLC-mediated transmembrane transport,Transport of small molecules
R-HSA-433137,R-HSA-425407,R-HSA-382551,"Sodium-coupled sulphate, di- and tri-carboxylate transporters",SLC-mediated transmembrane transport,Transport of small molecules
R-HSA-425561,R-HSA-425407,R-HSA-382551,Sodium/Calcium exchangers,SLC-mediated transmembrane transport,Transport of small molecules
R-HSA-425986,R-HSA-425407,R-HSA-382551,Sodium/Proton exchangers,SLC-mediated transmembrane transport,Transport of small molecules
R-HSA-9669936,R-HSA-5663202,R-HSA-1643685,Sorafenib-resistant KIT mutants,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-9674404,R-HSA-5663202,R-HSA-1643685,Sorafenib-resistant PDGFR mutants,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-1300642,R-HSA-1187000,R-HSA-1474165,Sperm Motility And Taxes,Fertilization,Reproduction
R-HSA-1660661,R-HSA-556833,R-HSA-1430728,Sphingolipid de novo biosynthesis,Metabolism of lipids,Metabolism
R-HSA-428157,R-HSA-556833,R-HSA-1430728,Sphingolipid metabolism,Metabolism of lipids,Metabolism
R-HSA-1295596,R-HSA-9006934,R-HSA-162582,Spry regulation of FGF signaling,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-1295596,R-HSA-9006934,R-HSA-162582,Spry regulation of FGF signaling,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-1295596,R-HSA-9006934,R-HSA-162582,Spry regulation of FGF signaling,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-1295596,R-HSA-9006934,R-HSA-162582,Spry regulation of FGF signaling,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-69541,R-HSA-69620,R-HSA-1640170,Stabilization of p53,Cell Cycle Checkpoints,Cell Cycle
R-HSA-211994,R-HSA-211859,R-HSA-1430728,Sterols are 12-hydroxylated by CYP8B1,Biological oxidations,Metabolism
R-HSA-211736,R-HSA-109581,R-HSA-5357801,Stimulation of the cell death response by PAK-2p34,Apoptosis,Programmed Cell Death
R-HSA-2672351,R-HSA-983712,R-HSA-382551,Stimuli-sensing channels,Ion channel transport,Transport of small molecules
R-HSA-390522,R-HSA-390522,R-HSA-397014,Striated Muscle Contraction,Striated Muscle Contraction,Muscle contraction
R-HSA-1614517,R-HSA-71291,R-HSA-1430728,Sulfide oxidation to sulfate,Metabolism of amino acids and derivatives,Metabolism
R-HSA-1614635,R-HSA-71291,R-HSA-1430728,Sulfur amino acid metabolism,Metabolism of amino acids and derivatives,Metabolism
R-HSA-9669934,R-HSA-5663202,R-HSA-1643685,Sunitinib-resistant KIT mutants,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-9674401,R-HSA-5663202,R-HSA-1643685,Sunitinib-resistant PDGFR mutants,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-9635465,R-HSA-5663205,R-HSA-1643685,Suppression of apoptosis,Infectious disease,Disease
R-HSA-9636569,R-HSA-5663205,R-HSA-1643685,Suppression of autophagy,Infectious disease,Disease
R-HSA-9637687,R-HSA-5663205,R-HSA-1643685,Suppression of phagosomal maturation,Infectious disease,Disease
R-HSA-5683826,R-HSA-5683826,R-HSA-392499,Surfactant metabolism,Surfactant metabolism,Metabolism of proteins
R-HSA-69052,R-HSA-69278,R-HSA-1640170,Switching of origins to a post-replicative state,"Cell Cycle, Mitotic",Cell Cycle
R-HSA-69052,R-HSA-69239,R-HSA-69306,Switching of origins to a post-replicative state,Synthesis of DNA,DNA Replication
R-HSA-8849932,R-HSA-6794362,R-HSA-112316,Synaptic adhesion-like molecules,Protein-protein interactions at synapses,Neuronal System
R-HSA-3000170,R-HSA-3000171,R-HSA-1474244,Syndecan interactions,Non-integrin membrane-ECM interactions,Extracellular matrix organization
R-HSA-174495,R-HSA-5663205,R-HSA-1643685,"Synthesis And Processing Of GAG, GAGPOL Polyproteins",Infectious disease,Disease
R-HSA-171286,R-HSA-5663205,R-HSA-1643685,Synthesis and processing of ENV and VPU,Infectious disease,Disease
R-HSA-2142816,R-HSA-556833,R-HSA-1430728,Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE),Metabolism of lipids,Metabolism
R-HSA-2142712,R-HSA-556833,R-HSA-1430728,Synthesis of 12-eicosatetraenoic acid derivatives,Metabolism of lipids,Metabolism
R-HSA-2142770,R-HSA-556833,R-HSA-1430728,Synthesis of 15-eicosatetraenoic acid derivatives,Metabolism of lipids,Metabolism
R-HSA-2142688,R-HSA-556833,R-HSA-1430728,Synthesis of 5-eicosatetraenoic acids,Metabolism of lipids,Metabolism
R-HSA-1483171,R-HSA-556833,R-HSA-1430728,Synthesis of BMP,Metabolism of lipids,Metabolism
R-HSA-1483076,R-HSA-556833,R-HSA-1430728,Synthesis of CL,Metabolism of lipids,Metabolism
R-HSA-69239,R-HSA-69278,R-HSA-1640170,Synthesis of DNA,"Cell Cycle, Mitotic",Cell Cycle
R-HSA-69239,R-HSA-69239,R-HSA-69306,Synthesis of DNA,Synthesis of DNA,DNA Replication
R-HSA-446199,R-HSA-597592,R-HSA-392499,Synthesis of Dolichyl-phosphate,Post-translational protein modification,Metabolism of proteins
R-HSA-446205,R-HSA-597592,R-HSA-392499,Synthesis of GDP-mannose,Post-translational protein modification,Metabolism of proteins
R-HSA-2142696,R-HSA-556833,R-HSA-1430728,Synthesis of Hepoxilins (HX) and Trioxilins (TrX),Metabolism of lipids,Metabolism
R-HSA-1855183,R-HSA-1483249,R-HSA-1430728,"Synthesis of IP2, IP, and Ins in the cytosol",Inositol phosphate metabolism,Metabolism
R-HSA-1855204,R-HSA-1483249,R-HSA-1430728,Synthesis of IP3 and IP4 in the cytosol,Inositol phosphate metabolism,Metabolism
R-HSA-1855231,R-HSA-1483249,R-HSA-1430728,Synthesis of IPs in the ER lumen,Inositol phosphate metabolism,Metabolism
R-HSA-1855191,R-HSA-1483249,R-HSA-1430728,Synthesis of IPs in the nucleus,Inositol phosphate metabolism,Metabolism
R-HSA-77111,R-HSA-556833,R-HSA-1430728,Synthesis of Ketone Bodies,Metabolism of lipids,Metabolism
R-HSA-2142691,R-HSA-556833,R-HSA-1430728,Synthesis of Leukotrienes (LT) and Eoxins (EX),Metabolism of lipids,Metabolism
R-HSA-2142700,R-HSA-556833,R-HSA-1430728,Synthesis of Lipoxins (LX),Metabolism of lipids,Metabolism
R-HSA-1483166,R-HSA-556833,R-HSA-1430728,Synthesis of PA,Metabolism of lipids,Metabolism
R-HSA-1483191,R-HSA-556833,R-HSA-1430728,Synthesis of PC,Metabolism of lipids,Metabolism
R-HSA-1483213,R-HSA-556833,R-HSA-1430728,Synthesis of PE,Metabolism of lipids,Metabolism
R-HSA-1483148,R-HSA-556833,R-HSA-1430728,Synthesis of PG,Metabolism of lipids,Metabolism
R-HSA-1483226,R-HSA-556833,R-HSA-1430728,Synthesis of PI,Metabolism of lipids,Metabolism
R-HSA-1483248,R-HSA-556833,R-HSA-1430728,Synthesis of PIPs at the ER membrane,Metabolism of lipids,Metabolism
R-HSA-1660514,R-HSA-556833,R-HSA-1430728,Synthesis of PIPs at the Golgi membrane,Metabolism of lipids,Metabolism
R-HSA-1660516,R-HSA-556833,R-HSA-1430728,Synthesis of PIPs at the early endosome membrane,Metabolism of lipids,Metabolism
R-HSA-1660517,R-HSA-556833,R-HSA-1430728,Synthesis of PIPs at the late endosome membrane,Metabolism of lipids,Metabolism
R-HSA-1660499,R-HSA-556833,R-HSA-1430728,Synthesis of PIPs at the plasma membrane,Metabolism of lipids,Metabolism
R-HSA-8847453,R-HSA-556833,R-HSA-1430728,Synthesis of PIPs in the nucleus,Metabolism of lipids,Metabolism
R-HSA-1483101,R-HSA-556833,R-HSA-1430728,Synthesis of PS,Metabolism of lipids,Metabolism
R-HSA-2162123,R-HSA-556833,R-HSA-1430728,Synthesis of Prostaglandins (PG) and Thromboxanes (TX),Metabolism of lipids,Metabolism
R-HSA-446210,R-HSA-597592,R-HSA-392499,Synthesis of UDP-N-acetyl-glucosamine,Post-translational protein modification,Metabolism of proteins
R-HSA-8866652,R-HSA-597592,R-HSA-392499,Synthesis of active ubiquitin: roles of E1 and E2 enzymes,Post-translational protein modification,Metabolism of proteins
R-HSA-192105,R-HSA-556833,R-HSA-1430728,Synthesis of bile acids and bile salts,Metabolism of lipids,Metabolism
R-HSA-193775,R-HSA-556833,R-HSA-1430728,Synthesis of bile acids and bile salts via 24-hydroxycholesterol,Metabolism of lipids,Metabolism
R-HSA-193807,R-HSA-556833,R-HSA-1430728,Synthesis of bile acids and bile salts via 27-hydroxycholesterol,Metabolism of lipids,Metabolism
R-HSA-193368,R-HSA-556833,R-HSA-1430728,Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol,Metabolism of lipids,Metabolism
R-HSA-5358493,R-HSA-597592,R-HSA-392499,Synthesis of diphthamide-EEF2,Post-translational protein modification,Metabolism of proteins
R-HSA-162699,R-HSA-597592,R-HSA-392499,Synthesis of dolichyl-phosphate mannose,Post-translational protein modification,Metabolism of proteins
R-HSA-162699,R-HSA-597592,R-HSA-392499,Synthesis of dolichyl-phosphate mannose,Post-translational protein modification,Metabolism of proteins
R-HSA-480985,R-HSA-597592,R-HSA-392499,Synthesis of dolichyl-phosphate-glucose,Post-translational protein modification,Metabolism of proteins
R-HSA-2142670,R-HSA-556833,R-HSA-1430728,Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET),Metabolism of lipids,Metabolism
R-HSA-162710,R-HSA-597592,R-HSA-392499,Synthesis of glycosylphosphatidylinositol (GPI),Post-translational protein modification,Metabolism of proteins
R-HSA-1855167,R-HSA-1483249,R-HSA-1430728,Synthesis of pyrophosphates in the cytosol,Inositol phosphate metabolism,Metabolism
R-HSA-446219,R-HSA-597592,R-HSA-392499,Synthesis of substrates in N-glycan biosythesis,Post-translational protein modification,Metabolism of proteins
R-HSA-75876,R-HSA-556833,R-HSA-1430728,Synthesis of very long-chain fatty acyl-CoAs,Metabolism of lipids,Metabolism
R-HSA-6782861,R-HSA-72306,R-HSA-8953854,Synthesis of wybutosine at G37 of tRNA(Phe),tRNA processing,Metabolism of RNA
R-HSA-422085,R-HSA-2980736,R-HSA-392499,"Synthesis, secretion, and deacylation of Ghrelin",Peptide hormone metabolism,Metabolism of proteins
R-HSA-381771,R-HSA-2980736,R-HSA-392499,"Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)",Peptide hormone metabolism,Metabolism of proteins
R-HSA-400511,R-HSA-2980736,R-HSA-392499,"Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP)",Peptide hormone metabolism,Metabolism of proteins
R-HSA-5358752,R-HSA-5663202,R-HSA-1643685,T41 mutants of beta-catenin aren't phosphorylated,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-445989,R-HSA-168249,R-HSA-168256,TAK1 activates NFkB by phosphorylation and activation of IKKs complex,Innate Immune System,Immune System
R-HSA-445989,R-HSA-168249,R-HSA-168256,TAK1 activates NFkB by phosphorylation and activation of IKKs complex,Innate Immune System,Immune System
R-HSA-445989,R-HSA-168249,R-HSA-168256,TAK1 activates NFkB by phosphorylation and activation of IKKs complex,Innate Immune System,Immune System
R-HSA-445989,R-HSA-168249,R-HSA-168256,TAK1 activates NFkB by phosphorylation and activation of IKKs complex,Innate Immune System,Immune System
R-HSA-445989,R-HSA-1280215,R-HSA-168256,TAK1 activates NFkB by phosphorylation and activation of IKKs complex,Cytokine Signaling in Immune system,Immune System
R-HSA-445989,R-HSA-168249,R-HSA-168256,TAK1 activates NFkB by phosphorylation and activation of IKKs complex,Innate Immune System,Immune System
R-HSA-445989,R-HSA-168249,R-HSA-168256,TAK1 activates NFkB by phosphorylation and activation of IKKs complex,Innate Immune System,Immune System
R-HSA-445989,R-HSA-168249,R-HSA-168256,TAK1 activates NFkB by phosphorylation and activation of IKKs complex,Innate Immune System,Immune System
R-HSA-445989,R-HSA-168249,R-HSA-168256,TAK1 activates NFkB by phosphorylation and activation of IKKs complex,Innate Immune System,Immune System
R-HSA-445989,R-HSA-168249,R-HSA-168256,TAK1 activates NFkB by phosphorylation and activation of IKKs complex,Innate Immune System,Immune System
R-HSA-6791462,R-HSA-5668914,R-HSA-1643685,"TALDO1 deficiency: failed conversion of  Fru(6)P, E4P to SH7P, GA3P",Diseases of metabolism,Disease
R-HSA-6791055,R-HSA-5668914,R-HSA-1643685,"TALDO1 deficiency: failed conversion of SH7P, GA3P to Fru(6)P, E4P",Diseases of metabolism,Disease
R-HSA-8854214,R-HSA-199991,R-HSA-5653656,TBC/RABGAPs,Membrane Trafficking,Vesicle-mediated transport
R-HSA-201681,R-HSA-195721,R-HSA-162582,TCF dependent signaling in response to WNT,Signaling by WNT,Signal Transduction
R-HSA-202403,R-HSA-1280218,R-HSA-168256,TCR signaling,Adaptive Immune System,Immune System
R-HSA-5221030,R-HSA-212165,R-HSA-74160,"TET1,2,3 and TDG demethylate DNA",Epigenetic regulation of gene expression,Gene expression (Transcription)
R-HSA-8866911,R-HSA-73857,R-HSA-74160,TFAP2 (AP-2) family regulates transcription of cell cycle factors,RNA Polymerase II Transcription,Gene expression (Transcription)
R-HSA-8866910,R-HSA-73857,R-HSA-74160,TFAP2 (AP-2) family regulates transcription of growth factors and their receptors,RNA Polymerase II Transcription,Gene expression (Transcription)
R-HSA-8866906,R-HSA-73857,R-HSA-74160,TFAP2 (AP-2) family regulates transcription of other transcription factors,RNA Polymerase II Transcription,Gene expression (Transcription)
R-HSA-8869496,R-HSA-73857,R-HSA-74160,TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation,RNA Polymerase II Transcription,Gene expression (Transcription)
R-HSA-2173789,R-HSA-9006936,R-HSA-162582,TGF-beta receptor signaling activates SMADs,Signaling by TGFB family members,Signal Transduction
R-HSA-2173791,R-HSA-9006936,R-HSA-162582,TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition),Signaling by TGFB family members,Signal Transduction
R-HSA-3656532,R-HSA-5663202,R-HSA-1643685,TGFBR1 KD Mutants in Cancer,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-3656535,R-HSA-5663202,R-HSA-1643685,TGFBR1 LBD Mutants in Cancer,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-3645790,R-HSA-5663202,R-HSA-1643685,TGFBR2 Kinase Domain Mutants in Cancer,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-3642279,R-HSA-5663202,R-HSA-1643685,TGFBR2 MSI Frameshift Mutants in Cancer,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-5602566,R-HSA-5260271,R-HSA-1643685,TICAM1 deficiency - HSE,Diseases of Immune System,Disease
R-HSA-168927,R-HSA-168249,R-HSA-168256,"TICAM1, RIP1-mediated IKK complex recruitment",Innate Immune System,Immune System
R-HSA-9014325,R-HSA-168249,R-HSA-168256,"TICAM1,TRAF6-dependent induction of TAK1 complex",Innate Immune System,Immune System
R-HSA-9013973,R-HSA-168249,R-HSA-168256,TICAM1-dependent activation of IRF3/IRF7,Innate Immune System,Immune System
R-HSA-5602410,R-HSA-5260271,R-HSA-1643685,TLR3 deficiency - HSE,Diseases of Immune System,Disease
R-HSA-9013957,R-HSA-168249,R-HSA-168256,TLR3-mediated TICAM1-dependent programmed cell death,Innate Immune System,Immune System
R-HSA-5676594,R-HSA-1280215,R-HSA-168256,TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway,Cytokine Signaling in Immune system,Immune System
R-HSA-75893,R-HSA-73887,R-HSA-162582,TNF signaling,Death Receptor Signalling,Signal Transduction
R-HSA-5357956,R-HSA-73887,R-HSA-162582,TNFR1-induced NFkappaB signaling pathway,Death Receptor Signalling,Signal Transduction
R-HSA-5357786,R-HSA-73887,R-HSA-162582,TNFR1-induced proapoptotic signaling,Death Receptor Signalling,Signal Transduction
R-HSA-5626978,R-HSA-73887,R-HSA-162582,TNFR1-mediated ceramide production,Death Receptor Signalling,Signal Transduction
R-HSA-5668541,R-HSA-1280215,R-HSA-168256,TNFR2 non-canonical NF-kB pathway,Cytokine Signaling in Immune system,Immune System
R-HSA-5669034,R-HSA-1280215,R-HSA-168256,TNFs bind their physiological receptors,Cytokine Signaling in Immune system,Immune System
R-HSA-5628897,R-HSA-73857,R-HSA-74160,TP53 Regulates Metabolic Genes,RNA Polymerase II Transcription,Gene expression (Transcription)
R-HSA-6803207,R-HSA-73857,R-HSA-74160,TP53 Regulates Transcription of Caspase Activators and Caspases,RNA Polymerase II Transcription,Gene expression (Transcription)
R-HSA-6791312,R-HSA-73857,R-HSA-74160,TP53 Regulates Transcription of Cell Cycle Genes,RNA Polymerase II Transcription,Gene expression (Transcription)
R-HSA-5633008,R-HSA-73857,R-HSA-74160,TP53 Regulates Transcription of Cell Death Genes,RNA Polymerase II Transcription,Gene expression (Transcription)
R-HSA-6796648,R-HSA-73857,R-HSA-74160,TP53 Regulates Transcription of DNA Repair Genes,RNA Polymerase II Transcription,Gene expression (Transcription)
R-HSA-6803211,R-HSA-73857,R-HSA-74160,TP53 Regulates Transcription of Death Receptors and Ligands,RNA Polymerase II Transcription,Gene expression (Transcription)
R-HSA-6803204,R-HSA-73857,R-HSA-74160,TP53 Regulates Transcription of Genes Involved in Cytochrome C Release,RNA Polymerase II Transcription,Gene expression (Transcription)
R-HSA-6804116,R-HSA-73857,R-HSA-74160,TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest,RNA Polymerase II Transcription,Gene expression (Transcription)
R-HSA-6804114,R-HSA-73857,R-HSA-74160,TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest,RNA Polymerase II Transcription,Gene expression (Transcription)
R-HSA-6804115,R-HSA-73857,R-HSA-74160,TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain,RNA Polymerase II Transcription,Gene expression (Transcription)
R-HSA-6803205,R-HSA-73857,R-HSA-74160,TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain,RNA Polymerase II Transcription,Gene expression (Transcription)
R-HSA-5602571,R-HSA-5260271,R-HSA-1643685,TRAF3 deficiency - HSE,Diseases of Immune System,Disease
R-HSA-918233,R-HSA-168249,R-HSA-168256,TRAF3-dependent IRF activation pathway,Innate Immune System,Immune System
R-HSA-933541,R-HSA-168249,R-HSA-168256,TRAF6 mediated IRF7 activation,Innate Immune System,Immune System
R-HSA-975110,R-HSA-168249,R-HSA-168256,TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling,Innate Immune System,Immune System
R-HSA-975110,R-HSA-168249,R-HSA-168256,TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling,Innate Immune System,Immune System
R-HSA-933542,R-HSA-168249,R-HSA-168256,TRAF6 mediated NF-kB activation,Innate Immune System,Immune System
R-HSA-975138,R-HSA-168249,R-HSA-168256,TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation,Innate Immune System,Immune System
R-HSA-975138,R-HSA-168249,R-HSA-168256,TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation,Innate Immune System,Immune System
R-HSA-937072,R-HSA-168249,R-HSA-168256,TRAF6-mediated induction of TAK1 complex within TLR4 complex,Innate Immune System,Immune System
R-HSA-75158,R-HSA-73887,R-HSA-162582,TRAIL  signaling,Death Receptor Signalling,Signal Transduction
R-HSA-937061,R-HSA-168249,R-HSA-168256,TRIF(TICAM1)-mediated TLR4 signaling,Innate Immune System,Immune System
R-HSA-2562578,R-HSA-168249,R-HSA-168256,TRIF-mediated programmed cell death,Innate Immune System,Immune System
R-HSA-187042,R-HSA-9006934,R-HSA-162582,TRKA activation by NGF,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-3295583,R-HSA-983712,R-HSA-382551,TRP channels,Ion channel transport,Transport of small molecules
R-HSA-1299503,R-HSA-1296071,R-HSA-112316,TWIK related potassium channel (TREK),Potassium Channels,Neuronal System
R-HSA-1299361,R-HSA-1296071,R-HSA-112316,TWIK-related alkaline pH activated K+ channel (TALK),Potassium Channels,Neuronal System
R-HSA-1299344,R-HSA-1296071,R-HSA-112316,TWIK-related spinal cord K+ channel (TRESK),Potassium Channels,Neuronal System
R-HSA-1299316,R-HSA-1296071,R-HSA-112316,TWIK-releated acid-sensitive K+ channel (TASK),Potassium Channels,Neuronal System
R-HSA-9033500,R-HSA-9033241,R-HSA-9609507,TYSND1 cleaves peroxisomal proteins,Peroxisomal protein import,Protein localization
R-HSA-380095,R-HSA-372790,R-HSA-162582,Tachykinin receptors bind tachykinins,Signaling by GPCR,Signal Transduction
R-HSA-1299308,R-HSA-1296071,R-HSA-112316,Tandem of pore domain in a weak inwardly rectifying K+ channels (TWIK),Potassium Channels,Neuronal System
R-HSA-1299287,R-HSA-1296071,R-HSA-112316,Tandem pore domain halothane-inhibited K+ channel (THIK),Potassium Channels,Neuronal System
R-HSA-1296346,R-HSA-1296071,R-HSA-112316,Tandem pore domain potassium channels,Potassium Channels,Neuronal System
R-HSA-167243,R-HSA-5663205,R-HSA-1643685,Tat-mediated HIV elongation arrest and recovery,Infectious disease,Disease
R-HSA-167246,R-HSA-5663205,R-HSA-1643685,Tat-mediated elongation of the HIV-1 transcript,Infectious disease,Disease
R-HSA-174417,R-HSA-73886,R-HSA-1640170,Telomere C-strand (Lagging Strand) Synthesis,Chromosome Maintenance,Cell Cycle
R-HSA-174430,R-HSA-73886,R-HSA-1640170,Telomere C-strand synthesis initiation,Chromosome Maintenance,Cell Cycle
R-HSA-171319,R-HSA-73886,R-HSA-1640170,Telomere Extension By Telomerase,Chromosome Maintenance,Cell Cycle
R-HSA-157579,R-HSA-73886,R-HSA-1640170,Telomere Maintenance,Chromosome Maintenance,Cell Cycle
R-HSA-166665,R-HSA-168249,R-HSA-168256,Terminal pathway of complement,Innate Immune System,Immune System
R-HSA-977068,R-HSA-597592,R-HSA-392499,Termination of O-glycan biosynthesis,Post-translational protein modification,Metabolism of proteins
R-HSA-5656169,R-HSA-73893,R-HSA-73894,Termination of translesion DNA synthesis,DNA Damage Bypass,DNA Repair
R-HSA-1474151,R-HSA-196854,R-HSA-1430728,"Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation",Metabolism of vitamins and cofactors,Metabolism
R-HSA-844615,R-HSA-168249,R-HSA-168256,The AIM2 inflammasome,Innate Immune System,Immune System
R-HSA-844623,R-HSA-168249,R-HSA-168256,The IPAF inflammasome,Innate Immune System,Immune System
R-HSA-844455,R-HSA-168249,R-HSA-168256,The NLRP1 inflammasome,Innate Immune System,Immune System
R-HSA-844456,R-HSA-168249,R-HSA-168256,The NLRP3 inflammasome,Innate Immune System,Immune System
R-HSA-1663150,R-HSA-597592,R-HSA-392499,The activation of arylsulfatases,Post-translational protein modification,Metabolism of proteins
R-HSA-2453902,R-HSA-2187338,R-HSA-9709957,The canonical retinoid cycle in rods (twilight vision),Visual phototransduction,Sensory Perception
R-HSA-1428517,R-HSA-1428517,R-HSA-1430728,The citric acid (TCA) cycle and respiratory electron transport,The citric acid (TCA) cycle and respiratory electron transport,Metabolism
R-HSA-167826,R-HSA-1428517,R-HSA-1430728,The fatty acid cycling model,The citric acid (TCA) cycle and respiratory electron transport,Metabolism
R-HSA-2514856,R-HSA-2187338,R-HSA-9709957,The phototransduction cascade,Visual phototransduction,Sensory Perception
R-HSA-167827,R-HSA-1428517,R-HSA-1430728,The proton buffering model,The citric acid (TCA) cycle and respiratory electron transport,Metabolism
R-HSA-2187335,R-HSA-2187338,R-HSA-9709957,The retinoid cycle in cones (daylight vision),Visual phototransduction,Sensory Perception
R-HSA-8852276,R-HSA-69278,R-HSA-1640170,The role of GTSE1 in G2/M progression after G2 checkpoint,"Cell Cycle, Mitotic",Cell Cycle
R-HSA-164952,R-HSA-5663205,R-HSA-1643685,The role of Nef in HIV-1 replication and disease pathogenesis,Infectious disease,Disease
R-HSA-8849175,R-HSA-71291,R-HSA-1430728,Threonine catabolism,Metabolism of amino acids and derivatives,Metabolism
R-HSA-456926,R-HSA-76002,R-HSA-109582,Thrombin signalling through proteinase activated receptors (PARs),"Platelet activation, signaling and aggregation",Hemostasis
R-HSA-428930,R-HSA-76002,R-HSA-109582,Thromboxane signalling through TP receptor,"Platelet activation, signaling and aggregation",Hemostasis
R-HSA-209968,R-HSA-71291,R-HSA-1430728,Thyroxine biosynthesis,Metabolism of amino acids and derivatives,Metabolism
R-HSA-210993,R-HSA-202733,R-HSA-109582,Tie2 Signaling,Cell surface interactions at the vascular wall,Hemostasis
R-HSA-420029,R-HSA-446728,R-HSA-1500931,Tight junction interactions,Cell junction organization,Cell-Cell communication
R-HSA-1222538,R-HSA-5663205,R-HSA-1643685,Tolerance by Mtb to nitric oxide produced by macrophages,Infectious disease,Disease
R-HSA-1222387,R-HSA-5663205,R-HSA-1643685,Tolerance of reactive oxygen produced by macrophages,Infectious disease,Disease
R-HSA-168142,R-HSA-168249,R-HSA-168256,Toll Like Receptor 10 (TLR10) Cascade,Innate Immune System,Immune System
R-HSA-181438,R-HSA-168249,R-HSA-168256,Toll Like Receptor 2 (TLR2) Cascade,Innate Immune System,Immune System
R-HSA-168164,R-HSA-168249,R-HSA-168256,Toll Like Receptor 3 (TLR3) Cascade,Innate Immune System,Immune System
R-HSA-166016,R-HSA-168249,R-HSA-168256,Toll Like Receptor 4 (TLR4) Cascade,Innate Immune System,Immune System
R-HSA-168176,R-HSA-168249,R-HSA-168256,Toll Like Receptor 5 (TLR5) Cascade,Innate Immune System,Immune System
R-HSA-168181,R-HSA-168249,R-HSA-168256,Toll Like Receptor 7/8 (TLR7/8) Cascade,Innate Immune System,Immune System
R-HSA-168138,R-HSA-168249,R-HSA-168256,Toll Like Receptor 9 (TLR9) Cascade,Innate Immune System,Immune System
R-HSA-168179,R-HSA-168249,R-HSA-168256,Toll Like Receptor TLR1:TLR2 Cascade,Innate Immune System,Immune System
R-HSA-168188,R-HSA-168249,R-HSA-168256,Toll Like Receptor TLR6:TLR2 Cascade,Innate Immune System,Immune System
R-HSA-168898,R-HSA-168249,R-HSA-168256,Toll-like Receptor Cascades,Innate Immune System,Immune System
R-HSA-5250968,R-HSA-5663205,R-HSA-1643685,Toxicity of botulinum toxin type A (botA),Infectious disease,Disease
R-HSA-5250958,R-HSA-5663205,R-HSA-1643685,Toxicity of botulinum toxin type B (botB),Infectious disease,Disease
R-HSA-5250971,R-HSA-5663205,R-HSA-1643685,Toxicity of botulinum toxin type C (botC),Infectious disease,Disease
R-HSA-5250955,R-HSA-5663205,R-HSA-1643685,Toxicity of botulinum toxin type D (botD),Infectious disease,Disease
R-HSA-5250992,R-HSA-5663205,R-HSA-1643685,Toxicity of botulinum toxin type E (botE),Infectious disease,Disease
R-HSA-5250981,R-HSA-5663205,R-HSA-1643685,Toxicity of botulinum toxin type F (botF),Infectious disease,Disease
R-HSA-5250989,R-HSA-5663205,R-HSA-1643685,Toxicity of botulinum toxin type G (botG),Infectious disease,Disease
R-HSA-5250982,R-HSA-5663205,R-HSA-1643685,Toxicity of tetanus toxin (tetX),Infectious disease,Disease
R-HSA-1679131,R-HSA-168249,R-HSA-168256,Trafficking and processing of endosomal TLR,Innate Immune System,Immune System
R-HSA-399719,R-HSA-112315,R-HSA-112316,Trafficking of AMPA receptors,Transmission across Chemical Synapses,Neuronal System
R-HSA-416993,R-HSA-112315,R-HSA-112316,Trafficking of GluR2-containing AMPA receptors,Transmission across Chemical Synapses,Neuronal System
R-HSA-5624138,R-HSA-5617833,R-HSA-1852241,Trafficking of myristoylated proteins to the cilium,Cilium Assembly,Organelle biogenesis and maintenance
R-HSA-75944,R-HSA-75944,R-HSA-74160,Transcription from mitochondrial promoters,Transcription from mitochondrial promoters,Gene expression (Transcription)
R-HSA-1362277,R-HSA-69278,R-HSA-1640170,Transcription of E2F targets under negative control by DREAM complex,"Cell Cycle, Mitotic",Cell Cycle
R-HSA-1362300,R-HSA-69278,R-HSA-1640170,Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1,"Cell Cycle, Mitotic",Cell Cycle
R-HSA-9682708,R-HSA-5663205,R-HSA-1643685,Transcription of SARS-CoV-1 sgRNAs,Infectious disease,Disease
R-HSA-9694786,R-HSA-5663205,R-HSA-1643685,Transcription of SARS-CoV-2 sgRNAs,Infectious disease,Disease
R-HSA-167172,R-HSA-5663205,R-HSA-1643685,Transcription of the HIV genome,Infectious disease,Disease
R-HSA-6781827,R-HSA-5696398,R-HSA-73894,Transcription-Coupled Nucleotide Excision Repair (TC-NER),Nucleotide Excision Repair,DNA Repair
R-HSA-69895,R-HSA-69620,R-HSA-1640170,Transcriptional  activation of  cell cycle inhibitor p21,Cell Cycle Checkpoints,Cell Cycle
R-HSA-8953750,R-HSA-73857,R-HSA-74160,Transcriptional Regulation by E2F6,RNA Polymerase II Transcription,Gene expression (Transcription)
R-HSA-8986944,R-HSA-73857,R-HSA-74160,Transcriptional Regulation by MECP2,RNA Polymerase II Transcription,Gene expression (Transcription)
R-HSA-3700989,R-HSA-73857,R-HSA-74160,Transcriptional Regulation by TP53,RNA Polymerase II Transcription,Gene expression (Transcription)
R-HSA-8853884,R-HSA-73857,R-HSA-74160,Transcriptional Regulation by VENTX,RNA Polymerase II Transcription,Gene expression (Transcription)
R-HSA-2151201,R-HSA-1592230,R-HSA-1852241,Transcriptional activation of mitochondrial biogenesis,Mitochondrial biogenesis,Organelle biogenesis and maintenance
R-HSA-69560,R-HSA-69620,R-HSA-1640170,Transcriptional activation of p53 responsive genes,Cell Cycle Checkpoints,Cell Cycle
R-HSA-2173793,R-HSA-9006936,R-HSA-162582,Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer,Signaling by TGFB family members,Signal Transduction
R-HSA-2173793,R-HSA-73857,R-HSA-74160,Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer,RNA Polymerase II Transcription,Gene expression (Transcription)
R-HSA-8878171,R-HSA-73857,R-HSA-74160,Transcriptional regulation by RUNX1,RNA Polymerase II Transcription,Gene expression (Transcription)
R-HSA-8878166,R-HSA-73857,R-HSA-74160,Transcriptional regulation by RUNX2,RNA Polymerase II Transcription,Gene expression (Transcription)
R-HSA-8878159,R-HSA-73857,R-HSA-74160,Transcriptional regulation by RUNX3,RNA Polymerase II Transcription,Gene expression (Transcription)
R-HSA-5578749,R-HSA-211000,R-HSA-74160,Transcriptional regulation by small RNAs,Gene Silencing by RNA,Gene expression (Transcription)
R-HSA-8864260,R-HSA-73857,R-HSA-74160,Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors,RNA Polymerase II Transcription,Gene expression (Transcription)
R-HSA-9616222,R-HSA-9616222,R-HSA-1266738,Transcriptional regulation of granulopoiesis,Transcriptional regulation of granulopoiesis,Developmental Biology
R-HSA-452723,R-HSA-452723,R-HSA-1266738,Transcriptional regulation of pluripotent stem cells,Transcriptional regulation of pluripotent stem cells,Developmental Biology
R-HSA-9690406,R-HSA-9690406,R-HSA-1266738,Transcriptional regulation of testis differentiation,Transcriptional regulation of testis differentiation,Developmental Biology
R-HSA-381340,R-HSA-381340,R-HSA-1266738,Transcriptional regulation of white adipocyte differentiation,Transcriptional regulation of white adipocyte differentiation,Developmental Biology
R-HSA-166020,R-HSA-168249,R-HSA-168256,Transfer of LPS from LBP carrier to CD14,Innate Immune System,Immune System
R-HSA-917977,R-HSA-917937,R-HSA-382551,Transferrin endocytosis and recycling,Iron uptake and transport,Transport of small molecules
R-HSA-72766,R-HSA-72766,R-HSA-392499,Translation,Translation,Metabolism of proteins
R-HSA-72649,R-HSA-72766,R-HSA-392499,Translation initiation complex formation,Translation,Metabolism of proteins
R-HSA-9679504,R-HSA-5663205,R-HSA-1643685,Translation of Replicase and Assembly of the Replication Transcription Complex,Infectious disease,Disease
R-HSA-9694676,R-HSA-5663205,R-HSA-1643685,Translation of Replicase and Assembly of the Replication Transcription Complex,Infectious disease,Disease
R-HSA-9683701,R-HSA-5663205,R-HSA-1643685,Translation of Structural Proteins,Infectious disease,Disease
R-HSA-9694635,R-HSA-5663205,R-HSA-1643685,Translation of Structural Proteins,Infectious disease,Disease
R-HSA-110320,R-HSA-73893,R-HSA-73894,Translesion Synthesis by POLH,DNA Damage Bypass,DNA Repair
R-HSA-5656121,R-HSA-73893,R-HSA-73894,Translesion synthesis by POLI,DNA Damage Bypass,DNA Repair
R-HSA-5655862,R-HSA-73893,R-HSA-73894,Translesion synthesis by POLK,DNA Damage Bypass,DNA Repair
R-HSA-110312,R-HSA-73893,R-HSA-73894,Translesion synthesis by REV1,DNA Damage Bypass,DNA Repair
R-HSA-110313,R-HSA-73893,R-HSA-73894,Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template,DNA Damage Bypass,DNA Repair
R-HSA-1445148,R-HSA-199991,R-HSA-5653656,Translocation of SLC2A4 (GLUT4) to the plasma membrane,Membrane Trafficking,Vesicle-mediated transport
R-HSA-202430,R-HSA-1280218,R-HSA-168256,Translocation of ZAP-70 to Immunological synapse,Adaptive Immune System,Immune System
R-HSA-112315,R-HSA-112315,R-HSA-112316,Transmission across Chemical Synapses,Transmission across Chemical Synapses,Neuronal System
R-HSA-112307,R-HSA-112307,R-HSA-112316,Transmission across Electrical Synapses,Transmission across Electrical Synapses,Neuronal System
R-HSA-174362,R-HSA-211859,R-HSA-1430728,Transport and synthesis of PAPS,Biological oxidations,Metabolism
R-HSA-174362,R-HSA-71387,R-HSA-1430728,Transport and synthesis of PAPS,Metabolism of carbohydrates,Metabolism
R-HSA-168874,R-HSA-5663205,R-HSA-1643685,"Transport of HA trimer, NA tetramer and M2 tetramer from the endoplasmic reticulum to the Golgi Apparatus",Infectious disease,Disease
R-HSA-72202,R-HSA-72203,R-HSA-8953854,Transport of Mature Transcript to Cytoplasm,Processing of Capped Intron-Containing Pre-mRNA,Metabolism of RNA
R-HSA-159231,R-HSA-72203,R-HSA-8953854,Transport of Mature mRNA Derived from an Intronless Transcript,Processing of Capped Intron-Containing Pre-mRNA,Metabolism of RNA
R-HSA-159236,R-HSA-72203,R-HSA-8953854,Transport of Mature mRNA derived from an Intron-Containing Transcript,Processing of Capped Intron-Containing Pre-mRNA,Metabolism of RNA
R-HSA-159234,R-HSA-72203,R-HSA-8953854,Transport of Mature mRNAs Derived from Intronless Transcripts,Processing of Capped Intron-Containing Pre-mRNA,Metabolism of RNA
R-HSA-168271,R-HSA-5663205,R-HSA-1643685,Transport of Ribonucleoproteins into the Host Nucleus,Infectious disease,Disease
R-HSA-425366,R-HSA-425407,R-HSA-382551,"Transport of bile salts and organic acids, metal ions and amine compounds",SLC-mediated transmembrane transport,Transport of small molecules
R-HSA-190827,R-HSA-199991,R-HSA-5653656,Transport of connexins along the secretory pathway,Membrane Trafficking,Vesicle-mediated transport
R-HSA-190872,R-HSA-199991,R-HSA-5653656,Transport of connexons to the plasma membrane,Membrane Trafficking,Vesicle-mediated transport
R-HSA-804914,R-HSA-425407,R-HSA-382551,Transport of fatty acids,SLC-mediated transmembrane transport,Transport of small molecules
R-HSA-159763,R-HSA-597592,R-HSA-392499,Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus,Post-translational protein modification,Metabolism of proteins
R-HSA-432030,R-HSA-445717,R-HSA-382551,Transport of glycerol from adipocytes to the liver by Aquaporins,Aquaporin-mediated transport,Transport of small molecules
R-HSA-425393,R-HSA-425407,R-HSA-382551,Transport of inorganic cations/anions and amino acids/oligopeptides,SLC-mediated transmembrane transport,Transport of small molecules
R-HSA-83936,R-HSA-425407,R-HSA-382551,Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane,SLC-mediated transmembrane transport,Transport of small molecules
R-HSA-727802,R-HSA-425407,R-HSA-382551,Transport of nucleotide sugars,SLC-mediated transmembrane transport,Transport of small molecules
R-HSA-879518,R-HSA-425407,R-HSA-382551,Transport of organic anions,SLC-mediated transmembrane transport,Transport of small molecules
R-HSA-382551,R-HSA-382551,R-HSA-382551,Transport of small molecules,Transport of small molecules,Transport of small molecules
R-HSA-159230,R-HSA-72203,R-HSA-8953854,Transport of the SLBP Dependant Mature mRNA,Processing of Capped Intron-Containing Pre-mRNA,Metabolism of RNA
R-HSA-159227,R-HSA-72203,R-HSA-8953854,Transport of the SLBP independent Mature mRNA,Processing of Capped Intron-Containing Pre-mRNA,Metabolism of RNA
R-HSA-425397,R-HSA-425407,R-HSA-382551,"Transport of vitamins, nucleosides, and related molecules",SLC-mediated transmembrane transport,Transport of small molecules
R-HSA-948021,R-HSA-597592,R-HSA-392499,Transport to the Golgi and subsequent modification,Post-translational protein modification,Metabolism of proteins
R-HSA-75109,R-HSA-556833,R-HSA-1430728,Triglyceride biosynthesis,Metabolism of lipids,Metabolism
R-HSA-163560,R-HSA-556833,R-HSA-1430728,Triglyceride catabolism,Metabolism of lipids,Metabolism
R-HSA-8979227,R-HSA-556833,R-HSA-1430728,Triglyceride metabolism,Metabolism of lipids,Metabolism
R-HSA-450513,R-HSA-450531,R-HSA-8953854,"Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA",Regulation of mRNA stability by proteins that bind AU-rich elements,Metabolism of RNA
R-HSA-5467348,R-HSA-5663202,R-HSA-1643685,Truncations of AMER1 destabilize the destruction complex,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-71240,R-HSA-71291,R-HSA-1430728,Tryptophan catabolism,Metabolism of amino acids and derivatives,Metabolism
R-HSA-446107,R-HSA-446728,R-HSA-1500931,Type I hemidesmosome assembly,Cell junction organization,Cell-Cell communication
R-HSA-427589,R-HSA-425407,R-HSA-382551,Type II Na+/Pi cotransporters,SLC-mediated transmembrane transport,Transport of small molecules
R-HSA-8963684,R-HSA-71291,R-HSA-1430728,Tyrosine catabolism,Metabolism of amino acids and derivatives,Metabolism
R-HSA-5689603,R-HSA-597592,R-HSA-392499,UCH proteinases,Post-translational protein modification,Metabolism of proteins
R-HSA-5602415,R-HSA-5260271,R-HSA-1643685,UNC93B1 deficiency - HSE,Diseases of Immune System,Disease
R-HSA-5689880,R-HSA-597592,R-HSA-392499,Ub-specific processing proteases,Post-translational protein modification,Metabolism of proteins
R-HSA-2142789,R-HSA-196854,R-HSA-1430728,Ubiquinol biosynthesis,Metabolism of vitamins and cofactors,Metabolism
R-HSA-69601,R-HSA-69620,R-HSA-1640170,Ubiquitin Mediated Degradation of Phosphorylated Cdc25A,Cell Cycle Checkpoints,Cell Cycle
R-HSA-75815,R-HSA-69278,R-HSA-1640170,Ubiquitin-dependent degradation of Cyclin D,"Cell Cycle, Mitotic",Cell Cycle
R-HSA-438066,R-HSA-112315,R-HSA-112316,"Unblocking of NMDA receptors, glutamate binding and activation",Transmission across Chemical Synapses,Neuronal System
R-HSA-162585,R-HSA-5663205,R-HSA-1643685,Uncoating of the HIV Virion,Infectious disease,Disease
R-HSA-168336,R-HSA-5663205,R-HSA-1643685,Uncoating of the Influenza Virion,Infectious disease,Disease
R-HSA-381119,R-HSA-2262752,R-HSA-8953897,Unfolded Protein Response (UPR),Cellular responses to stress,Cellular responses to stimuli
R-HSA-176974,R-HSA-69278,R-HSA-1640170,Unwinding of DNA,"Cell Cycle, Mitotic",Cell Cycle
R-HSA-176974,R-HSA-69239,R-HSA-69306,Unwinding of DNA,Synthesis of DNA,DNA Replication
R-HSA-5339562,R-HSA-5663205,R-HSA-1643685,Uptake and actions of bacterial toxins,Infectious disease,Disease
R-HSA-5210891,R-HSA-5663205,R-HSA-1643685,Uptake and function of anthrax toxins,Infectious disease,Disease
R-HSA-5336415,R-HSA-5663205,R-HSA-1643685,Uptake and function of diphtheria toxin,Infectious disease,Disease
R-HSA-70635,R-HSA-71291,R-HSA-1430728,Urea cycle,Metabolism of amino acids and derivatives,Metabolism
R-HSA-77108,R-HSA-556833,R-HSA-1430728,Utilization of Ketone Bodies,Metabolism of lipids,Metabolism
R-HSA-195399,R-HSA-9006934,R-HSA-162582,VEGF binds to VEGFR leading to receptor dimerization,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-194313,R-HSA-9006934,R-HSA-162582,VEGF ligand-receptor interactions,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-4420097,R-HSA-9006934,R-HSA-162582,VEGFA-VEGFR2 Pathway,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-5218921,R-HSA-9006934,R-HSA-162582,VEGFR2 mediated cell proliferation,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-5218920,R-HSA-9006934,R-HSA-162582,VEGFR2 mediated vascular permeability,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-8866423,R-HSA-174824,R-HSA-382551,VLDL assembly,"Plasma lipoprotein assembly, remodeling, and clearance",Transport of small molecules
R-HSA-8964046,R-HSA-174824,R-HSA-382551,VLDL clearance,"Plasma lipoprotein assembly, remodeling, and clearance",Transport of small molecules
R-HSA-8866427,R-HSA-174824,R-HSA-382551,VLDLR internalisation and degradation,"Plasma lipoprotein assembly, remodeling, and clearance",Transport of small molecules
R-HSA-5619094,R-HSA-5619115,R-HSA-1643685,Variant SLC6A14 may confer susceptibility towards obesity,Disorders of transmembrane transporters,Disease
R-HSA-5619101,R-HSA-5619115,R-HSA-1643685,Variant SLC6A20 contributes towards hyperglycinuria (HG) and iminoglycinuria (IG),Disorders of transmembrane transporters,Disease
R-HSA-5660686,R-HSA-5619115,R-HSA-1643685,Variant SLC6A20 contributes towards hyperglycinuria (HG) and iminoglycinuria (IG),Disorders of transmembrane transporters,Disease
R-HSA-432040,R-HSA-445717,R-HSA-382551,Vasopressin regulates renal water homeostasis via Aquaporins,Aquaporin-mediated transport,Transport of small molecules
R-HSA-388479,R-HSA-372790,R-HSA-162582,Vasopressin-like receptors,Signaling by GPCR,Signal Transduction
R-HSA-5653656,R-HSA-5653656,R-HSA-5653656,Vesicle-mediated transport,Vesicle-mediated transport,Vesicle-mediated transport
R-HSA-180585,R-HSA-5663205,R-HSA-1643685,Vif-mediated degradation of APOBEC3G,Infectious disease,Disease
R-HSA-168325,R-HSA-5663205,R-HSA-1643685,Viral Messenger RNA Synthesis,Infectious disease,Disease
R-HSA-168330,R-HSA-5663205,R-HSA-1643685,Viral RNP Complexes in the Host Cell Nucleus,Infectious disease,Disease
R-HSA-192823,R-HSA-5663205,R-HSA-1643685,Viral mRNA Translation,Infectious disease,Disease
R-HSA-9694322,R-HSA-5663205,R-HSA-1643685,Virion Assembly and Release,Infectious disease,Disease
R-HSA-9679509,R-HSA-5663205,R-HSA-1643685,Virion Assembly and Release,Infectious disease,Disease
R-HSA-168268,R-HSA-5663205,R-HSA-1643685,Virus Assembly and Release,Infectious disease,Disease
R-HSA-2187338,R-HSA-2187338,R-HSA-9709957,Visual phototransduction,Visual phototransduction,Sensory Perception
R-HSA-196819,R-HSA-196854,R-HSA-1430728,Vitamin B1 (thiamin) metabolism,Metabolism of vitamins and cofactors,Metabolism
R-HSA-196843,R-HSA-196854,R-HSA-1430728,Vitamin B2 (riboflavin) metabolism,Metabolism of vitamins and cofactors,Metabolism
R-HSA-199220,R-HSA-196854,R-HSA-1430728,Vitamin B5 (pantothenate) metabolism,Metabolism of vitamins and cofactors,Metabolism
R-HSA-196836,R-HSA-196854,R-HSA-1430728,Vitamin C (ascorbate) metabolism,Metabolism of vitamins and cofactors,Metabolism
R-HSA-196791,R-HSA-556833,R-HSA-1430728,Vitamin D (calciferol) metabolism,Metabolism of lipids,Metabolism
R-HSA-8877627,R-HSA-196854,R-HSA-1430728,Vitamin E,Metabolism of vitamins and cofactors,Metabolism
R-HSA-211916,R-HSA-211859,R-HSA-1430728,Vitamins,Biological oxidations,Metabolism
R-HSA-964975,R-HSA-196854,R-HSA-1430728,Vitamins B6 activation to pyridoxal phosphate,Metabolism of vitamins and cofactors,Metabolism
R-HSA-1296072,R-HSA-1296071,R-HSA-112316,Voltage gated Potassium channels,Potassium Channels,Neuronal System
R-HSA-180897,R-HSA-5663205,R-HSA-1643685,Vpr-mediated induction of apoptosis by mitochondrial outer membrane permeabilization,Infectious disease,Disease
R-HSA-180910,R-HSA-5663205,R-HSA-1643685,Vpr-mediated nuclear import of PICs,Infectious disease,Disease
R-HSA-180534,R-HSA-5663205,R-HSA-1643685,Vpu mediated degradation of CD4,Infectious disease,Disease
R-HSA-5620916,R-HSA-5617833,R-HSA-1852241,VxPx cargo-targeting to cilium,Cilium Assembly,Organelle biogenesis and maintenance
R-HSA-3238698,R-HSA-195721,R-HSA-162582,WNT ligand biogenesis and trafficking,Signaling by WNT,Signal Transduction
R-HSA-201688,R-HSA-195721,R-HSA-162582,WNT mediated activation of DVL,Signaling by WNT,Signal Transduction
R-HSA-9673324,R-HSA-5663205,R-HSA-1643685,WNT5:FZD7-mediated leishmania damping,Infectious disease,Disease
R-HSA-5140745,R-HSA-195721,R-HSA-162582,"WNT5A-dependent internalization of FZD2, FZD5 and ROR2",Signaling by WNT,Signal Transduction
R-HSA-5099900,R-HSA-195721,R-HSA-162582,WNT5A-dependent internalization of FZD4,Signaling by WNT,Signal Transduction
R-HSA-8848584,R-HSA-556833,R-HSA-1430728,Wax and plasmalogen biosynthesis,Metabolism of lipids,Metabolism
R-HSA-9640463,R-HSA-556833,R-HSA-1430728,Wax biosynthesis,Metabolism of lipids,Metabolism
R-HSA-5545619,R-HSA-5663202,R-HSA-1643685,XAV939 stabilizes AXIN,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-381038,R-HSA-2262752,R-HSA-8953897,XBP1(S) activates chaperone genes,Cellular responses to stress,Cellular responses to stimuli
R-HSA-211981,R-HSA-211859,R-HSA-1430728,Xenobiotics,Biological oxidations,Metabolism
R-HSA-2032785,R-HSA-73857,R-HSA-74160,YAP1- and WWTR1 (TAZ)-stimulated gene expression,RNA Polymerase II Transcription,Gene expression (Transcription)
R-HSA-1606322,R-HSA-168249,R-HSA-168256,ZBP1(DAI) mediated induction of type I IFNs,Innate Immune System,Immune System
R-HSA-435368,R-HSA-425407,R-HSA-382551,Zinc efflux and compartmentalization by the SLC30 family,SLC-mediated transmembrane transport,Transport of small molecules
R-HSA-442380,R-HSA-425407,R-HSA-382551,Zinc influx into cells by the SLC39 gene family,SLC-mediated transmembrane transport,Transport of small molecules
R-HSA-435354,R-HSA-425407,R-HSA-382551,Zinc transporters,SLC-mediated transmembrane transport,Transport of small molecules
R-HSA-450302,R-HSA-168249,R-HSA-168256,activated TAK1 mediates p38 MAPK activation,Innate Immune System,Immune System
R-HSA-450302,R-HSA-168249,R-HSA-168256,activated TAK1 mediates p38 MAPK activation,Innate Immune System,Immune System
R-HSA-450302,R-HSA-168249,R-HSA-168256,activated TAK1 mediates p38 MAPK activation,Innate Immune System,Immune System
R-HSA-450302,R-HSA-168249,R-HSA-168256,activated TAK1 mediates p38 MAPK activation,Innate Immune System,Immune System
R-HSA-450302,R-HSA-1280215,R-HSA-168256,activated TAK1 mediates p38 MAPK activation,Cytokine Signaling in Immune system,Immune System
R-HSA-450302,R-HSA-168249,R-HSA-168256,activated TAK1 mediates p38 MAPK activation,Innate Immune System,Immune System
R-HSA-450302,R-HSA-168249,R-HSA-168256,activated TAK1 mediates p38 MAPK activation,Innate Immune System,Immune System
R-HSA-450302,R-HSA-168249,R-HSA-168256,activated TAK1 mediates p38 MAPK activation,Innate Immune System,Immune System
R-HSA-450302,R-HSA-168249,R-HSA-168256,activated TAK1 mediates p38 MAPK activation,Innate Immune System,Immune System
R-HSA-450302,R-HSA-168249,R-HSA-168256,activated TAK1 mediates p38 MAPK activation,Innate Immune System,Immune System
R-HSA-9717316,R-HSA-5663202,R-HSA-1643685,alectinib resistant ALK mutants,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-2046104,R-HSA-556833,R-HSA-1430728,alpha-linolenic (omega3) and linoleic (omega6) acid metabolism,Metabolism of lipids,Metabolism
R-HSA-2046106,R-HSA-556833,R-HSA-1430728,alpha-linolenic acid (ALA) metabolism,Metabolism of lipids,Metabolism
R-HSA-1307965,R-HSA-9006934,R-HSA-162582,betaKlotho-mediated ligand binding,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-9717319,R-HSA-5663202,R-HSA-1643685,brigatinib-resistant ALK mutants,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-418457,R-HSA-418346,R-HSA-109582,cGMP effects,Platelet homeostasis,Hemostasis
R-HSA-192869,R-HSA-5663205,R-HSA-1643685,cRNA Synthesis,Infectious disease,Disease
R-HSA-9717323,R-HSA-5663202,R-HSA-1643685,ceritinib-resistant ALK mutants,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-9702581,R-HSA-5663202,R-HSA-1643685,crenolanib-resistant FLT3 mutants,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-9717326,R-HSA-5663202,R-HSA-1643685,crizotinib-resistant ALK mutants,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-203615,R-HSA-202131,R-HSA-1430728,eNOS activation,Metabolism of nitric oxide: NOS3 activation and regulation,Metabolism
R-HSA-9702590,R-HSA-5663202,R-HSA-1643685,gilteritinib-resistant FLT3 mutants,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-9702596,R-HSA-5663202,R-HSA-1643685,lestaurtinib-resistant FLT3 mutants,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-9702998,R-HSA-5663202,R-HSA-1643685,linifanib-resistant FLT3 mutants,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-9717329,R-HSA-5663202,R-HSA-1643685,lorlatinib-resistant ALK mutants,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-72187,R-HSA-72203,R-HSA-8953854,mRNA 3'-end processing,Processing of Capped Intron-Containing Pre-mRNA,Metabolism of RNA
R-HSA-72086,R-HSA-72086,R-HSA-8953854,mRNA Capping,mRNA Capping,Metabolism of RNA
R-HSA-75072,R-HSA-75072,R-HSA-8953854,mRNA Editing,mRNA Editing,Metabolism of RNA
R-HSA-75064,R-HSA-75072,R-HSA-8953854,mRNA Editing: A to I Conversion,mRNA Editing,Metabolism of RNA
R-HSA-72200,R-HSA-75072,R-HSA-8953854,mRNA Editing: C to U Conversion,mRNA Editing,Metabolism of RNA
R-HSA-72172,R-HSA-72203,R-HSA-8953854,mRNA Splicing,Processing of Capped Intron-Containing Pre-mRNA,Metabolism of RNA
R-HSA-72163,R-HSA-72203,R-HSA-8953854,mRNA Splicing - Major Pathway,Processing of Capped Intron-Containing Pre-mRNA,Metabolism of RNA
R-HSA-72165,R-HSA-72203,R-HSA-8953854,mRNA Splicing - Minor Pathway,Processing of Capped Intron-Containing Pre-mRNA,Metabolism of RNA
R-HSA-429958,R-HSA-429914,R-HSA-8953854,mRNA decay by 3' to 5' exoribonuclease,Deadenylation-dependent mRNA decay,Metabolism of RNA
R-HSA-430039,R-HSA-429914,R-HSA-8953854,mRNA decay by 5' to 3' exoribonuclease,Deadenylation-dependent mRNA decay,Metabolism of RNA
R-HSA-166208,R-HSA-165159,R-HSA-162582,mTORC1-mediated signalling,MTOR signalling,Signal Transduction
R-HSA-9702600,R-HSA-5663202,R-HSA-1643685,midostaurin-resistant FLT3 mutants,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-77286,R-HSA-556833,R-HSA-1430728,mitochondrial fatty acid beta-oxidation of saturated fatty acids,Metabolism of lipids,Metabolism
R-HSA-77288,R-HSA-556833,R-HSA-1430728,mitochondrial fatty acid beta-oxidation of unsaturated fatty acids,Metabolism of lipids,Metabolism
R-HSA-372708,R-HSA-354192,R-HSA-162582,p130Cas linkage to MAPK signaling for integrins,Integrin signaling,Signal Transduction
R-HSA-372708,R-HSA-76002,R-HSA-109582,p130Cas linkage to MAPK signaling for integrins,"Platelet activation, signaling and aggregation",Hemostasis
R-HSA-171007,R-HSA-9006934,R-HSA-162582,p38MAPK events,Signaling by Receptor Tyrosine Kinases,Signal Transduction
R-HSA-69563,R-HSA-69620,R-HSA-1640170,p53-Dependent G1 DNA Damage Response,Cell Cycle Checkpoints,Cell Cycle
R-HSA-69580,R-HSA-69620,R-HSA-1640170,p53-Dependent G1/S DNA damage checkpoint,Cell Cycle Checkpoints,Cell Cycle
R-HSA-69610,R-HSA-69620,R-HSA-1640170,p53-Independent DNA Damage Response,Cell Cycle Checkpoints,Cell Cycle
R-HSA-69613,R-HSA-69620,R-HSA-1640170,p53-Independent G1/S DNA damage checkpoint,Cell Cycle Checkpoints,Cell Cycle
R-HSA-193704,R-HSA-73887,R-HSA-162582,p75 NTR receptor-mediated signalling,Death Receptor Signalling,Signal Transduction
R-HSA-193670,R-HSA-73887,R-HSA-162582,p75NTR negatively regulates cell cycle via SC1,Death Receptor Signalling,Signal Transduction
R-HSA-209543,R-HSA-73887,R-HSA-162582,p75NTR recruits signalling complexes,Death Receptor Signalling,Signal Transduction
R-HSA-193697,R-HSA-73887,R-HSA-162582,p75NTR regulates axonogenesis,Death Receptor Signalling,Signal Transduction
R-HSA-193639,R-HSA-73887,R-HSA-162582,p75NTR signals via NF-kB,Death Receptor Signalling,Signal Transduction
R-HSA-9702605,R-HSA-5663202,R-HSA-1643685,pexidartinib-resistant FLT3 mutants,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-111995,R-HSA-372790,R-HSA-162582,phospho-PLA2 pathway,Signaling by GPCR,Signal Transduction
R-HSA-9702614,R-HSA-5663202,R-HSA-1643685,ponatinib-resistant FLT3 mutants,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-9702620,R-HSA-5663202,R-HSA-1643685,quizartinib-resistant FLT3 mutants,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-6793080,R-HSA-72312,R-HSA-8953854,rRNA modification in the mitochondrion,rRNA processing,Metabolism of RNA
R-HSA-6790901,R-HSA-72312,R-HSA-8953854,rRNA modification in the nucleus and cytosol,rRNA processing,Metabolism of RNA
R-HSA-72312,R-HSA-72312,R-HSA-8953854,rRNA processing,rRNA processing,Metabolism of RNA
R-HSA-8868766,R-HSA-72312,R-HSA-8953854,rRNA processing in the mitochondrion,rRNA processing,Metabolism of RNA
R-HSA-8868773,R-HSA-72312,R-HSA-8953854,rRNA processing in the nucleus and cytosol,rRNA processing,Metabolism of RNA
R-HSA-9702577,R-HSA-5663202,R-HSA-1643685,semaxanib-resistant FLT3 mutants,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-191859,R-HSA-194441,R-HSA-8953854,snRNP Assembly,Metabolism of non-coding RNA,Metabolism of RNA
R-HSA-9702624,R-HSA-5663202,R-HSA-1643685,sorafenib-resistant FLT3 mutants,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-9702632,R-HSA-5663202,R-HSA-1643685,sunitinib-resistant FLT3 mutants,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-2033515,R-HSA-5663202,R-HSA-1643685,t(4;14) translocations of FGFR3,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-379724,R-HSA-72766,R-HSA-392499,tRNA Aminoacylation,Translation,Metabolism of proteins
R-HSA-6787450,R-HSA-72306,R-HSA-8953854,tRNA modification in the mitochondrion,tRNA processing,Metabolism of RNA
R-HSA-6782315,R-HSA-72306,R-HSA-8953854,tRNA modification in the nucleus and cytosol,tRNA processing,Metabolism of RNA
R-HSA-72306,R-HSA-72306,R-HSA-8953854,tRNA processing,tRNA processing,Metabolism of RNA
R-HSA-6785470,R-HSA-72306,R-HSA-8953854,tRNA processing in the mitochondrion,tRNA processing,Metabolism of RNA
R-HSA-6784531,R-HSA-72306,R-HSA-8953854,tRNA processing in the nucleus,tRNA processing,Metabolism of RNA
R-HSA-9708296,R-HSA-211000,R-HSA-74160,"tRNA-derived small RNA (tsRNA or tRNA-related fragment, tRF) biogenesis",Gene Silencing by RNA,Gene expression (Transcription)
R-HSA-9703009,R-HSA-5663202,R-HSA-1643685,tamatinib-resistant FLT3 mutants,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-9702636,R-HSA-5663202,R-HSA-1643685,tandutinib-resistant FLT3 mutants,Diseases of signal transduction by growth factor receptors and second messengers,Disease
R-HSA-199992,R-HSA-199991,R-HSA-5653656,trans-Golgi Network Vesicle Budding,Membrane Trafficking,Vesicle-mediated transport
R-HSA-192814,R-HSA-5663205,R-HSA-1643685,vRNA Synthesis,Infectious disease,Disease
R-HSA-192905,R-HSA-5663205,R-HSA-1643685,vRNP Assembly,Infectious disease,Disease
